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Summary
This thesis combines the quantification of a new arterial spin labelling (ASL) se-
quence, and the development of a diffusion weighted ASL (DWASL) sequence, to
examine blood brain barrier (BBB) impairment. The blood brain barrier (BBB) main-
tains the delicate neuroenvironment in the brain by controlling influx and efflux of
cells and molecules. Many neurological disorders are effected by an impairment
of the BBB. Current magnetic resonance imaging (MRI) methods to image BBB dys-
function involve the use of a contrast agent, which is invasive and not sensitive to
subtle changes in BBB permeability. Non-invasive MR methods such as ASL, are able
to measure perfusion and produce cerebral blood flow (CBF) maps of the brain. ASL
however has an inherently low signal and therefore development of high signal-to-
noise ratio (SNR) sequences are needed. Multiple boli ASL (mbASL) is a high SNR
sequence that would be suitable for producing CBF maps but lacks quantification.
Human African trypanosomiasis (HAT), a parasitic disease native to Africa, results
in a progressive diffuse impairment of the BBB throughout the disease course. A
murine model of HAT was used to examine water exchange and cerebral blood flow
changes with DWASL.
Chapter 1 outlines the current literature on the blood brain barrier, HAT and
splenomegaly. Chapter 2 introduces the theory of MRI, which is the imaging method
used throughout the thesis. Chapter 3 provides a literature review of the ASL se-
quence and subsequent development of diffusion weighted ASL. The review out-
lines the main ASL sequences and introduces multiple boli ASL, followed by diffu-
sion weighted ASL. These two sequences are used throughout this thesis.
Chapter 4, the first results chapter, experimentally validates the quantification of
the mbASL sequence. Chapter 5 outlines the development of diffusion weighted
mbASL which could potentially image changes in water exchange across the BBB.
Chapter 6 and Chapter 7 use the HAT mouse model first to examine changes in the
water exchange in the brain and then to serially image changes in spleen volume.
Multiple Boli ASL
Arterial spin labelling (ASL) is an MR technique that can be used to measure per-
fusion in the brain, where the sequence is inherently low in SNR due to the sub-
traction of labelled and non labelled images to examine blood flow. A new ASL
sequence, multiple boli ASL, was developed as a high SNR alternative to the cur-
ii
rent ASL sequences. However, the sequence lacked quantification with no current
kinetic model able to describe mbASL as it uses a train of adiabatic pulses to label
the arterial blood. The first thesis hypothesis is thus:
• Modification of the Buxton kinetic model will accurately describe the multiple
boli ASL signal and produce cerebral blood flow values that agree with current
literature.
To test this hypothesis, the mbASL sequence was successfully quantified and exper-
imentally validated in rodents. The number of labelling pulses needed to obtain
pseudo-continuous labelling was optimised and the distribution of signal at dif-
ferent delay times was fitted to the new mbASL kinetic model. High SNR mbASL
images were produced with cerebral blood flow values agreeing with the literature.
Diffusion Weighted ASL
A current non-invasive method to image water exchange in the brain is diffusion
weighted ASL. This sequence uses a diffusion gradient pair to separate the intravas-
cular (IV) or extravascular (EV) signal from labelled water. It was hypothesised
that:
• By adding diffusion gradients to the mbASL sequence, a diffusion weighted
mbASL will be sensitive to changes in water exchange.
To test this theory, the diffusion weighted mbASL sequence was developed to use a
new interleaving data collection and perform multiple b-values in the same scan.
By increasing the delay time between labelling and imaging, a significant differ-
ence in signal was seen, showing the sequence was sensitive to changes in water
exchange in the brain. The sequence produced similar results to studies in the
literature using DWASL in humans.
Application of DWASL to HAT
Human African trypanosomiasis is a parasitic disease that affects sub Sahara Africa.
A murine model of HAT, developed at the University of Glasgow, exhibits a diffuse
BBB impairment that progressively worsens over the course of infection. Research
iii
into the BBB impairment in HAT has been performed using contrast enhanced MRI,
with no research using a non-invasive method. It was therefore proposed that:
• DWASL would be able to image changes in the permeability of the blood brain
barrier in HAT infected mice that have not been detected using conventional
contrast enhanced MR.
Exploration of this hypothesis showed no significant difference in the pseudo-
permeability of the BBB between the uninfected and infected time points. Data
from the late stage of the infection suggested a drop in the rate of water exchange.
A further study monitoring the weight of the wet and dry brain to examine the wa-
ter content in infected and non-infected mice saw a significant decrease in the
water content of infected brains. Overall the study demonstrated the expected
increase in water exchange did not occur, and instead suggested that the sequence
is either not yet sensitive enough to detect the small changes in water exchange in
the HAT infected brain or there are not large changes in water transfer as expected.
Serial Imaging of Splenomegaly
Splenomegaly is an enlargement of the spleen and a known symptom of HAT,
which is observed in rodents, cattle and humans. Although the extent of the
splenomegaly has been measured invasively by examining the organ post-mortem,
the change in splenomegaly has not been measured serially. Therefore the follow-
ing two questions were investigated:
• Is MRI able to image splenomegaly serially in a murine model of HAT and
correlate with clinical and histological parameters?
• Do the procedures associated with serial MR scanning and blood sampling
induce changes in the spleen of healthy mice?
Two experiments were conducted: to measure splenomegaly serially throughout
five infection time points and to assess the effects of serial MR imaging and sam-
pling on the spleen. Significant changes were seen in the spleen of infected mice
compared to pre-infection in MR images. No changes were seen in the healthy
mice. Haematological analysis demonstrated that the infected mice developed
anaemia as the study progressed, where the healthy mice showed no haematolog-
ical changes compared to the published normal range values.
iv
“If you walk the footsteps of a stranger
You’ll learn things you never knew, you never knew”
Alan Merkin
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Chapter 1
The Blood Brain Barrier, Human
African Trypanosomiasis and the
Spleen
This chapter discusses the blood brain barrier (BBB) along with the current imaging
methods and their limitations. A biological model for disruption of the BBB is hu-
man African trypanosomiasis (HAT). This disease is described along with the current
research findings from investigation using MRI. The chapter closes by exploring the
current literature surrounding the development of splenomegaly, a common clini-
cal manifestation associated with trypanosome infection.
1.1 The Blood Brain Barrier and CNS
1.1.1 The Central Nervous System
The central nervous system (CNS) is comprised of the brain and spinal cord. The
brain can be split into the brain stem, which is the continuation of the spinal cord
and the cerebellum, and the cerebrum (Brodal 2010). The spinal cord contains
grey and white matter. The grey matter contains motor neurons and sensory neu-
rons, with the white matter containing ascending tracks which carry signals and
descending tracks that let the brain control the spinal cord neurons. The cerebrum
consists of two central hemispheres that are divided by the longitudinal cerebral
fissure (Brodal 2010). The cerebrum includes the cerebral cortex (composed of a
folded sheet of grey matter), hippocampus and basal ganglia. The brain contains
interstitial fluid, which surrounds the neurons and glia. The ventricles and exter-
nal surfaces of the brain contain cerebral spinal fluid (CSF), which is produced in
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the ventricles by the choroid plexus (Segal 2000).
1.1.2 History of the Blood Brain Barrier
In the late 1800s, Paul Ehrlich experimentally showed that intravenously injected
dye stains the tissue and organs of animals with the exception of the brain and
spinal cord (Ehrlich 1900). Ehrlich attributed this lack of uptake to a low affin-
ity of the nervous tissue to the dye. The concept of a barrier was first hypoth-
esised by Max Lewandowsky in 1900 (Lewandowsky 1900). Lewandowsky intra-
venously injected sodium ferrocyanide and found no pharmacological effects on
the nervous system, but symptoms appeared however, after direct injection of
the sodium ferrocyanide into the brain. Following these experiments, the term
‘blut hirn schranke’ or ‘blood brain barrier’ was first coined by Lewandowsky. One
of Ehrlich’s students, Edwin Goldmann, further demonstrated the concept of this
‘brain barrier’ by using the dye trypan blue. When directly injecting the trypan
blue in to the cerebral spinal fluid (CSF) of a dog, he found the brain was stained
but the body of the animal was not. When he preformed the opposite experiment,
by intravenously injecting the dye into the body of the animal, he found the body
stained but not the brain (Goldmann 1909; Goldmann 1913). These experiments
showed a clear division between the peripheral and cerebral compartments con-
firming the ‘barrier’ hypothesis.
Lina Stern, a Russian scientist, performed many experiments on the CNS by inject-
ing different agents and dyes into the blood, cerebral ventricles and subarachnoid
space in the 1920s. Stern’s experiments showed amongst other observations, that
all substances from the brain will eventually reach the blood, but not all substances
in the blood will reach the brain, and that the subarachnoid space is connected
to the cerebral ventricles (Vein 2008). Stern concluded that a barrier must exist
to protect the CNS and called it the hematoencephalic barrier (Stern 1922; Stern
1921). Stern further found that certain treatments administered via the blood-
stream did not cross into the CNS, most notably the injection of an anti-tetanus
medication did not treat the tetanus once it was established in the CNS, unless
injected directly into the brain (Vein 2008).
The fundamental features of the BBB were established by Reese and Karnovsky in
1967, by intravenous injection of horseradish peroxidase to mice and examination
of the cerebral cortex using electron microscopy. The main findings showed that
the peroxidase was not present beyond the vascular endothelium, but was seen in
the lumina of the blood vessels, with low numbers of vesicles which did not appear
to transport the peroxidase (Reese et al. 1967). Reese and colleagues believed that
the tight junctions between the endothelial cells were responsible for preventing
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the peroxidase from leaving the vessels and concluded that a barrier was present
at the ultra-structural level. This study demonstrated that the brain endothelium
was less permeable to peroxidase than of the heart or skeletal muscle, where per-
oxidase has been shown to penetrate through the endothelial cell layer, suggesting
a difference in ‘tightness’ of the junctions present between the endothelial cells
(Reese et al. 1967).
1.1.3 Blood Brain Barrier
The blood brain barrier is one of three barriers that exist in the central nervous
system, along with the blood-CSF barrier and the arachnoid barrier (Figure 1.2).
The primary function of the BBB is to regulate the exchanges between the blood
and brain. It is a semi-permeable diffusion barrier, consisting of endothelial cells
with tight junctions (TJs) formed between them. These junctions, formed from
the membrane proteins claudin, occludin and junction adhesion molecules, plus
cytoplasmic accessory proteins, regulate and restrict the movement of molecules
in and out of the brain (Ballabh et al. 2004). The endothelial cells joined by tight
junctions, line the capillary walls and are crucial in the prevention of toxic sub-
stances entering the brain. The endothelial cells can act as mediators between the
blood and brain, whilst regulating the transport and metabolism of substances go-
ing between the blood and brain (Cardoso et al. 2010). The basement membrane,
which separates the perivascular space from the brain parenchyma, surrounds the
endothelial cells with pericytes embedded within the membrane. Pericytes, also
known as vascular smooth muscle cells, help regulate microcirculatory blood flow
and provide structural support to help maintain the integrity of the tight junctions
(Gursoy-Ozdemir et al. 2017). Astrocytes are a type of glial cell, which provide
support for the endothelial cells (Persidsky et al. 2006) and are important in the
function of neurons. Astrocyte end-feet surround most of the brain capillary and
interact with the basement membrane. The endothelial cells, tight junctions,
basement membrane, pericytes, astrocytes, neurons and microglia cells together
form the neurovascular unit (NVU) (Figure 1.1) that are essential for maintaining
the health and function of the CNS (Cardoso et al. 2010).
1.1.3.1 Transport Across the BBB
There are multiple pathways that can be used to access the brain. Passive dif-
fusion across the BBB occurs either through (transcellular transport) or between
the vascular endothelial cells (paracellular transport) (Cardoso et al. 2010). Small
lipophilic molecules such as carbon dioxide and oxygen can cross into the brain
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Capillary
Tight Junction
Astrocyte
Pericyte
Endothelial Cell
Microglia
Figure 1.1: Components of the blood brain barrier
The blood brain barrier consists of endothelial cells joined by tight junctions. Along with astrocytes, pericytes, neurons
and microglia, they make up the neurovascular units, crucial for maintaining homeostasis in the brain. The figure design is
based on (Abbott, Ronnback, et al. 2006).
by transcellular diffusion. For paracellular transport, ions and solutes can diffuse
between the cells, depending on their concentration gradient. Polar molecules,
such as glucose and amino acids, cannot cross into the brain by diffusion pathways.
These molecules are transported by solute carriers (SLCs) which are based in the
lipid bilayer of the endothelial cell membrane at both the luminal and abluminal
surfaces. This control helps to preserve the polarity of the barrier by limiting the
free movement of the molecules from one side of the endothelium to the other
(Abbott, Patabendige, et al. 2010). ATP-binding cassette (ABC) transporters are ef-
flux pumps that consume ATP and transport lipophilic compounds out of the brain
(Lalatsa et al. 2018) and function to protect the brain from toxic molecules. How-
ever, this also acts as a barrier to potential drug treatments, preventing many
chemotherapeutic agents from entering the CNS.
1.1.3.2 Water Transport Across the BBB
Although water molecules can cross the BBB by crossing the cell plasma membrane
directly (Papadopoulos et al. 2013), the primary water channel in the brain, formed
by the protein aquaporin-4 (AQP4), plays a major part in water transportation
in the brain. AQP4 is found in the astrocytes and the choroid plexus epithelial
cells, suggesting that AQP4 facilitates the flow of water in and out of the brain.
As water is a small molecule, it can diffuse through the endothelial cells of the
BBB, with Papadopoulos’ review on AQP4 showing that multiple studies support the
idea that AQP4 plays a major part in determining the permeability of the BBB to
water (Papadopoulos et al. 2013). Badaut et al. demonstrated that animals with a
silenced AQP4 expression had a decreased water mobility measure of the apparent
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diffusion coefficient (ADC) of the brain. Furthermore, Eugen et al. showed a
seven fold-reduced osmotic water permeability in astrocytes that were taken from
AQP4-deficient mice. Haj-Yasein demonstrated a reduction in brain water uptake
in AQP4 knockout mice. Overall, there is a plethora of evidence supporting a role
of AQP4 in the passage of water in and out of the brain.
1.1.4 The Blood-CSF barrier
The choroid plexus, found in the lateral, third and fourth ventricles, is responsi-
ble for the production of CSF (Abbott 2004). The capillaries in the stroma of the
choroid plexus are fenestrated, allowing the movement of small molecules across
the endothelial cells to enter the stroma of the choroid plexus. The blood-CSF
barrier is formed by the choroid plexus epithelial cells which are joined by tight
junctions and prevent molecules from entering the ventricular CSF (Figure 1.2).
The choroid plexus is the main producer of CSF, with the CSF passing through the
ventricles to circulate in the cerebral and spinal subarachnoid spaces. The blood
CSF barrier lacks several of the cellular components comprising the BBB and is
considered to be “leakier” than the more abundant BBB.
1.1.5 The Arachnoid Barrier
The CNS is surrounded by connective tissue known as the meninges. The meninges
is comprised of three membrane layers: the pia mater, the arachnoid mater, and
the dura mater. The dura mater forms the outermost layer and is attached to the
arachnoid mater (Brodal 2010). It is comprised of dense fibrous tissue (Papadopou-
los et al. 2013). The subarachnoid space is formed between the arachnoid barrier
and the underlying pia and contains CSF. The arachnoid mater is composed of
multiple layers, with the innermost layer cells joined together by tight junctions,
which limits entry of molecules into the subarachnoid CSF (Haines 2018).
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1.2 Permeability
If a porous material allows a fluid to pass through it, it can be described as perme-
able. The permeability of a porous material is therefore a measure of how perme-
able the substance is, and is measured in m2 or the darcy (1 darcy ≈ 10−12m2). The
permeability of a porous material can be described by Darcy’s law, which relates
the flow rate and properties of the fluid to the pressure gradient applied across
the material:
v = K
η
DP
Dx (1.1)
where v is the flow velocity of the fluid, K is the permeability of the material, η is
the dynamic viscosity, DP is the applied pressure difference and Dx is thickness of
the material (Ichikawa et al. 2012).
The blood brain barrier (BBB) can be considered a porous material due to the tight
junctions between the endothelial cells. The exchange of molecules between the
capillary and the tissue is limited by the size of the tight junctions and the different
mechanisms in place to maintain homeostasis in the brain. An estimation of the
permeability of the BBB can be described by:
Kw =
PS
Vc
(1.2)
where Kw is the water exchange rate constant (min−1), PS is the permeability
surface area product of water (ml/100g/min) and Vc is the capillary distribution
volume of water (ml/100g). Kw describes the exchange of water across the BBB
and is used as an estimate of the permeability of the barrier.
1.2.1 Permeability and Disruption of the Blood Brain Barrier
The permeability of the blood brain barrier is controlled by multiple factors, in-
cluding endothelial cells, astrocytes, pericytes and microglia cells. Astrocytes and
microglia are involved in maintaining and protecting the BBB but can amplify in-
flammation and cellular damage when there is disruption of the BBB. Structural
changes that affect the barrier can be endothelial cell damage during inflamma-
tion, breakdown of glia limitans and changes to the astrocytic end-feet (Varatharaj
et al. 2017). The tight junctions are essential for the overall integrity of the BBB
(Almutairi et al. 2016). Changes in the structure of the tight junctions or altered
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protein expression can result in dysfunction.
The disruption of the BBB can cause serious issues in many disorders and diseases.
In brain tumours, there is increased vascular permeability due to a poorly devel-
oped BBB, with a loss of tight junction integrity (Deeken et al. 2007). Cerebral
oedema is also associated with tumours. Neuroinflammation is seen in diseases
such as Alzheimer’s disease and multiple sclerosis, with migration of leukocytes
into the brain (Zenaro et al. 2017). This migration can cause signal changes which
lead to the loss of tight junction molecules such as occludin. In ischaemic stroke,
there is a disruption of the tight junctions, which leads to an increased permeabil-
ity of the BBB and contributes towards cerebral oedema (Sandoval et al. 2008).
1.3 Current Methods for Probing Blood Brain Barrier
Disruption
1.3.1 Contrast Agents
Current methods of imaging blood brain barrier disruption using MRI include the in-
travenous injection of an exogenous paramagnetic contrast agent (CA). The most
commonly used contrast agents are gadolinium (Gd) based, where the gadolinium
ion is chelated to a molecule, to reduce toxicity. An example of a contrast agent
is gadolinium- diethylenetriamine pentaacetic acid (Gd-DPTA) (Carr et al. 1984).
Gadolinium is paramagnetic due to having seven unpaired electrons in its 4f outer
shell and is one of only four elements that can become magnetic at room tempera-
ture; iron, nickel and cobalt being the other three. This makes Gadolinium useful
as an MRI contrast agent as it shortens the T1 relaxation of the surrounding tissue,
which is observed in a T1 weighted image as bright signal. T2 shortening is also
seen where there is high concentration of the CA but the dominant effect will be
seen for T1. Contrast agents are unable to cross the blood brain barrier when it is
intact due to their molecular weight and charge (Tofts 2003).
1.3.2 Dynamic Contrast Enhanced MRI
Quantitative measurements of blood brain barrier permeability can be performed
using dynamic contrast enhanced MRI (DCE-MRI). The basic principle of DCE-MRI
is to take an image without contrast enhancement followed by a series of images
taken after the contrast agent has been administered as a bolus. By fitting the sig-
nal from each of the images taken to a tracer pharmacokinetic model, a value of
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Ktrans or permeability can be found. Ktrans describes the transfer rate of molecules
into the interstitial space from the plasma space (Barnes et al. 2016). To quantita-
tively measure Ktrans, there are multiple kinetic models that have been developed
to fit DCE-MRI data. Early versions of kinetic models for DCE-MRI were based on
Toft’s works in the early 1990s (Tofts 1997). They were able to measure Ktrans,
interstitial volume ve, and cerebral blood volume (CBV). These models were not
able to measure CBF due to low temporal resolution. More developed models us-
ing higher quality data from improved hardware and imaging sequences, are able
to measure CBF along with the permeability-surface area product (PS) (Sourbron
et al. 2013). Simpler methods that are semi-quantitative can be used to measure
the area under a signal enhancement curve. A qualitative method for looking at
changes in BBB integrity is by taking one image before the CA has been injected and
one after, known as contrast enhanced MRI (CE-MRI). If the barrier is compromised,
the CA will be able to cross into the brain tissue and the resulting subtracted image
will have brighter regions where the CA resides.
1.4 Limitations to Using DCE-MRI for Probing BBB
Changes
DCE-MRI has become the clinical standard in MRI for imaging permeability in the
brain, however there are limitations to the method. DCE-MRI is able to show sig-
nal enhancement where there are large changes in BBB integrity. However, where
there are small subtle changes in the BBB, the technique lacks sensitivity, failing
to show changes in conditions such as dementia, acute stroke and glioma invasion
(Armitage et al. 2011; Brix et al. 1991; Raja et al. 2018). This is due to the low
concentration and weak relaxivity of contrast agents, which limits their ability to
increase the relaxation rate of the tissue around them (Werner et al. 2008). This
means there is a sensitivity threshold below which no changes will be detected,
even if the BBB has been compromised. A study by Dickie et al. showed changes in
BBB integrity in an Alzheimer’s rat model using a water exchange technique. These
changes were not detected using a contrast agent (Dickie et al. 2019), demonstrat-
ing the lack of sensitivity for current contrast agents.
Although the use of contrast agents has been approved in humans since the late
1980s (Lohrke et al. 2016), there have been reports of Gadolinium deposition de-
tected in multiple tissues in the body (Grobner 2006; Kanda et al. 2014; McDonald
et al. 2017). This questions the continued use of exogenous contrast agents. Fur-
thermore, contrast agents are unsuitable for patients suffering from kidney dis-
ease, with reports of continued use of CAs causing nephrogenic systemic fibrosis
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(NSF) in patients (Grobner 2006). The combination of low sensitivity to subtle
changes in the BBB and questions over the continued use of contrast agents wel-
comes the introduction of non-invasive methods to image the BBB without the use
of an exogenous contrast agent.
1.4.1 Using DWASL to Measure Kw
Multiple studies using DWASL have produced measurements of Kw in the brain. For
example, a decrease in the value of Kw was seen in an ischaemic stroke model
(Tiwari et al. 2017). In addition, a decrease in the exchange rate for patients with
sleep apnea has been seen, where it was suggested the decrease comes from an
increased permeability of the BBB to water (Palomares et al. 2015).
The exchange rate can be measured using various methods and models. A com-
monly used model is the single pass approximation (SPA) model (Section 3.3.2)
which was used to determine the water exchange rate (St Lawrence, Owen, et al.
2012). DWASL was used to measure Kw, although St Lawrence suggested that the ar-
terial transit time (ATT) and the signal from arterial blood could affect the results.
Measuring Kw was also difficult due to the inherently low SNR from ASL sequences,
and the lower SNR seen from the diffusion weighting of DWASL (St Lawrence, Owen,
et al. 2012). To avoid the complexity of fitting to the SPA model, a simplified
method was to measure the ratio of signal between a diffusion weighted ASL im-
age and a non diffusion weighted image. This approximated the exchange of la-
belled signal between the capillaries and tissue (Wang, Fernandez-Seara, et al.
2007). Although this was not a quantitative measure of permeability, it gave a
pseudo-permeability value that could estimate changes in the water exchange.
1.5 Human African Trypanosomiasis
Human African trypanosomiasis (HAT), more commonly known as sleeping sickness,
is a parasitic disease that is endemic in Sub-Saharan Africa. Trypanosomes are
single-celled protozoan organisms which belong to the genus Trypanosoma. These
parasites are transmitted to humans via the bite of its vector, the tsetse fly (WHO
2013). Trypanosoma brucei is a species of Trypanosoma (Figure 1.3) comprising
three subspecies. Two of these subspecies can infect humans; T. b. rhodesiense,
found in East and Southern Africa and T. b. gambiense, which is mainly found in
West Africa (WHO 2013). The third subspecies T. b. brucei is able to infect cattle
and other animals. For T. b. rhodesiense, the parasite can mainly be found in
10
antelope and cattle reservoirs, with some human involvement. In contrast, for T.
b. gambiense, the parasite reservoir is almost exclusively from humans.
Trypanosoma
Trypanozoon
T. (T.) brucei
T. (T.) b. brucei
T. (T.) b. rhodesiense
T. (T.) b. gambiense 
Genus
Subgenus
Species
Subspecies
Figure 1.3: A simplified classification scale of the genus Trypanosoma
Trypanosomes were found to be the cause of the cattle disease known as nagana in
1895 by the Scottish pathologist and microbiologist David Bruce (Bruce 1895) and
the parasite was known as Trypanosoma brucei. There had been reports of a sleep-
ing disease which affected humans, with no known cause at the time. The first
observation of trypanosomes in human blood was made by Robert Forde in 1901
in Gambia, and identified by Joseph Dutton in 1902 (Dutton et al. 1902). Dutton
suggested that the species be named Trypanosoma gambiense. In the same year,
Aldo Castellani found trypanosomes in the CSF of patients infected with sleep-
ing sickness and suggested that the trypanosomes were the cause of the disease
(Castellani 1903). Bruce confirmed this in 1903 and demonstrated that sleeping
sickness is transmitted by tsetse flies. The parasite was subsequently name Try-
panosoma brucei gambiense, after it was determined that Trypanosoma brucei and
Trypanosoma gambiense were the same species. The third subspecies T. b. rhode-
siense was discovered in 1910 by John Stephens and Harold Fantham (Stephens et
al. 1910).
1.5.1 Life Cycle of Trypanosoma brucei
The start of the life cycle of the trypanosome occurs when an infected tsetse
fly bites a susceptible animal or human (Vickerman 1985). Mature metacyclic
trypanosomes enter the mammalian blood stream and multiply by binary fission,
transforming into long slender trypomastigotes. The trypanosome surface is cov-
ered by a variable surface glycoprotein (VSG) coat, allowing constant antigenic
variation, meaning the trypanosomes can avoid the host’s immune response (Vick-
erman et al. 1988). The long slender forms are replaced by the short stumpy forms
which are then ingested by the tsetse fly when it feeds on its host. In the midgut,
the stumpy forms undergo multiple biochemical and anatomical changes, trans-
forming into the procyclic stage, with a loss of the VSG coat. This development is
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associated with a switch of the primary energy source from glucose to proline (Vick-
erman 1985). In the salivary glands, they transform in trypomastogites and acquire
a surface coat. Following this, they transform into the infective form metacyclic
(Vickerman et al. 1988). The mature metacylics are transferred to the mammalian
host by the feeding of the tsetse fly and the cycle begins again (Figure 1.4).
Figure 1.4: Trypanosome brucei development cycle
Figure adapted from (Matthews 2005). The life cycle of the trypanosome will start when trypanosomes are injected into a
mammalian host. After transforming into stumpy forms they are taken in a blood meal from the tsetse fly and ingested into
the midgut. After losing their glycoprotein coat and undergoing multiple transformations in the midgut and salivary glands,
the metacylics regain their coat and can infect the mammalian host when the tsetse fly feeds again.
In the mammalian host, the parasites initially reside in the blood and lymph nodes
from where they disseminate to many organs including the skin, spleen, liver, heart
and eyes. This is known as the haemolymphatic, or early-stage of the disease. The
late or encephalitic-stage occurs when the parasite crosses the BBB and enters into
the CNS (Kennedy 2008). During the late-stage, neuroinflammation develops with
infiltration of lymphocytes, macrophages and plasma cells into the brain, most
prominently in the white matter. Perivascular cuffing with inflammatory cells and
the activation of astrocytes is also a commonly reported characteristic of late-
stage sleeping sickness (Kennedy 2008), along with microglia activation later in
the neuroinflammatory response.
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1.5.2 HAT and the Blood Brain Barrier
Although the presence of trypanosomes within the brain has been recognised for
over a century, it remains unclear how the parasites gain access to the CNS. Studies
investigating BBB function have been performed using the injection of fluorescent
dye (Philip et al. 1994) to assess damage in a rat model of the disease. A loss
of barrier integrity was seen as the infection advanced to the later stage, with
fluorescence detected at day 21 post-infection in localised areas before becom-
ing more widespread. Crucially, there was no correlation between the areas of
the BBB damage and presence of parasites. In a study by Mulenga et al., the ef-
fect of trypanosomes on the tight junctions of the BBB was investigated (Mulenga
et al. 2001). Staining for the tight junction markers occludin and ZO-1, showed
no difference between the control and infected groups, suggesting that there is no
damage to the tight junctions during the infection. Small numbers of trypanosomes
were detected in the brain parenchyma from day 12 post-infection with the ma-
jority confined to the blood vessels. From day 40 post-infection on-wards, numer-
ous parasites were detected in the brain. No loss of occludin or leakage of IgG
into the parenchyma was seen, suggesting that a loss of tight junction integrity is
not needed for trypanosomes to invade the brain (Mulenga et al. 2001). There is
also suggestion that trypanosomes transmigrate through the vessels in the choroid
plexus and then cross the blood-CSF-barrier before entering the brain parenchyma
via the perivascular space (Schmidt 1983). However further work is required to
establish the invasion pathways unequivocally.
1.5.3 Symptoms, Diagnosis and Treatment of HAT
1.5.3.1 Symptoms of HAT
In the early stage of the disease, symptoms are usually non-specific and present a
few weeks after a tsetse fly bite. These include headaches, weight loss, fatigue
and fever. Misdiagnosis can happen at this stage as symptoms can overlap with
other illnesses. As the disease progresses, the symptoms become more serious
with the development of lymphadenopathy and enlargement of the spleen and
liver. Issues with cardiac and opthalmological functions are also seen (Kennedy
2013). Symptoms associated with the late stage of the disease include mental and
motor system disturbances and the presence of abnormal reflexes. The late stage
sleep disturbances are what gives HAT its alternate name ‘sleeping sickness’, due
to the high number of patients reporting problems such as a reversal of the sleep/
wake cycle, insomnia or uncontrolled sleep and changes to their sleep pattern
(Kristensson et al. 2010).
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The disease is currently determined as having progressed to the later stage when
there is a white blood cell count above 5/µL, or the detection of trypanosomes in
the cerebral spinal fluid (CSF) (WHO 2013). This is checked via lumbar puncture.
Accurate determination of the stage of the disease is crucial to direct the most ef-
fective chemotherapeutic strategy due to the toxicity of the regimens require for
treatment of late stage infections (Section 1.5.3.3). Typically, the clinical differ-
ences in symptoms of HAT are used to determine if the disease is in its early or late
stage. However many of these symptoms are present in both stages which can make
determining the disease stage difficult (WHO 2013). Eventually the symptoms will
manifest into a coma and eventual death if the infection remains untreated. This
can occur in a matter of weeks to months in cases of T. b. rhodiense or months to
years for T. b. gambiense.
1.5.3.2 Diagnosis of HAT
The typical method of diagnosing T. b. rhodesiense is to examine a wet blood
smear of peripheral blood to detect trypanosomes. This is problematic in T. b.
gambiense, where the very low parasitemia level is often below the threshold
for microscopic detection. Clinical signs can be misleading when determining the
stage of the disease and therefore are not used in diagnosis.
According to the World Health Organisation (WHO), the difference in the early and
late stage of HAT is determined by the level of parasite and white blood cell count in
the CSF (WHO 2013) described above. Since the concentration of immunoglobulin
(IgM) level in the CSF increases when there is parasite involvement in the CNS, this
can be examined for diagnostic purposes. However, this is impractical for stage
determination due to the lack of reagents and facilities in rural health centres
(Lejon et al. 2005).
1.5.3.3 Treatment of HAT
Current treatment of HAT depends on the form and stage of the disease. Drugs used
as early stage treatments cannot penetrate the BBB and late stage treatments are
toxic and require hospitalisation. For chemotherapy of early stage T. b. gambi-
ense, the drug pentamidine is used and for T. b. rhodesiense, the drug suramin.
One of the main issues with the use of these drugs is that they are unavailable as
an oral treatment and must be given parenterally as a course of intramuscular (IM)
or intravenous (IVen) injections respectively.
The only drug for treating late stage T. b. rhodesiense infections is melarsoprol.
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This requires hospitalisation for treatment as it must be administered as 10-daily
infusions given by a strictly intravenous route. Until recently, melarsoprol was
used to treat all cases of late-stage HAT, and although effective, the development
of post-treatment reactive encephalopathy (PTRE) occurs in 5-10 % of patients,
where half will die (Kennedy and Rodgers 2019). A new treatment for late stage T.
b. gambiense means that melarsoprol is no longer the first line treatment for this
variant of the disease. Since 2009 a combined regimen of oral nifurtimox and IVen
eflornithine has been the recommended treatment for late-stage T. b. gambiense
(Lejon et al. 2005). However this is not suitable for treatment of late-stage T. b.
rhodesiense infection which still replies on the use of melarsoprol.
1.5.4 Current Statistics
T. b. gambiense is the most prevalent of the two forms of HAT, accounting for
approximately 97% of all HAT cases (WHO 2013). There has been a steady decline
in cases in the last 10-20 years, with input from multiple areas including the WHO,
African governments, non-government organisations, research charities and the
pharmaceutical industry to curb the disease. Effective disease surveillance and
treatment to reduce disease transmission has caused case numbers to decrease
rapidly since the 1990s when the last epidemic was seen (WHO 2013). The disease
almost exclusively affects Africa, with the exception of a few traveller cases. The
number of reported cases of HAT was 2,164 in 2016, a decrease of 92 % compared
to 2000 when 26,550 were recorded (Franco et al. 2018). Preliminary figures from
the WHO suggest that less than 1500 cases of T. b. gambiense occurred in the
year 2017 but it is believed there is under reporting in the amount of cases for
both strains of the disease (Barrett, 2018). Almost 57 million people are at risk of
infection from T. b. gambiense with a lower 12.3 million people at risk from T. b.
rhodesiense (WHO 2013).
1.5.5 The Use of MRI in HAT
1.5.5.1 Clinical MRI
The literature regarding HAT and MRI is scarce. Studies are limited to case reports
from single patients who contracted HAT whilst in Africa with subsequent diag-
nosis once they have left Africa. An African patient living in Germany presented
symptoms that were initially diagnosed as Lyme disease. Following no response
to the treatment for Lyme disease, further tests were performed and the patient
was diagnosed with T. b. gambiense, with parasites detected in a brain biopsy
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Figure 1.5: The distribution of HAT between 2012-2016
Figure adapted from (Franco et al. 2018). Cases of T. b. gambiense are typically seen in West Africa, with cases of T. b.
rhodesiense seen in Southern and Eastern Africa. For 2012-2016, 22,281 cases of HAT were reported.
using PCR. This biopsy was initially performed to rule out lymphoma or gliomato-
sis cerebri. MRI findings showed deep grey matter and hemispheric white matter
enhancement on T2-FLAIR images. A follow-up scan 2 years later, after success-
ful treatment with eflornithine and rehabilitation, showed reduction of the white
matter signal changes along with no-detectable trypanosome-specific antibodies
(Wengert et al. 2014).
Over a four-year period, serial MRI was performed on a female refugee from An-
gola diagnosed with late-stage T. b. gambiense, two years after her arrival in the
Netherlands (Kager et al. 2009). Initial T2-weighted and FLAIR MR images showed
a hyperintense signal in the white matter, before a diagnosis was made. After
14 days of treatment with eflornithine, MRI findings showed similar hyperintense
white matter regions along with perivascular enhancement near the right basal
nuclei, with more overt changes in the right hemisphere. Nine months after treat-
ment, MRI images showed only minor improvement, although there had been con-
siderable physical and mental improvement. Follow-up scans at two and four years
post-treatment detected small areas of the hyperintense signal, with the right lat-
eral ventricle enlarged, as seen in previous scans, consistent with brain tissue loss
(Kager et al. 2009).
Patel et al. described a series of three cases of HAT, two cases of T. b. gambiense
and one T. b. rhodesiense case, where MRI was performed (Patel et al. 2018). Case
1 describes a 58-year-old Nigerian woman diagnosed with T. b. gambiense where
T2W FLAIR images showed the characteristic high signal intensity in the deep white
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matter seen in other cases reports. The T2W FLAIR images were complemented by
diffusion weighted imaging (DWI) and an apparent diffusion coefficient (ADC) map,
along with susceptibility weighted imaging (SWI). DWI showed restricted diffusion
in the posterior limbs of the internal capsules with microhaemorrhages seen in
the globus pallidus, thalamus and left internal capsule using SWI. Following treat-
ment with nifurtimox and eflornithine, a 4-month review showed resolution of the
restricted diffusion and an improvement of the high signal in the white and grey
matter (Patel et al. 2018). In Case 2, a 62-year-old Sierra Leone male was diag-
nosed with T. b. gambiense after microscopy of bone marrow following admission
to an intensive care unit revealed trypanosomes, which were subsequently de-
tected in the peripheral blood. He was treated with nifurtimox and eflornithine.
T2W FLAIR images showed bilateral high signal intensity in the deep white matter,
which extended to the cerebellum and brain stem. A follow-up MRI three months
after the initial scans showed improvement in the deep white matter signal with
blooming artefact seen on a SWI image. Case 3 discusses a 38-year-old British man
who travelled throughout Africa for two years, and was diagnosed with HAT during
a visit to hospital in South Africa due to fatigue, febrile episodes, headaches and
distorted sleep. Following unsuccessful chemotherapy and multiple relapses, T2W
MRI showed hyperintense signal in the white matter along with restricted diffusion
in the internal capsules and corpus callosum. A follow-up scan six months after his
final treatment showed reduced T2W hyperintensity in the deep white matter and
resolution of the restricted diffusion.
a b c d
Figure 1.6: Clinical MRI images for three patients with HAT
Adapted figure from (Patel et al. 2018) with MRI results for three cases of HAT. Figure a) shows a T2W FLAIR from Case 1
with high signal seen in the deep white matter. Figure b) shows the same symptoms for the patient from Case 2. Figure c)
is from Case 3 with high signal intensity seen and a 6 month follow up scan for Case 3 is shown in Figure d) where there is
reduced hyperintensity.
Although there is limited MR data in HAT cases, the findings highlight the presence
of hyperintense signal in the deep white matter and grey matter from T2W FLAIR
images (Figure 1.6). Furthermore, restricted diffusion and microhaemorrhages
were seen in all cases, although in different brain regions. Follow up scans showed
a reduction in the hyperintensities although some residual signal enhancement can
remained present in MRI images years after final drug treatments. Additional pre-
clinical studies are therefore needed to explore the integrity of the BBB in relation
to HAT in greater detail.
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1.5.5.2 Pre-Clinical MRI
MRI has been employed in a murine model using CE-MRI to show that there is a
reduction in BBB integrity during the late-stage infection in a HAT mouse model
(Rodgers, McCabe, et al. 2011). A comparison of signal change between images
taken from uninfected animals and mice scanned at day 28 post-infection showed
a mean increase of 20.4% in signal after contrast injection, indicating the presence
of BBB impairment in the infected mice. This loss of integrity does not correlate
with the mild neuroinflammatory reaction, with no trypanosomes detected on his-
tological examination of the brain parenchyma of the infected mice. These results
could indicate that at this point in the infection the brain still maintains the tight
regulatory process that is responsible for the control of inflammatory cell transmi-
gration and proliferation in the brain.
Further research to determine when BBB impairment becomes apparent in the HAT
murine model was undertaken using the same mouse model (Rodgers, Bradley, et
al. 2017). In this model, late-stage is defined as day 21 post-infection, when early-
stage drugs can no longer treat the parasite infection, indicating parasites are es-
tablished within the brain. By comparing MRI results from various time points (un-
infected controls, days 7, 14, 21, 28 post-infection), a significant change in CE-MRI
was seen from day-14 post-infection onward (Figure 1.7) along with a significant
neuroinflammatory response. Parasites were detected in the brain by quantitative
PCR, from day-7 post-infection. Both the immune response and early parasite de-
tection, along with BBB impairment, indicate that significant changes occur before
the onset of late-stage disease. It was shown that the amount of parasite detected
in the brain does not correlate with the level of impairment of the BBB.
MRI has also been used for imaging changes in BBB impairment following treatment
for HAT. In this study, mice were treated with a curative regimen comprising oral
melarsoprol cyclodextrin complex, beginning at day 21 post-infection. CE-MRI was
performed at 24-hours, 8-days and 15-days following drug treatment. These scans
showed complete resolution of the BBB impairment present at day 21 post-infection
with signal changes comparable to those found in uninfected mice (Rodgers, Jones,
et al. 2011).
These results are crucial to the on-going research into diagnosing and treating
HAT in humans. In addition they challenge the criteria currently used for stage
determination in HAT as they show that inflammation and parasite detection as
well as BBB-impairment are present before CNS stage infection has established.
At present, there is no in-vivo research of MRI in HAT without the use of a contrast
agent. Current research shows HAT is a well characterised model showing pro-
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Figure 1.7: Evidence of BBB impairment in HAT
Adapted figure from (Rodgers, Bradley, et al. 2017). Percentage signal change maps and corresponding T2 weighted MR
image from an uninfected mouse and a mouse infected with HAT at day 28 post-infection. Signal change can be seen clearly
in the infected mouse, with enhancement in the cerebral cortex, thalamus and pons. The signal enhancement demonstrates
BBB impairment in this murine model.
gressive breakdown in the BBB, with BBB changes apparent over the whole brain.
This makes HAT a desirable model to explore changes in permeability that could
be tracked over time through the early and late stages of infection.
1.6 The Spleen
The spleen, located in the abdomen, is the largest secondary immune organ, con-
sisting of two distinct compartments, the red pulp and white pulp (Cesta 2006).
It is dark red, with a triangular cross-section and elongated shape. The spleen
accounts for approximately 0.2 % of the body weight of a rat and is responsible for
initiating the immune response to blood-borne antigens by the production of IgM
antibodies. The spleen is the major second line of defence against these antigens
in the blood stream that are not recognised by the body’s immune system (Tilanus
2005). The spleen filters the blood to remove old or abnormal red blood cells and
immunoglobulin-coated blood cells. For some haematological diseases, this organ
helps to produce red blood cells when bone marrow fails and hematopoiesis cannot
take place.
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Figure 1.8: Schematic of the Spleen
The blood supply to the spleen comes from the afferent splenic artery, which branches into central arterioles and are
sheathed by the white pulp. The white pulp contains T-cells, B-cells and periarteriolar lymphatic sheath. The ends of the
central arterioles are surrounded by cords in the red pulp. Image taken from (Mebius et al. 2005).
The spleen is supplied with blood via the splenic artery which branches off from
the celiac artery, with the splenic vein draining the spleen (Kindt et al. 2007).
The smaller branches of the spleen are sheathed by lymphoid tissue, forming the
white pulp (Figure 1.8). The red and white pulp are separated by the marginal
zone. Around a quarter of the body’s lymphocytes are stored in the spleen. The
most important cells for splenic function are macrophages, monocytes, natural
killer (NK) cells and T and B cells (Kindt et al. 2007). T cells and B cells are both
a type of lymphocyte cell. They originate from stem cells in the bone marrow,
with the immature T cells maturing in the thymus before moving to the spleen,
lymph nodes or lymphoid tissue. B cells will mature in the bone marrow before
moving to multiple sites in the body. When B cells interact with foreign antigens,
they become antibody secreting cells called plasma cells. This is usually achieved
with help from T helper cells (Cano RLE 2013). Plasma cells are produced in large
numbers when an antibody response is needed and reside mostly in the lymph nodes
and white pulp of the spleen (Elmore 2006).
1.6.1 Red Pulp
The red pulp is a blood filter that removes any foreign bodies and damaged ery-
throcytes, along with storing iron, platelets and erythrocytes. The main function
of the red pulp is blood filtration. The red pulp has sinuses that are filled with
platelet rich blood. Between these sinuses there are cellular cords made of retic-
ular cells and fibres. The cords do not have an endothelial cell lining (Mebius et al.
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2005). These cords are mixed with macrophages, B- and T- cells, plasma cells and
monocytes. Reticulocytes are able to pass through the epithelial cell layer of the
splenic cords and continue into the blood stream whereas the older or abnormal
blood cells are trapped by the splenic cords. The macrophages in the red pulp will
phagocytose ageing red blood cells and regulate the the recycling of iron (Bronte et
al. 2013). The red pulp constitutes approximately 70 % of the total spleen volume
in a normal adult (Kindt et al. 2007).
1.6.2 White Pulp
The white pulp initiates the cellular immune response to blood-borne antigens and
stores around a quarter of the body’s lymphocytes (Cesta 2006). The white pulp has
periarterial lymphatic sheaths (PALS) surrounding the arterial vessels, in particular
the central artery and central arterioles and follicles. These PALS contain tightly
packed T-cells and dendritic cells. The follicles contain B- and T- cells. B-cells are
generally found in the innermost area of the follicle, with the surrounding marginal
zone containing the T-cells (Kindt et al. 2007). The normal histopathology of the
spleen will be discussed in great detail in Chapter 7 of this thesis.
1.6.3 Splenomegaly in HAT
Splenomegaly describes the enlargement of the spleen, due to an increase in cel-
lularity and vascularity (Tilanus 2005). This can occur in response to infection,
disease, altered splenic blood flow or immune disorders. The increase in the size
of the spleen can range from mild to massive (McKenzie et al. 2018). In humans,
a normal spleen measures approximately 10cm in length but can reach 40cm in
splenomegaly. The three main mechanisms that cause splenomegaly are conges-
tion, infiltration and increased splenic function. If there is a blockage in the vas-
culature of the spleen, this can lead to the pooling of blood in the red pulp which
in turn leads to dilated veins and sinuses. The spleen can also enlarge due to phys-
iological stress. This could be from infection, blood loss or hemodilution, where
the spleen will usually return to its normal size. An increase in spleen size can also
be observed over the course of pregnancy.
One of the many symptoms of HAT is splenomegaly (Kennedy 2013) and this has
also been reported in animals infected with trypanosomes. Murray et al. reported
an enlargement of the spleen in mice infected with T. brucei (stabilate TREU 667)
with a mean weight of 1.44g at day 21 post-infection compared to a normal spleen
weight of 0.13g (Murray et al. 1974a). In addition this study showed an increase
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in the number of erythrocytes and macrophages in the spleen and also in other
organs and tissues of the body following trypanosome infection. In another study
investigating the causes of anaemia in trypanosomiasis, splenomegaly was reported
in mice infected with T. brucei stabilate TREU 667. An increase from a mean spleen
weight of 0.23g to 0.85g was seen in mice infected for 30 days. In the early stage
of the disease there was a loss of erythrocyte volume, indicating anaemia. At
eight weeks after infection, there was an increase in plasma and blood volume
reported with the number of erythrocytes increasing (Amole et al. 1982). Anosa
et al. reported a 26 fold increase in the spleen weight in a group of infected mice
(T. brucei stabilate EATRO 110) compared to uninfected mice. The mice that were
determined anaemic had a larger spleen weight compared to the non-anaemic mice
at the end of the experimental infection. The spleens of these mice contained a
larger number of activated macrophages, along with an increase in the population
of plasma cells, lymphocytes and mott cells (Anosa et al. 1984). The infected mice
had tightly packed cells in the spleen, with transformed lymphocytes present in the
infected mice but not the uninfected mice. Overall there was a large increase in
the cell population per unit area and a general enlargement of the spleen overall.
Splenomegaly has also been reported in clinical cases of HAT. Clinical observa-
tions of patients with HAT saw splenomegaly in both early and late stage patients
infected with T. b. rhodesiense (MacLean et al. 2010). Mild anaemia was also
recorded in many of the patients. Ultrasound investigations in two patients diag-
nosed with HAT in Italy in 2004 detected splenomegaly with the spleen measuring
20cm and 19.5cm. These patients also displayed haematological changes including
a marked decrease in leukocyte numbers and haemoglobin with an increase in the
concentration of IgM (Bisoffi et al. 2005). The development of splenomegaly is
more frequently observed in children rather than adults (WHO 2013).
1.6.4 Imaging of the Spleen
There has been no exploration of splenomegaly in trypanosome infected mice using
MR imaging. MRI imaging of the spleen has been documented however, with and
without the use of contrast agent. The spleen shows a high signal intensity (in
comparison to the liver) in T2 weighted images and a lower signal intensity in T1
weighted images (Palas et al. 2013). Giraudeau et al. used 19F MRI to image the
mouse liver and spleen. They measured the T1 value of the spleen as 2200ms and
partial oxygen pressure as 75mmHg. Although this study was aimed at examining
values of oxygen tension, they also produced an anatomical 1H image showing the
spleen (Giraudeau et al. 2012). Smirnov et al. used magnetically labelled particles
for imaging the mouse spleen. By injecting hybridoma cells that were labelled with
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anionic γ − Fe2O3 superparamagnetic iron oxide nanoparticles, they were able to
show changes in the spleen MRI signal intensity (Figure 1.9). The signal in the
spleen dropped due to the collection of these iron oxide nanoparticles (Smirnov
et al. 2004).
Figure 1.9: MRI of a mouse spleen after injection of magnetic particles
Image modified from (Smirnov et al. 2004). The spleen is indicated by the white ellipse. MR imaging of the mouse using a
gradient echo sequence (GRE) was taken 24 hours after IP injection of magnetically labelled hybridomas. The signal in the
spleen dropped in the injected mice compared to the control. The aim of the research was to show signal intensity changes
could be shown in the spleen using a 1.5T clinical magnet.
1.7 Relevance to the Thesis
The aim of the research was to investigate the permeability of the BBB non-invasively.
To do this, HAT was chosen as a murine disease model that had known BBB impair-
ment. The disease would be able to provide a progressive diffuse impairment of
the BBB that could be imaged over the course of the infection. Further research
into the disease revealed limited knowledge of the splenomegaly in HAT, therefore
an experiment was designed to serially investigate splenomegaly for the first time
in HAT non-invasively.
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Chapter 2
Magnetic Resonance Imaging
In this chapter, the basics of nuclear magnetic resonance and magnetic resonance
imaging is outlined. Information has come from multiple sources (Bushong 1996;
Feynman et al. 2006; Young et al. 2011; Levitt 2008; Tofts 2003; Callaghan 1991),
unless specifically stated. There are many other books and papers on the topic.
2.1 Nuclear Magnetic Resonance
2.1.1 Principles of Magnetic Resonance
Magnetic resonance exploits the properties of the nucleus, focusing on how it re-
acts with the world around it. Some nuclei have the intrinsic property known as
nuclear spin angular momentum, sometimes called spin. When considering a ro-
tating body in a classical physics description, it can be described as having angular
momentum and interacting with the gravitational field around it. Nuclei possess an
intrinsic spin angular momentum, L. The particles that make up the nucleus (elec-
trons, protons and neutrons) also possess angular momentum and interact with the
electromagnetic field around them. The values of nuclear spin angular momentum
are quantised (for I ̸= 0), and have discrete integer or 12 integer values:
L = [I(I+ 1)]1/2 h¯ (2.1)
where I is the nuclear spin quantum number and h¯ is Planck’s constant.
Some nuclei possess a magnetic moment, which describes the tendency of an ob-
ject to interact with an external magnetic field. The magnetic moment arises from
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the gyromagnetic ratio, γ, a constant which is specific to each nuclei and its spin
angular momentum. The magnetic moment, µ, is thus:
µ = γL (2.2)
This thesis will be concerned with only hydrogen nuclei 1H, which have a nuclear
spin quantum number I = 12 and, thus, two energy levels (2I+ 1), known more
commonly as the spin-up and spin-down states. In the absence of a magnetic field,
these two states are degenerate with the spin direction for an ensemble of nuclei
being randomly distributed. If a nucleus is then placed in a magnetic field, the
magnetic moment µ will equal:
µ = γL = γ h¯I (2.3)
Classically, in the presence of an external magnetic field, the nuclear magnetic
moment will experience a torque and, hence, will proceed to precess about the
magnetic field direction. The energy, E, associated with µ is:
E = −µ·B = −γ· h¯· I·B (2.4)
where B is the static magnetic field.
This static magnetic field will cause a separation in energy levels of the spin-up and
spin-down states, known as Zeeman Splitting (Figure 2.1). This quantisation of the
spin angular momentum, L, occurs along the direction of the magnetic field. When
the magnetic moment is parallel with the static field direction (spin-up), it has a
lower energy (E−) with m = -1/2, and when opposed to the field (spin-down), a
higher energy (E+) with m = +1/2, where m is the z-component of the spin angular
momentum.
The energy difference between the two states is as follows:
DE = E− − E+ = [−(−12)γ· h¯·B]− [−(
1
2)γ· h¯·B] = γ h¯·B (2.5)
Planck’s equation states:
DE = h¯w (2.6)
By combining Equations 2.5 and 2.6 , this gives the following relationship:
γ h¯B = h¯w0 (2.7)
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Figure 2.1: Zeeman Splitting
The separation of the energy level into two states is known as Zeeman Splitting. The spin-up and spin-down states are
shown, with the static magnetic field denoted by B0.
Which gives the Larmor equation:
w0 = (−)γB0 (2.8)
where the sign of γ depends on the nucleus in question. Equation 2.8 describes
the angular frequency, w0, associated with nuclei (I = 12) precessing in an external
magnetic field, B0. A classical derivation of Equation 2.8 can be seen in Appendix
A. For the hydrogen nucleus at 7 Tesla, the value of γ is 42.58 MHz/T which gives
a precession frequency, ω0, of ∼ 300 MHz.
In an external magnetic field, the population of the two spin states is given by a
Boltzmann distribution, with more spins in the spin-up state at the lower energy
level (Figure 2.2). A vector summation of this ensemble of spins is called the net
magnetisation:
M =
∑
i
µi (2.9)
The total number of spins is N = N− + N+ with the ratio of the spins states being:
N+
N−
= e
DE
KBT = e
h¯γB
KBT (2.10)
where DE = E−− E+, KB is the Boltzmann constant and T is temperature in Kelvin.
When thermal energy is greater than the energy difference between spin states
(KBT >> h¯γB), then this becomes:
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Figure 2.2: Distribution of nuclear spins
The net magnetisation arising from a larger number of spins in the spin up state.
DN
N =
N− − N+
N+ + N−
≈ h¯γB02KBT
(2.11)
This relationship shows that the number of excess spins in the lower state can
be increased by either increasing the magnetic field strength or decreasing the
temperature of the sample (not viable for biological samples). By increasing the
number of the lower state spins, this creates a larger net magnetisation which
increases the overall MR signal. For the hydrogen nucleus at room temperature in
a 7T magnet, DNN ≈ 10−6. From Avogadro’s constant, one mole of water contains
1023 water molecules. This means in each 1ml of water, the signal for ∼ 1017 spins
are available for imaging.
2.1.2 The Bloch Equations
The net magnetisation will precess around the magnetic field B0 with a frequency,
w0, and will have a spin angular momentum L. The rate of change of angular
momentum is equivalent to torque, t and so:
dL
dt = t = M× B (2.12)
This means that:
d
dtL =
d
dt
M
γ
= M× B (2.13)
and therefore:
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dM
dt = γM× B (2.14)
Equation 2.14 is the basis of the Bloch equations. Expanding the cross product will
give the following for the individual components of magnetisation:
dMx
dt = γ(MyBz − ByMz)
dMy
dt = γ(BxMz −MxBz)
dMz
dt = γ(MxBy − BxMy)
(2.15)
If an external, static magnetic field is applied in the z-direction, the Bx and By
components will be equal to zero and, hence, spins will precess around the Bz
direction. This simplifies the Bloch equations to:
dMx(t)
dt = γMy(t)Bz
dMy(t)
dt = −γMx(t)Bz
dMz(t)
dt = 0
(2.16)
The equations in 2.16 hold in the absence of relaxation mechanisms, described in
Section 2.2. By incorporating relaxation effects into Equation 2.16:
dMx(t)
dt = γMy(t)Bz −
Mx(t)
T2
dMy(t)
dt = −γMx(t)Bz −
My(t)
T2
dMz(t)
dt = −
M0 −Mz
T1
(2.17)
Following a 90° pulse, the solutions to Equation 2.17 are:
Mx(t) = e
−t
T2 [Mx(0)cos(ω0t) +My(0)sin(ω0t)]
My(t) = e
−t
T2 [My(0)cos(ω0t)−Mx(0)sin(ω0t)]
Mz(t) = Mz(0)e
−t
T1 +M0(1− e
−t
T1 )
(2.18)
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2.1.3 RF Pulses & Frame of Reference
In MRI, the frame of reference is the coordinate system used to view the precession
of the net magnetisation. The net magnetisation can precess with a frequency from
10s to 100s of MHz, with a frequency of 300 MHz for a 7T static field, when viewed in
the laboratory frame. By introducing the concept of a rotating frame of reference
and transforming the coordinates of the laboratory frame so that the new frame is
rotating at the B1 frequency, the net magnetisation will appear stationary due to
the effects of the B0 field disappearing.
When an ensemble of 1H nuclei is placed in a static magnetic field, B0, precession
around the B0 direction will occur. If an oscillating magnetic field (referred to as
B1) is applied perpendicular to B0, this will cause M to precess around the B1 di-
rection. This short oscillating field is known as a radio frequency pulse (RF pulse).
Once this pulse has been turned off, the net magnetisation will return to equilib-
rium. The amount of rotation that the net magnetisation experiences because of
the RF pulse is known as the flip angle. For the most basic of pulses, namely, the
rectangular RF pulse of constant amplitude B1, the flip angle, α, can be described
using the pulse length, tp, and gyromagnetic ratio:
α = w1 tp = γB1tp (2.19)
The use of a rotating frame of reference means that the effects of the B0 field dis-
appear and the B1 field appears static rather than rotating. The net magnetisation
is now acted upon only by the B1 magnetic field, meaning that the net magneti-
sation will precess with a frequency ω1 = γB1. As B1 is much smaller than B0, the
precession can be measured in kHz rather than MHz.
2.1.4 Adiabatic Excitation
Adiabatic excitation is a special case of RF excitation, where the B1 field is applied
very gradually. In the rotating frame, the rotation is at the frequency of the B1
field, ω1. If the B1 field is applied off-resonance, the effect of the B0 field does
not disappear from the rotating frame completely, and B′z is given by:
B′z =
ω0 − ω1
γ
= B0 −
ω1
γ
(2.20)
When ω1 is at the Larmor frequency, B′z is zero. From this, a Beff field is produced,
which is the resultant vector between B1 and B′z. The magnetisation M will pre-
cess around this Beff field. For adiabatic excitation, the B1 field is applied below
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resonance (ω1 < ω0), very gradually increased to resonance (ω1 = ω0) and then
above resonance (ω1 > ω0). Adiabatic conditions are required for the magnetisa-
tion to precess around and follow the Beff field as it sweeps through the frequency
range. The B1 field needs to be strong enough and applied slowly enough, with the
adiabatic condition expressed as:
|dθdt | ≪ γ|Beff| (2.21)
Where:
θ = arctan( B1(t)Bz′ (t)
) (2.22)
is the angle that Beff makes with the z-axis. This can be arranged to give the
adiabatic factor η:
η = γ
|Beff|
|dθdt |
(2.23)
After B1 has been swept through the frequency range, M will be inverted by 180°,
which is known as adiabatic inversion. Compared to normal amplitude modu-
lated rectangular RF pulses, these adiabatic pulses are amplitude- and frequency-
modulated. They are mostly insensitive to B1 inhomogeneity and frequency offset
effects. This is due to the pulses being less sensitive to RF miscalibration. The flip
angle is not proportional to B1 magnitude and pulse length compared to the typical
rectangular pulses, but depends on how the B1 field varies in amplitude and phase
throughout the inversion. The adiabatic pulses used in this thesis are hyperbolic
secant pulses.
2.2 Relaxation
Following excitation by an RF pulse, a spin ensemble will return to precess at its
equilibrium, B0. This return to equilibrium is known as relaxation. T1 relaxation
describes the relaxation of the longitudinal component of magnetisation, with T2
relaxation describing the relaxation of the transverse component.
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2.2.1 T1 Relaxation
The return of the net magnetisation along the z-axis is known as longitudinal, spin-
lattice or T1 relaxation. This relaxation is due to the interactions between the spins
and the surrounding lattice. The resulting recovery is illustrated in Figure 2.3.
Figure 2.3: T1 Relaxation
Following RF excitation, as time increases, the value of the magnetisation in the z direction will increase until it reaches
M0. The rotating frame is shown.
After the RF pulse is switched off, the spins system starts to lose energy as it returns
to the equilibrium state, M0. In quantum mechanical terms, this can be described
as the spins losing energy as they transition from a higher to a lower energy state.
This heat energy is absorbed by the surrounding environment and re-establishes
thermal equilibrium. Following a 90° pulse, the recovery of the signal follows an
exponential curve, and is characterised by the following (for t ≥ 0):
Mz(t) = M0(1− e
−t
T1 ) (2.24)
Known as ‘saturation recovery’, this recovery is characterised by the time constant
T1. A correlation time τc , describes the characteristic time for a molecule to rotate
one radian. These rotations will cause fluctuations in the local magnetic field of
nearby nuclei. Smaller molecules that tumble faster will have smaller correlation
times than lager molecules. Water molecules have a correlation time of ∼ 10−12s.
If the value of 1τc is close to the Larmor frequency, the value of T1 will be short.
For pure liquids, such as water, the T1 value is largely dependent on the strength
of the magnet, with increasing field strength giving a longer T1 value. The T1 of
water at 7T is approximately 3 seconds. For in-vivo experiments, the value of T1 is
dependent on the surrounding tissue. Water molecules have restricted movement
in tissue, with an exchange between the hydrogen molecules of the water and
tissue. This results in a longer average correlation time and shorter T1 values.
Larger molecules, such as fat, will also have shorter T1 values.
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2.2.2 T2 Relaxation
Transverse relaxation is the loss of signal in the transverse plane due to a loss of
phase coherence. Due to the random tumbling motions of magnetic moments in a
liquid, the individual magnetic moments have their own local fluctuating magnetic
fields. Although these fields are small compared to the main B0 field, as the mag-
netic moments interact with each other (dipole-dipole interactions) this will cause
a fluctuating local field which changes the precessional frequencies of individual
magnetic moments. Following excitation, the difference in precession frequency
results in a loss of phase coherence and the loss of transverse signal (Figure 2.4).
Figure 2.4: T2 Relaxation
Following RF excitation, as time increases, the spins will dephase and there is a loss of M in the transverse plane.
The T2 relaxation decay can be described as follows (for t ≥ 0):
Mxy(t) = M0e
−t
T2 (2.25)
The decay of the net magnetisation M is not caused only by dipole-dipole interac-
tions, but also by inhomogeneities in the B0 magnetic field. The combination of
dipole-dipole interactions and magnetic field inhomogeneities results in a faster
loss of transverse magnetisation. This faster relaxation time is known as T2*. The
rate at which T2* decays is described as:
1
T2∗
=
1
T2
+
1
T′2
(2.26)
where T′2 is the effect from the field inhomogeneities.
In pure water T1 = T2, however T2 values will generally decrease as the magnetic
field strength increases. The value of T2 in biological tissue is always shorter than
T1. For a biological sample which has large molecules, there will be a higher prob-
ability of interactions (from the longer correlation times) between the spin local
magnetic fields of the molecules. This results in more frequent energy exchanges
and a shorter T2.
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2.3 Origin of the MR Signal
After an RF pulse has tipped the net magnetisation, M, to have a component that
precesses in the transverse plane at ω0, an oscillating magnetic field is generated.
This will induce a small current in a receiver coil placed in the transverse plane.
This signal is known as a free induction decay (FID). Faraday’s law of induction says
that a changing magnetic field will induce a current in a conductor. The current
generated in the coil is proportional to the rate of change of the magnetic field,
where the induced current will oppose the applied field.
RF
Signal
Figure 2.5: The FID signal generated from an RF pulse
Following a 90° RF pulse, the net magnetisation will precess in the transverse plane. As the net magnetisation returns to
its equilibrium position, the oscillating magnetic field that is generated will be detected as a small current, producing the
FID.
In the xy-plane before relaxation occurs, the signal from M can be split into real
and imaginary components:
Sx ∝ Mxcos(θ)
Sy ∝ Mysin(θ)
(2.27)
The real component of the signal is proportional to Mx and the imaginary compo-
nent of the signal is proportional to My (Figure 2.6).
M
x
y
Figure 2.6: Phase of a net magnetisation of spins in a magnetic field
The precession of M in a magnetic field, B0, at the Larmor frequency ω0 will have a phase value θ.
The phase is given by θ = ω0t and, using Euler’s formula, the signal is:
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S ∝ (cos(θ) + isin(θ))
S ∝ eiθ ∝ eiω0t ∝ eiγB0t
(2.28)
where γ is the gyromagnetic ratio, B0 is the static magnetic field and t is the time
after the RF pulse is applied.
2.3.1 Gradients and Slice Selection
In an ensemble of spins, the individual magnetic moments will precess at the same
frequency, ω0. If a small additional magnetic field is applied, that linearly varies
with position, this will cause the precession frequency to be dependent on position
(Figure 2.7). This is called a magnetic field gradient and is defined (for the x-
direction) as:
Gx =
δBz
δx (2.29)
xx1
Δω
Sample
B0
Figure 2.7: Gradient application
A sample with a gradient applied to linearly vary the precession frequencies of the magnetic moments contained in the
selected slice.
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In the laboratory frame, the magnetic field is:
B = B0 + Gx· x1 (2.30)
where the precession frequency is defined as:
ω = γB0 + γGx· x1 (2.31)
This precession frequency holds for the laboratory frame of reference. In the
rotating frame of reference, ω1 = ω0 when on-resonance:
ω = γGx· x1 (2.32)
The signal for a sample x1 is given by:
ds ∝ ρ(x1)eiγGx·x1tdx (2.33)
with ρ(x1) the spin density of the sample at position x1.
By combining Equations 2.31 and 2.33, the signal of the sample at the x1 position
is:
ds(Gx,t) = ρ(x1)e
iγGx·x1tdx (2.34)
The signal (in the rotating frame) for the sample over x is thus:
S(Gx,t) ∝
∫ ∞
−∞
ρ(x)eiγGx·xtdx (2.35)
The MR signal will result in a summation of the signals from all the magnetic mo-
ments contained in the sample.
By using the substitution kx = 12piγGxt, the signal in one-dimension is:
S(k) ∝
∫ ∞
−∞
ρ(x)ei2pikx·xdx (2.36)
and for two dimensions:
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S(kx,ky) ∝
∫ ∞
−∞
∫ ∞
−∞
ρ(x, y)ei2pi(kx·x+ky·y)dx dy (2.37)
Thus, there is a Fourier relationship between S(kx,ky) and ρ(x, y).
2.3.2 Encoding, k-Space and Fourier Transform
Magnetic field gradients can be used to select a slice for imaging. Here, a gradient
is applied perpendicular to the direction of the slice select direction. While this
gradient is turned on, the frequencies of the magnetic moments will vary along
the gradient direction (Figure 2.7). When a narrow bandwidth RF pulse is applied
at the same time as the gradient and the precession frequency matches that of
the magnetic moments in the slice, the magnetic moments of the same frequency
as the RF pulse will be excited. To frequency encode the signal, this gradient is
applied perpendicularly to the the slice and phase direction.
To encode the sample in the direction perpendicular to the read and slice direc-
tions, a gradient, known as the phase encoding gradient, is applied. This gradient
causes the magnetic moments precession frequency to depend on position and
causes a permanent phase shift once the gradient is turned off. This phase shift
(ϕ) can be described by:
ϕ = γGy· t (2.38)
where Gy is the strength of the gradient and t is the time of the gradient.
Data points are collected in a cartesian coordinate grid known as ‘k-space’. The MR
signal is sampled at multiple points with each data point being a complex signal that
contains real and imaginary components. The low frequency data in the middle
of k-space contains information about the bulk of the image. The high frequency
data at the periphery of k-space contains the finer details of the image.
Application of a Fourier transform in both the frequency and phase encoding di-
rections (2DFT) will produce a spin density value for each data point with a real
and imaginary output. It should be made clear that each point in k-space does not
translate directly to each pixel in the final image. Each k-space point contains spa-
tial frequency and phase information about the whole image. The final MR image
is constructed by taking the magnitude of the complex spin density data.
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2.4 Pulse Sequences
An MRI pulse sequence describes the temporal combination of gradients (x, y, z) and
RF pulses. These are used to acquire an MR image. The most relevant sequences
to this thesis are described below.
2.4.1 Gradient Echo & Spoiled Gradient Echo MRI
For gradient echo MRI, an excitation pulse (where the flip angle α < 90°) is simul-
taneously applied with a slice selective gradient, followed by a small refocusing
gradient (half the size of the slice selective gradient) (Elster 1993). A read de-
phase gradient is used to rapidly dephase the spins in the transverse plane by al-
tering their resonant frequencies (Figure 2.8). The read gradient is applied again
in the opposite direction, creating the gradient echo (both of these gradients have
the same area). Gradient echo can be using for imaging, with a line of k-space
collected for each TR.
Kx
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Read
Phase
Slice
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Crusher Slice
Read dephase
Read encode Phase encode
Slice rephase
Figure 2.8: Acquiring one data point in k-space using a gradient echo sequence
The gradient echo sequence uses a combination of dephase and rephase gradients to produce the MR signal. The different
gradients are indicated on the image by different colours. When used for imaging, each line of k-space is filled in one TR.
The phase gradient is applied at the same time as the read dephase gradient to
phase encode the spins. This is repeated for each line of k-space. The time taken
for this to occur, and more accurately, the time between each excitation pulse,
is known as the repetition time (TR). The time between the middle of the excita-
tion pulse and the middle of the echo is called the echo time (TE). The value of
the phase gradient determines which line of k-space is collected during the read
gradient. Small values of the flip angle are typically used, with the optimal angle
for the maximum signal given by the Ernst angle:
αE = arccos (e
− TRT1 ) (2.39)
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Compared to the conventional gradient echo sequence, in a spoiled gradient echo
sequence, spoiler gradients are used to purposely disrupt the T2 signal before the
next TR starts. This permits weighting of the signal for for T1 (see Section 2.4.6).
2.4.2 Spin Echo MRI
The spin echo sequence is a combination of a 90° and 180° pulse. The sequence
starts with a 90° RF excitation pulse with a slice selective gradient simultaneously
applied (Figure 2.9). This excitation pulse tips the net magnetisation into the trans-
verse plane where a FID will occur but is not imaged. By applying a 180° refocusing
pulse along simultaneously with a slice selective gradient, the net magnetisation
within the slice is refocused. The time between the middle of the RF pulse and the
middle of the spin echo is the echo time. The refocusing pulse occurs at half of
TE. The spin echo sequence acquires k-space in the same way as a gradient echo,
with one line of k-space acquired during each TR.
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Figure 2.9: A spin echo MRI sequence
A spin echo sequence uses a refocusing 180° pulse to generate an echo after the first FID. It is this echo that is used for the
MR signal. As seen for GE-MRI, a single line of k-space is acquired for each TR.
2.4.3 RARE
A faster acquisition method than spin-echo imaging is rapid imaging with refocused
echoes (RARE) (Hennig et al. 1986). This sequence uses different phase encoding
gradients for each additional echo, compared to a conventional spin-echo sequence
which uses one phase encoding gradient per TR. The RARE sequence allows for fast
acquisition of data to fill k-space (Figure 2.10) meaning multiple k-space lines can
be filled in each TR. It is often referred to as a ‘fast spin-echo’ or ‘turbo spin-echo’
sequence.
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Figure 2.10: A RARE sequence schematic
A RARE sequence uses a combination of different phase encoding gradients to generate multiple echos in the same TR. RARE
can acquire multiple lines of k-space in the same TR, making it faster than conventional spin echo.
2.4.4 Echo Planar Imaging
Echo planar imaging (EPI) is one of the fastest MRI acquisition methods. EPI can
acquire the full k-space in one excitation, or in multiple ‘shots’, making the overall
scan duration shorter than other MR sequences. EPI can use either a spin echo
sequence (T2 weighted) or a gradient echo sequence (T2∗ weighted). To fill k-
space, multiple gradient echoes which have different phase steps are acquired by
using rephasing (blipped) gradients (Figure 2.11). The read gradient is pseudo-
continuously applied, with the polarity changing between positive and negative.
To change each k-space line, short phase gradients are applied before each new
echo (blipped EPI) (Stehling et al. 1991).
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Figure 2.11: A schematic of the spin echo EPI sequence
EPI can be used to collect the entire k-space in one TR by using using multiple rephasing gradients with a pseudo-continuously
applied read gradient.
Although EPI has a reduced imaging time and uses less RF power than other se-
quences, it has limited spatial resolution and can be more sensitive to motion
artefacts and magnetic field inhomogeneities.
2.4.5 Inversion Recovery
An inversion recovery sequence (see Figure 2.12) uses a spin-echo, EPI or RARE
sequence preceded by an 180° inversion pulse. This inversion pulse tips the net
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magnetisation from being aligned with the positive z-axis to the negative z-axis.
IR sequences can be used to examine the T1 contrast of different tissues. By first
applying the 180° inversion pulse, a small time delay (the inversion time, TI) is
used before a spin echo sequence. Immediately after the 90° excitation pulse of
the spin echo, different tissues in the imaging sample will have varying values of
longitudinal magnetisation. This will result in different levels of contrast in the
MRI image dependent on the value of TI used, with the resulting image being T1
weighted.
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Figure 2.12: An inversion recovery sequence schematic
An IR sequence has an 180° inversion pulse placed before a spin-echo, EPI or RARE. The sequence can be used to examine
the contrast of different tissues.
Inversion recovery sequences can be used to suppress the signal from a certain
type of tissue by using an appropriate TI value that is similar to the T1 value of the
tissue to be suppressed. When using a conventional spin echo sequence for IR, the
TI value can be chosen by:
TI = T1[ln(2)− ln(1 + e−
TR
T1 )] (2.40)
If TR >> T1, then Equation 2.40 can be reduced to:
TI = T1· ln(2) ≈ 0.69× T1 (2.41)
2.4.6 Image Contrast
Depending on the values of TR and TE used for certain pulse sequences, an image
can become ‘weighted’ towards either T1, T2, spin density or a combination of
them. This is extremely useful because different tissues and organs in the body
have different T1 and T2 values. These values depend on both the type of tissue
and on the strength of the magnet. As the strength of the magnet increases (for
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example from 3T to 7T), the T1 of a biological sample will increase, whilst the T2
will decrease. To change the contrast in an image, a combination of TR and TE is
used (Table 2.1). It is usually the value of TR that influences the T1 weighting and
TE that influences the T2 weighting.
TR TE Weighting
Short Short T1
Long Short Proton Density
Long Long T2
Table 2.1: Different image weightings for spin echo MRI
To create a T1-weighted image, the value of TR must be small compared to the
T1value of the tissue or organ that is being imaged. This weights the image to T1
as there is less time for the longitudinal component of the magnetisation to relax
back to equilibrium. This highlights the difference between the relaxation time of
the different tissues in the body. To minimise the effect of T2 and T2* relaxation,
a small TE value is also needed.
By comparison, to create T2 or T2* weighted images, the value of TR needs be much
larger than the T1 of the tissue or organ being imaged. By increasing TE, there is
a greater weighting of T2 or T2*. Although different sequences can be weighted
for T1 and T2, for T1 weighting an inversion recovery or RARE sequence (spin echo)
with a short TR can be used. For T2 weighting, a spin echo sequence can be used
and, for T2*, a gradient echo sequence.
2.4.7 Diffusion Weighted Imaging
Brownian motion, first discovered by Robert Brown in 1827, is the random move-
ment of particles when suspended in a liquid. The movement is from molecular
motion and can be used to describe the movement of molecules in a biological
sample. Different molecules have varying levels of free, hindered and restricted
molecular motion dependent on their properties and position. Einstein described
the movement of molecules as a random walk and demonstrated that they diffuse
by:
D = KBT6piηR (2.42)
where D is diffusivity, R is the radius of the Brownian particle, η is viscosity and KB
is the Boltzmann constant.
The molecular movement in a sample can be measured by the use of a pulsed
field gradient spin echo (PGSE) sequence (Figure 2.13), introduced by Stejskal and
Tanner (Stejskal et al. 1965).
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Figure 2.13: A schematic of the PFG sequence
The PFG sequence uses two gradients placed around a 180° pulse. After the 90° pulse, the first gradient will dephase the
spins in the transverse plane. The second pulse will rephase them. If there has been a displacement of spins during D, the
spins will not rephase completely and is identified as a drop in measured signal.
Consider a sample of fluid in a magnetic field where the focus is on a single water
molecule. After a 90° pulse, the molecule will precess in the transverse plane.
When the first gradient pulse is applied, the molecule will acquire a phase (in the
rotating frame):
Q1 = γδGx · x1 (2.43)
where x1 is the initial position of the particle and δ is the duration of the gradient.
During an observation time, D, the molecule will displace from the position x1, to a
new position x2. This could be due to multiple reasons such as diffusion, dispersion
or flow.
A 180° pulse is applied with a second gradient pulse following, resulting in a phase
shift of:
Q2 = γδGx · x2 (2.44)
With a resultant phase shift:
Q = Q1 −Q2 = γδGx · x1 − γδGx · x2 = γδGx · (x1 − x2) (2.45)
If X = x2 − x1 and q = 12piγδGx then:
Q = −2piq · X (2.46)
The signal is given by:
s(q) = s(0)e−iQ = e−i2piq·X (2.47)
It is important to note that the signal depends upon the displacement and not the
initial or final position. The total signal is an integral over all values of displace-
ment X, where P(X,D) is the probability of a displacement X.
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S(q,D) ∝
∫ ∞
−∞
P(X,D)ei2piqXdX (2.48)
This equation demonstrates a Fourier relationship between the probability of dis-
placement and the amplitude of the echo. A free unrestricted diffusion of molecules,
or Gaussian distribution of molecules, will give a probability distribution of:
P(X,D) = 1√
4piDD
e−X
2
4DD (2.49)
The signal intensity can thus be written using Equations 2.48 and 2.49:
S = S0e−4piq
2D(D− δ3 ) = S0e−γ
2G2δ2D(D− δ3 ) (2.50)
By using the relation:
b = γ2G2δ2(D− δ3) (2.51)
Equation 2.50 can be simplified to:
S = S0e−bD (2.52)
The signal attenuation due to relaxation is approximately independent of the ap-
plied diffusion gradient. By dividing by S0, this eliminates any relaxation effects
and the only dependence is on diffusion.
2.4.8 Using PGSE to Image Diffusion
A typical PGSE sequence is shown below in Figure 2.13. A pair of pulsed field gradi-
ents are applied around the 180° RF pulse in a spin echo sequence. The molecular
displacement itself is unaffected by scan parameters. By changing the parameters
of Equation 2.50, for example, the gradient strengths or observation times, will
change the amount of rephasing caused by the second gradient. If there has been
molecular displacement during the observation time, D, this will show as a drop in
signal intensity.
2.5 Scanner Hardware
An general overview of the magnet and hardware used in MR imaging is presented.
The main magnet consists of multiple coils that work together (Figure 2.14). In
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this thesis, a 7T Bruker pre-clinical imaging system is used.
Shielding
Main magnet
Gradient (+ shim)
Shielding
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Figure 2.14: The coils used in an MRI scanner
2.5.1 The Main Magnet
The main magnet contains the coil that carries the current that produces the main
B0 field. Typical superconducting magnets use niobium-titanium wire or niobium-
tin wire. Once the coil is charged with current, to keep its superconducting prop-
erties, the coil must be cooled in a bath of liquid helium at 4K. Either an additional
dewar of liquid nitrogen (77K) is used to slow the boil off of the the liquid helium
or a cold head compressor is used to compress the evaporating helium back to
liquid. The middle of the magnet (known as the bore of the magnet) is the most
homogeneous region and is where the sample is placed for scanning.
2.5.2 Shim Coils
Superconducting shim coils placed in the cryostat have currents passed through
them to create field gradients that maintain the homogeneity of the B0 field. Re-
sistive shims are outside the cryostat. First order shimming is provided by the
gradient coils whereas second order and above shimming is provided by additional
coils. The use of resistive shims means shimming can be adjusted for each patient.
2.5.3 Gradient Coils
Gradient coils are used to produce the pulsed field gradients in the three directions
needed for imaging. These coils work at room temperature by passing a direct
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current through the coils, producing a constant gradient which results in a linear
change of the magnetic field needed for frequency and phase encoding. The Z-
direction coils are usually a Maxwell pair whereas the X- and Y- gradient coils are
saddle coils. This is to allow the three sets of gradients to fit together.
2.5.4 RF Coils
Radio frequency (RF) coils are used to produce the B1 field. These coils are de-
signed to transmit the RF radiation, to receive the corresponding signal, or both.
A volume resonator can receive and transmit the RF radiation and is used for full
body imaging. Surface coils are smaller receive coils that can be placed next to a
body part to receive a higher signal. An example of this is using a head surface coil
for brain imaging. The RF coil transmits the RF radiation, which has the oscillating
B1 field component. This is applied perpendicular to the B0 field and is transmitted
as short RF pulses close to the Larmor frequency.
For this research, a 4-channel phased array mouse head surface coil and rat head
surface coil were used for receiving the signal. A phased array coil differs from a
single surface coil in that it has multiple surface coils that emit separate signals.
These signals will be based on the position of each coil and can provide extra
information that is not received from a signal coil. This also reduces the scan time
as it reduces the number of phase encoding steps needed to fill k-space.
2.5.5 Shielding
Shielding is used to reduce the fringe magnetic field produced from the MRI scan-
ner. This is achieved by active shield coils that are placed outside the main mag-
netic field coils (but still in the helium dewar) and produce a magnetic field that
opposes the main B0 field. Shielding of external RF in the magnet room is provided
by a Faraday cage.
2.5.6 Electronics
In addition to the main magnet and coils, multiple electronics are needed to be
able to run an MRI experiment. Figure 2.15 below shows the basic electronic com-
ponents of the MRI scanner.
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Figure 2.15: The electronics for a MRI scanner
2.5.6.1 Oscillator
The oscillator produces an oscillating electrical voltage that has a defined fre-
quency at or near the Larmor frequency. This carrier wave is sent to the modulator
and to the receiver electronics as a reference signal.
2.5.6.2 Modulator
The modulator is used to split the continuous oscillating carrier wave into small
pulses known as ‘RF pulses’, and modify the amplitude to change the pulse shape.
2.5.6.3 Amplifier
The RF amplifier amplifies the pulses received from the modulator that will be
used for the imaging sample. This generates the large current that will be needed
for the RF coils. The flip angle of the RF pulse is controlled by the amplifier, by
changing the gain of the amplifier using a transmit attenuator. The PharmaScan
MR scanner used for this thesis uses a 300W or 1kW amplifier.
2.5.6.4 Duplexer & Preamplifier
The RF coil detects a weak signal (∼mV) from the sample and the duplexer directs
this to the pre-amplifier where the signal is scaled to a larger voltage (V). The
duplexer is used to ensure there is a switch between the transmit and receive
electronics. The receiver electronics are extremely sensitive for detecting the
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small signal emitted from the sample and would be damaged by the high powered
transmit signal.
2.5.6.5 Receiver & ADC Converter
At 7T, the MRI signal oscillates at 300MHz, which can not be processed by the
ADC converter. Hence, the receiver uses the reference wave from the oscillator
for comparison to the receiver signal. Using a rotating frame of reference, this
converts the receiver signal to a lower frequency signal that can be processed.
The analogue-to-digital converter (ADC) is used to convert the analogue signal into
a digital output which is stored in the computer.
2.5.6.6 Computer
The computer console is used to control the scanner and run the MRI sequences.
The pulse sequences, gradients and other parameters can be controlled from this
input. The computer system also includes the image reconstruction methods to
generate the final MRI images.
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Chapter 3
Literature Review of ASL and DWASL
3.1 Abstract
This chapter first introduces the concept of arterial spin labelling (ASL) with a
literature review on the different types of ASL, before summarising the recent work
on multiple boli ASL (mbASL). Following this is a review of diffusion weighted ASL
(DWASL). These two sequences form the basis of the next three results chapters.
3.2 Arterial Spin Labelling
3.2.1 The first ASL Experiment
Arterial spin labelling (ASL) is a non-invasive imaging technique, that uses the en-
dogenous blood water flowing into the brain as a contrast agent. The method
introduced by Detre et al., was developed initially to measure cerebral perfusion
(Detre et al. 1992). In this experiment, saturation pulses were used to magnetically
label the arterial blood spins in the neck region as it travelled toward the brain.
Once a steady state of the labelled arterial blood spins was established in the
brain, the RF pulse was turned off and an image of the brain taken (label image).
Another image of the brain, known as the control image, was then taken, with the
labelling slice applied above the head, to account for magnetisation transfer (MT)
effects. By subtracting the two images, with and without labelling, the resulting
image will be perfusion weighted. Detre proposed that ASL could be sensitive to
cerebral blood flow (CBF) changes and could produce quantitative CBF maps.
Detre modified the Bloch equations (described in Section 2.1.2), to account for
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flow effects. Here the longitudinal magnetisation in the brain (Mb) is given as:
dMb
dt =
M0b −Mb
T1
+ fMa − f
λ
Mb (3.1)
where M0b is the fully relaxed value of Mb, λ is the blood-brain coefficient of water,
Ma is the concentration of longitudinal magnetisation of arterial blood water and f
is blood flow. To be able to fully quantify the method, multiple assumptions were
made. Detre assumed the labelled spins were exchanging immediately with the
brain tissue. Labelled spins, described by fMbλ , replaced the spins leaving the brain
through venous flow. The ASL model also assumed a complete saturation of blood
water and negligible relaxation of the spins until after exchange with tissue water.
At t = 0, where Ma = 0 after labelling, equation 3.1 was solved to give:
Mb(t) =
M0b
1 + fT1λ
{1 + fT1
λ
exp(−t( 1T1
+
f
λ
))} (3.2)
This meant Mb would be dependent on both f and the T1 of blood water, with an
apparent time constant given by:
1
T1app
=
1
T1
+
f
λ
(3.3)
Detre assumed that Mb decreased to a steady state magnetisation, Mssb , which could
be calculated by setting t =∞ and solving Equation 3.2:
Mssb
M0b
=
1
1 + fT1λ
(3.4)
The flow can thus be calculated by solving Equations 3.3 and 3.4:
f = λT1app
(1− M
ss
b
M0b
) (3.5)
The sequence was able to produce ASL images where an average change of signal
between the two images was 3.1% for a rat. With no cerebral blood flow the signal
change was expected to be zero in a dead rat, but a signal change of 1 % was found.
Detre attributed the value to spectrometer instability. To account for the signal
from the arterial intravascular volume, spoiler gradients were used around the
180° pulse in the imaging module. These spoiler gradients were used to suppress
the signal, with the contribution from the intravascular water being 0.6% of the
whole brain. Detre suggested the signal would make a small contribution, but that
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it could contribute to an over estimation of CBF.
Detre calculated the average value of cerebral blood flow for the rat brain to be
106 ml/100g/min, which he compared to a literature value of 100 ml/100g/min.
The good comparison with literature showed the assumptions used were reasonably
valid. To further validate the ASL model, CBF maps were produced using rats with
hypercapnea, where the average CBF value found was 227 ± 18 ml/100g/min.
3.2.2 Continuous ASL
Williams et al. introduced a different method for inverting arterial blood, namely
using adiabatic fast passage (Williams et al. 1992). This method was the first to
be known as ’Continuous ASL’ due to the long low power RF pulse that was used
(Figure 3.1). By using an adiabatic pulse for the inversion, rather than a saturation
pulse, an increase in temporal resolution was achieved, with the additional benefit
of being easier to implement. This new method produced mean CBF values of
139 ml/100g/min in the rat brain. The implementation of CASL in human studies
was challenging, due to the need for additional hardware (an extra coil for the
continuous RF pulse applied), along with the restrictions for specific absorption
rates (SAR). To compensate for this, a new ASL technique was developed that used
a short inversion pulse over a large labelling slab. This technique became known
as pulsed arterial spin labelling (PASL).
Head
Neck
Labelling plane
Imaging plane
ControlLabel
Figure 3.1: Continuous ASL schematic
Labelling takes place in the neck region using a long continuous RF pulse for CASL. The labelling pulse is placed above the
head for the control image to account for MT effects.
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3.2.3 Pulsed ASL
3.2.3.1 EPISTAR
Pulsed ASL was first introduced in 1994 by Edelman et al (Edelman et al. 1994). This
technique was known as echo-planar imaging and signal targeting with alternating
radio frequency (EPISTAR). Two echo-planar images had an interleaved acquisition
where one of the images had an RF inversion pulse applied to label the blood
(Figure 3.2). The RF pulse was 23ms in length, with a slab thickness of 90mm,
and much shorter than the pulse used in CASL. After application of the RF pulse, a
short delay was used before imaging, to allow time for the labelled arterial blood
to reach the imaging slice. A changeable delay time before imaging allowed the
signal from the labelled blood to be from the major arteries (400ms), the distal
branch arteries (800ms) or the capillaries and tissue (> 1000ms).
Head
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Labelling slab
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ControlLabel
Figure 3.2: Pulsed ASL schematic
The first pulsed ASL experiments used a thick slab to label the blood using a single short RF pulse. The pulse was placed
above the head to account for MT effects for the control image, similar to CASL.
A control inversion region was used to counteract magnetisation transfer effects,
as used by Detre et al. previously. There were issues with the control region
intersecting part of the brain, with the signal from veins appearing bright after
subtraction due to spin tagging. Quantitative maps of CBF were not produced in
this paper, however the technique was used to look at changes in brain activation
using the blood oxygenation level-dependent (BOLD) technique. Edelman used
PASL to show changes in the image signal intensity in the activated brain. The
PASL sequence showed considerable improvement over the initial work of Detre
and Williams. There was reduction in SAR, in addition to increased efficiency and
a reduced scan length from using an EPI sequence for image acquisition.
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3.2.3.2 FAIR
Another approach to using a single pulse for perfusion imaging was introduced as
flow-sensitive alternating inversion recovery (FAIR) by Kim et al in 1995 (Kim 1995).
Kim based FAIR on a protocol by Kwong et al (Kwong et al. 1995), and used slice-
selective inversion recovery imaging for identifying brain changes between sensory
activation and rest in humans. For FAIR, two inversion recovery images were ac-
quired, one with a non-selective inversion pulse and the other with a slice-selective
inversion pulse (Figure 3.3). An EPI module was used for image acquisition.
Head
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ControlLabel
Figure 3.3: FAIR Schematic
FAIR uses a non-slice-selective inversion pulse that covers the head for a human and covers most of the body or the full body
in rodents. For the control image, the inversion slice inverts only the imaging slice. This inversion slice is slightly larger
than the imaging slice.
For the slice-selective inversion (control), the blood water spins flow from out-
side the inversion slice to the intravascular compartment and then exchange with
the tissue water. These spins are fully relaxed. For the non-slice-selective inver-
sion (label), the inflowing spins are inverted and relax back to equilibrium due to
spin-lattice relaxation. Kwong’s protocol was able to qualitatively measure CBF.
Kim used FAIR to measure a quantitative value of CBF, and compared relative CBF
changes between rest and activated states in the brain. The FAIR sequence was
able to compensate for magnetisation transfer effects as the same RF inversion
pulse was applied in both label and control, with the control image having a slice-
selective gradient.
3.2.4 Pseudo-Continuous ASL
To compensate for the limitations of CASL, a variation of CASL called pseudo-
continuous ASL was introduced (Dai et al. 2008). Pseudo-continuous ASL (pCASL)
replaced the long RF pulse in CASL with a train of short duration, small flip an-
gle, slice selective RF pulses. A large number of pulses were used over a typical
2-3s labelling duration with a small gap (∼1ms) between them. pCASL reduced
the magnetisation transfer effects due to the larger gradients used in CASL. These
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gradients increased the resonant offset of the RF pulses, which reduced MT ef-
fects and increased the labelling efficiency (Alsop, Detre, et al. 2015). There was
an advantage to pCASL as it used only one coil, thereby addressing the additional
hardware issue of CASL. Furthermore, it did not need the continuous application
of RF power, lowering SAR levels (Dai et al. 2008).
3.2.5 Comparison of ASL Techniques
Usually PASL will have a higher labelling efficiency than CASL/pCASL. However,
CASL and pCASL have a higher signal and SNR. This is due to the temporal dura-
tion of the labelled bolus. In PASL, the labelled bolus is limited by the slab size
which in turn is limited by the dimensions of the transmit RF coil. CASL and pCASL
have a longer temporal duration which is proportional to the volume of labelled
blood. Overall, this means that CASL/pCASL have a higher signal and SNR com-
pared to PASL. Furthermore, there is a larger gap for labelled spins to travel in
PASL compared to pCASL so there are larger T1 decay effects (Alsop, Detre, et al.
2015).
Both PASL and pCASL have the advantage over CASL of not needing an extra coil for
labelling, meaning it is easier to implement on MRI systems. It has also been shown
that pCASL has a higher labelling efficiency than CASL (Wu et al. 2007). pCASL is
the current recommendation for clinical practise by the 2015 white paper from the
ISMRM perfusion study group (Alsop, Detre, et al. 2015).
3.2.6 Multiple Boli Arterial Spin Labelling
Multiple boli arterial spin labelling (mbASL) is a newly developed ASL sequence that
uses a train of adiabatic inversion pulses to label multiple boli of arterial blood as it
travels through the neck region (Figure 3.4) (Vallatos et al. 2018). mbASL combines
the high signal seen from pseudo-continuous labelling and the inversion slab in
PASL. The idea of a train of adiabatic pulses originates from Moffat et al. (Moffat
et al. 2005). The sequence was designed as an alternative to the original CASL
techniques that used flow driven adiabatic inversion. The train of pulses removed
the need for an additional labelling coil, whilst the use of adiabatic pulses kept the
labelling efficiency similar to pCASL 3.5. Moffat was able to produce CBF maps that
agreed with literature values and used them to examine a rat tumour model. The
sequence was not optimised however and was described as a pseudo-continuous
ASL. However, subsequently, the name pCASL has been widely used to describe a
different ASL sequence.
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Figure 3.4: mbASL Sequence
The mbASL sequence uses a train of adiabatic pulses to label multiple boli of blood as it passes through the neck region.
Following the labelling train, a short inversion time (TI) is used to allow the labelled blood to travel to the imaging plan. A
spin echo EPI readout is used to create the images.
A similar idea to mbASL was introduced by Ouyang et al. called pseudo-continuous
transfer insensitive labelling technique (pTILT). This sequence used a train of ap-
proximately 100 RF pulses to produce an ASL sequence similar to pCASL. The dif-
ference between pTILT and mbASL is the use of adiabatic pulses, with pTILT having
a lower SNR compared to pCASL sequences (Ouyang et al. 2011).
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Figure 3.5: Positioning of the mbASL labelling pulse
mbASL uses a labelling slice in the neck region for the label image. The labelling slice is placed above the head for the
control image to account for MT effects.
In Vallatos et al. paper, multiple parameters were examined with the aim of
optimising the sequence to be used with mice and rats. The number of pulses
needed for an optimal signal in mice and rats were shown to be different, with
rats needing a much higher number of pulses compared to mice. By varying the
delay time between labelling and imaging, it was shown that the labelled bolus sig-
nal peaked at different delay times dependent on the rodent strain. Experiments
performed on phantoms examined the use of various hyperbolic secant pulses for
labelling. The adiabatic parameters were varied to find the highest inversion ef-
ficiency. The mbASL sequence was compared to the standard manufacturer’s FAIR
sequence (Bruker), where it was found that mbASL had a higher overall signal and
SNR. For mice, at least a 20% increase in signal was seen in the brain compared
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to FAIR and a 60% increase in SNR. The increase in signal for rats was higher, with
between 100% and 200% for the different pulse types examined and an increase in
SNR of between 300% and 600% (Figure 3.6). Vallatos suggested that mbASL would
have an advantage over FAIR, particularly for rats. This is due to the short length
of the volume resonator typically used in pre-clinical MRI system, where the full
body of the rat is not fully inverted.
Figure 3.6: Signal increase for mbASL compared to FAIR
The signal increase for mbASL compared to the Bruker FAIR sequence for mice and rats, adapted from (Vallatos et al. 2018).
Multiple brain regions were examined with a 20% signal increase for mice and 60% for rats over FAIR.
Vallatos discussed a number of limitations of the mbASL sequence. CBF quantifi-
cation was not achieved, as the sequence was a hybrid of PASL and pCASL, and as
such, could not be described by current ASL kinetic models. A suggestion was made
that quantification for the thicker labelling slices could be made using a kinetic
model for PASL and for thinner labelling slices, a pCASL model. Furthermore, opti-
misation of associated parameters, such as the placement and size of the labelling
slice compared to the rodent, was needed.
3.3 Diffusion Weighted ASL
3.3.1 The Early Use of Crusher Gradients
The use of diffusion gradients in an ASL MRI sequence was first seen in the early
1990s by Williams et al (Williams et al. 1992), where vascular ’crusher’ gradients
were used to eliminate the contribution of the signal from labelled blood in the
arteries and veins. The assumption was made that these labelled spins do not con-
tribute to a change in signal intensity due to the small amount of arterial blood in
the brain (Williams et al. 1992). This idea was proven to be incorrect by Henkel-
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man et al. in their 1994 paper on measuring perfusion in the rat brain using IVIM
(Henkelman et al. 1994). By using a perfluorinated hydrocarbon (PFC) blood sub-
stitute, which was believed to be unable to cross the blood brain barrier (BBB),
the NMR signal measured would be only from flow of the PFC in the intravascular
space. By applying different values of gradient around the 180° pulse of the spin
echo sequence, they showed that signal attenuation occurred at a faster rate with
a small b-value compared to a larger b-value. The initial assumption in the IVIM
model, first introduced by Denis Le Bihan (Le Bihan et al. 1986), was that only
blood flow in the capillaries was contributing to the signal. This was contradicted
by the experimental data, which showed that IVIM was sensitive to flowing blood
in both the capillaries and the parent vasculature. This study provided evidence
that a single ‘apparent diffusion coefficient’ was not enough to explain the range
of diffusion values seen in the experiment. These findings were important as the
inclusion of the signal from arteries could cause an overestimation of CBF values
when quantification was applied.
3.3.2 Introducing the Two Compartment Model
Alsop and Detre first introduced the idea of a ‘two compartment model’ in 1996 to
address the issue of the signal from both the vasculature and the tissue contributing
to the images (Alsop and Detre 1996). Introducing a short delay time after the
labelling pulses reduced the sensitivity of the sequence to transit time effects. The
length of the post labelling delay (PLD) affected the contribution of the vascular
component and, ultimately, the transit time of the labelled spins became a function
of the PLD. Alsop showed that by choosing a suitable length of PLD, the signal from
the large vessels was reduced and that the use of bipolar gradients was needed
only if the transit time of the labelled spins to the vasculature was longer than the
PLD. Ye et al. were able to show in 1997 how substantial the signal drop was in
the DM image (49 %), from the effect of applying bipolar gradients. The decrease
of the signal in the control image with the same gradient strength was seen to be
only 3%. This was explained for the two different conditions. When no crusher
gradient was applied, the DM signal would be an equal combination of the signal
from the labelled arterial blood water and the labelled water contained in the
tissue. Consequently, when large crusher gradients were applied, the DM signal
was predominately from the labelled tissue water. Overall, there was seen to be
a dependence on the amplitude of the gradients for the DM signal.
Following Alsop and Detre’s work, in 2000 St Lawrence et al. suggested a more
accurate two compartment model, that would take into account restricted water
exchange (St Lawrence, Frank, et al. 2000). This was in comparison to the one-
56
compartment Kety model (Kety 1951), which assumed a free diffusion of the water
tracer between the tissue and capillaries. However, it was known that water is not
a freely diffusible tracer and, therefore, earlier models have underestimated CBF
values. The Kety model also assumed that the tagged water was located mainly in
the brain tissue. St Lawrence used a modification of the one-barrier distributed
parameter (1BDP) model, that assumed the labelled water that diffused into tissue
relaxed before it exchanged back into the capillaries. This was a reasonable as-
sumption due to the short T1 relaxation time for water of ∼1s at 1.5T. This model
was referred to as the single-pass approximation model (SPA). The SPA model sug-
gested that the signal from the arteries can be reduced by using crusher gradients,
but this signal contribution should still be considered in the kinetic model. This
was from the suggestion that crusher gradients would not affect the contribution
from the capillaries in human ASL experiments. Overall, the SPA model was a more
realistic model for measuring CBF values than the Kety model as it took into ac-
count different relaxation rates in the tissue and capillaries (St Lawrence, Frank,
et al. 2000).
3.3.3 Flow Encoding Arterial Spin Tagging (FEAST)
The work on introducing a delay time and accurate two-compartment model did
not address measuring the time taken for the labelled spins to travel through the
vasculature to the tissue. Wang et al. introduced a new ASL method to mea-
sure this arterial transit time (ATT): by taking the ratio of the DM signal from a
gradient-echo EPI ASL image with and without bipolar gradients. From this, they
could determine a transit time for tissue (Wang, Alsop, et al. 2003). An alternative
method at this point was to take images at multiple PLDs. The ASL sequence with
no gradient would have signal contributions from both the arterial compartment
and capillary/tissue compartment. The sequence with bipolar gradients would
suppress the vascular signal, leaving only the signal from the capillary/tissue com-
partment. By taking a ratio of the two signals, the tissue transit time could be
determined. Using Alsop’s two compartment model described above, they used a
PLD that was longer than the arterial transit time but shorter than the tissue transit
time. The assumption was that the labelled spins stayed in the vascular (arteries)
and microvascular (capillary) compartments rather than fully exchanging into the
tissue. Although this paper used bipolar gradients as a way to measure tissue tran-
sit time, it was again a method of suppressing the arterial signal. They were able
to show that the strength of the gradient and length of the pulse were important
factors when determining the tissue transit time, and that a longer gradient can
in turn produce a longer tissue transit time. The strength of the diffusion gradient
determined the optimal PLD, with a larger gradient meaning a longer PLD could
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be used. Wang et al. suggested that the PLD needed to be long enough for all the
labelled blood to enter into the imaging plane but short enough that the majority
had not passed into the microvasculature.
3.3.4 When Perfusion Meets Diffusion
Until the early 2000s, most studies had been focused on using ASL as a method to
non-invasively calculate CBF values in the brain, with or without diffusion gradi-
ents. Modelling of the ASL signal was becoming more sophisticated with Wang et
al. using the DWASL method to accurately measure water permeability in the brain
in 2007 (Wang, Fernandez-Seara, et al. 2007). This was also one of the first papers
to define diffusion weighted ASL as a sequence. By taking images at multiple b
values from b = 0 to 300 s/mm2, and fitting the data to a bi-exponential model, a
weighting factor for the signal from the flow dispersion in the capillaries and the
signal from the diffusion in the tissue could be measured. By measuring the signal
at different PLDs, they were able to statistically show that the capillary weighting
became less when the PLD was longer. Dependent on the value of the diffusion
gradient or PLD, the DWASL sequence could be made sensitive to the signal from
the arteries, capillaries or tissue. Wang showed the DWASL method could separate
the signal from the capillary and tissue compartments (known as the intravascular
(IV) and extravascular (EV) compartments) and had the potential to probe water
permeability values in the brain. The MRI data were used with the SPA model and
a value for the permeability surface-area product (PS) and, hence, the water per-
meability, Kw in the brain was calculated. This measure of permeability is not a
true permeability of the BBB, but an estimation.
The DWASL sequence was applied to a brain tumour patient, with an increase in
water permeability seen in the tumour region. A potential limitation to the tech-
nique was that there could be variations in ATT between normal tissue and tumour
tissue. This research provided evidence that DWASL could be used to non-invasively
measure the water permeability in the brain.
3.3.5 Combining Techniques
In 2011, St. Lawrence et al. combined the DWASL method with the FEAST method
to measure ATT and water permeability in the brain in a single scan time. By using
a combination of PLD times and b-values, they first determined the optimal values
for suppressing either the arterial or capillary signal (St Lawrence, Owen, et al.
2012). This was used in their two-stage protocol where they measured ATT by
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using b = 0 and 10 s/mm2 and a short PLD time and used b = 0 and 50 s/mm2 with
a longer PLD to separate the signal in the two compartments to be coming from
the capillaries and tissue, respectively. They were able to produce results for ATT
that were in agreement with values obtained using the FEAST method from Section
3.3.3 and results for Kw, the exchange rate of water across the BBB, that compared
with positron emission tomography (PET). This DWASL technique was used to look
at the water exchange across the BBB in obstructive sleep apnea by Palomares
et al. in 2015. By using DW-pCASL to measure the ATT, Kw and CBF values they
were able to show a difference in results between sleep apnea patients and control
patients (Palomares et al. 2015). The value of Kw was lower in both the white and
grey matter for the sleep apnea patients in addition to a reduced ratio of the signal
from DW-pCASL (b = 50)/pCASL (b = 0) compared to the control group. The drop in
Kw indicated an increase permeability of the BBB to water. The decrease in ratio
of signal between the two sequences (DW-pCASL/pCASL) also indicated that there
was a change in BBB integrity. Although a small sample size was used, which was
one of the limitations of the study, they were able to show that the DW-pCASL
sequence was sensitive to changes in the water exchange rate of the BBB and,
hence, could be used to examine permeability changes in the brain.
3.3.6 DWASL in Pre-Clinical Studies
The majority of literature on DWASL has focused on data obtained clinically. In
the early literature examining the effect of signal from the vascular compartment,
Silva et al. examined the combination of IVIM and ASL in their 1997 paper using rats
(Silva et al. 1997). This study was focused on using diffusion gradients to attenuate
the vascular signal so it would not cause an effect when measuring perfusion. Mul-
tiple b-values were applied, with the signal being fitted to a bi-exponential model
and thus demonstrating a split in the the signal from spins in the vascular or tissue
compartments. Overall, this study was described as IVIM and can be thought of as
an early introduction to the DWASL sequence, which is now used in more recent
literature.
A study by Kim et al. used the same process of combining IVIM and ASL to quanti-
tatively measure cerebral blood volume in 2006 (Kim and Kim 2006). This research
was used to demonstrate that the pseudo-diffusion component was from the spins
in the arterial blood, and that by separating the signal from the arterial blood and
the tissue, the arterial blood volume can be measured. They achieve this using
diffusion gradients. Although this technique was not being applied to measure BBB
permeability, it demonstrates a different use of diffusion gradients and ASL that
is useful for non-invasively imaging changes in the brain.
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In 2017 Tiwari et al. applied DWASL to an ischaemic stroke model in rats (Tiwari et
al. 2017). A continuous ASL sequence with diffusion gradients of b = 0 and 50 s/mm2
was used for imaging. Abnormal values of Kw were seen two days after stroke which
were similar to values obtained by DCE-MRI and histology. No significant results
using DWASL for Kw values at 90 minutes post-stroke were seen, which showed a
lack of sensitivity in the sequence at early stages in stroke. Overall, the study
showed that DWASL could be applied successfully in a pre-clinical model, although
limitations with signal and SNR needed to be addressed for the sequence to show
viable results.
Another pre-clinical application of DWASL was shown by Wells et al. using a multi-
directional DWASL sequence. Using a diffusion-weighted FAIR sequence for imag-
ing, a b-value of approximately b = 20 s/mm2 was applied in the X, Y and Z gradient
directions. They showed that DWASL could be sensitive to flow in different direc-
tions, which provided a novel approach to imaging micro-vascular flow patterns
using non-invasive MRI. It was suggested the protocol could be applied in a disease
model which has changes in cerebral blood flow (Wells, Thomas, et al. 2017).
3.3.7 Combining IVIM and ASL
More recent research from 2018 has reintroduced the concept of IVIM-ASL first
seen by (Silva et al. 1997). This study was focused on exploring the IVIM signal
in the brain and more specifically, where the signal for IVIM comes from in the
arterial tree, Zhang et al. used an ASL prepared IVIM sequence. By applying a
time-encoded pCASL module before the typical IVIM sequence, they acquired IVIM
data at multiple PLDs (Zhang et al. 2018). This allowed the group to show that
the typical single compartment model used in IVIM did not explain the observed
complex diffusion properties in the brain. By using different PLDs, they moni-
tored labelled blood at different points in its transit to the brain. They fitted the
acquired data to a bi-exponential model, which demonstrated the difference in
diffusion values between faster and slower flowing blood in the arterial tree. Due
to the time-encoded sequence which supplied data at a range of PLDs, they were
able to explore the origin of the IVIM signal, which had not been typically examined
in previous IVIM studies.
3.3.8 Applying DWASL using a 3D Readout
DWASL sequences typically use a 2D readout with a pCASL ASL module. Shao et al.,
in their 2019 paper, used the suggestion of the ISMRM white paper (Alsop, Detre,
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et al. 2015) and implemented a 3D GRASE readout for imaging with DWASL (Shao
et al. 2019). They were able to quantify Kw using a modification of the SPA model.
Separation of the fraction of signal from the capillary and tissue compartments was
performed by using a diffusion weighting of b = 50 s/mm2. The DWASL sequence
was applied to a group of elderly patients with a significant increase in values of
Kw found for patients with diabetes and hypercholesterolemia. This suggested that
DWASL could be used to image changes in water permeability with Kw as an imaging
biomarker for neurovascular disease.
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Chapter 4
Theoretical and Experimental
Assessment of a mbASL Kinetic Model
4.1 Introduction
This chapter describes the development and validation of a theoretical model for
the quantification of a new high SNR ASL technique (mbASL) that has been devel-
oped and optimised for use in rodent imaging. For mbASL to provide a compelling
alternative to currently employed ASL sequences such as pCASL or PASL, high SNR
needs to be combined with a robust quantification model and thus be able to pro-
duce CBF values that agree with the literature. To do this, a modified kinetic
model was developed and experimentally assessed in three animal strains. High
SNR mbASL images and CBF maps were produced for all rodents, with CBF values
that match the literature. The structure of this chapter was as follows:
1. The development of an mbASL kinetic model
• Introduction of the standard kinetic model and modifications required
to model mbASL
• Theoretical assessment on the effect of various mbASL parameters on
the resulting ASL signal
2. Experimental assessment of the mbASL kinetic model
• Optimal number of pulses for maximising signal
• Arterial transit time measurement
• Fitting the mbASL model to experimental data
• Producing quantitative CBF maps using mbASL
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4.2 Cerebral Blood Flow Quantification using ASL
Cerebral blood flow (CBF) is typically defined as the volume of arterial blood that is
delivered to the capillary bed of a unit volume of brain tissue per unit time (Alsop,
Detre, et al. 2015). Hence, CBF is normally measured in units of ml/100g/min.
Detre introduced the first model for quantification of CBF using arterial spin la-
belling (ASL), described in detail in Chapter 3. This early model makes a number
of assumptions, including no relaxation of labelled spins until after they exchange
with the tissue and that all the blood water has been saturated. Detre also as-
sumed there was instantaneous exchange of all labelled blood water between the
capillaries and tissue. Some sources of error have been identified in the measure-
ment of CBF in early studies. By not considering arterial transit time (ATT), this
can result in errors for estimation of CBF (Wegener et al. 2007). It was found that
by introducing a post-labelling delay time, this allows time for the majority of the
labelled blood to enter the imaging slice.
CBF measurements using ASL are usually validated against microsphere-based or
autoradiography techniques. Although these are considered the gold-standard
for measuring CBF, they are invasive and terminal. Generally, there has been
good agreement of ASL measurements compared to these techniques, although re-
ported values can vary, both clinically and pre-clinically. The ISMRM white paper
gives a CBF value range of between 40 - 100 mL/100g/min (Alsop, Detre, et al.
2015) in grey matter in humans. Parkes et al. reported CBF values from 53 - 62
mL/100g/min in the whole brain and 58 - 68 mL/100g/min in the grey matter for
men and woman (Parkes et al. 2004). A review paper of CBF values obtained from
ASL compared to positron emission tomography (Fan et al. 2016) from 2001 - 2016,
found a mean CBF of 42 ± 9 mL/100g/min for ASL in the whole brain, with 44 ± 9
mL/100g/min for PET. These results were within 15 % of each other.
Reported values of CBF in rodents are generally higher than those for clinical stud-
ies. Muir et al. reported a whole brain CBF value of 107 ± 8 mL/100g/min in mice
using a labelling coil placed at the heart (cardiac-spin-labelling technique) with 76
- 110 mL/100g/min in rats using continuous ASL. Muir et al. reported higher values
of 150 - 280 mL/100g/min using CASL (Muir et al. 2008). CBF values varied de-
pending on the anaesthetic gases used. Wegener et al. reported mean CBF values
of 103 ± 1 mL/100g/min in air and 180 ± 31 mL/100g/min for 5% CO2 for Wistar
rats. For a rat stroke model, Baskerville et al. reported CBF values of 157 - 177
mL/100g/min for the contralateral hemisphere and 9 - 104 mL/100g/min for the
ipsilateral hemisphere (Baskerville et al. 2012). For comparison between three rat
cohorts, Larkin compared multiphase pCASL measurements of CBF against autora-
diography measurements. They reported values of 100 - 111 mL/100g/min from
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multiphase pCASL and 108 - 122 mL/100g/min for autoradiography (Larkin et al.
2019).
There are multiple kinetic models which have been used to quantify CBF measure-
ments, with the Buxton model the most widely used (Buxton et al. 1998), detailed
in Section 4.3.1. Multiple assumptions have been made to provide a simplified ki-
netic model to estimate CBF. The ISMRM white paper (Alsop, Detre, et al. 2015)
suggests a simplified CBF model based on using a single inversion delay when scan-
ning. This model assumes that the entire labelled bolus has arrived in the tissue
being imaged and experiences T1 relaxation. Furthermore, it is also assumed there
is no outflow of labelled blood due to the tissue water pool being much larger than
the blood water pool.
Neither of the simplified models from the ISMRM white paper or Buxton’s general
kinetic model would be able to fully describe the signal produced from the mbASL
sequence due to its hybrid nature. However, Buxton’s model for PASL would be the
closest model to describe mbASL, and can be modified to take account of the train
of adiabatic inversion pulses used. Therefore, mbASL can be potentially described
as a multiple PASL due to the larger thickness of the labelling slab.
4.3 Theory
4.3.1 The Buxton Kinetic Model
In his 1998 paper, A General Kinetic Model for Quantitative Perfusion Imaging
with Arterial Spin Labelling, Buxton et al. (Buxton et al. 1998) produced a set of
equations that quantitatively describe the CASL and PASL sequences.
The general kinetic model is described as:
DM(t) = 2M0bf
∫ t
0
c(t′)r(t− t′)m(t− t′)dt′
= 2M0bfc(t) ∗ [r(t) m(t)] (4.1)
where M0b is the initial magnetisation, f is cerebral blood flow (CBF) and t is time
following labelling, measured in seconds. ∗ represents convolution. The model
is divided into three different signal conditions: the delivery function c(t), the
residue function r(t) and the magnetisation function m(t). These three functions
describe the net magnetisation in the tissue at a time t. The delivery function
(which is specific to PASL or CASL) describes the labelled blood arriving at time
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t. The residue function is the amount of labelled blood still in the tissue after
a time t. The magnetisation relaxation function describes the T1 relaxation of
the labelled blood water before arriving in the tissue (Buxton et al. 1998). The
standard model is summarised as:
c(t) = 0 0 < t < δ (a)
αe
−t
T1b (pulsed) δ < t < τ + δ (b)
αe
−δ
T1b (continuous)
0 τ + δ < t (c) (4.2)
r(t) = e
ft
λ
m(t) = e
−t
T1
Buxton assumed the following three conditions for the DM signal: (a) the time
before any labelled blood arrives in the imaging slice and hence no ASL signal. (b)
Labelled blood is arriving in the imaging plane and blood is also still being labelled.
(c) The signal when the labelling is finished but any remaining labelled blood is still
arriving into the imaging plane.
By combining Equations 4.1 & 4.2, the DM signal for pulsed ASL can be described
as:
DM(t) = 0 0 < t < δ (a)
= 2M0bf(t− δ)αe
−t
T1b qp(t) δ < t < τ + δ (b) (4.3)
= 2M0bfτe
−t
T1b qp(t) τ + δ < t (c)
with
qp(t) =
ekt(e−kδ − ekt)
k(t− δ) δ < t < τ + δ
=
ekt(e−kδ − e−k(τ+δ))
kτ τ + δ < t
k = 1T1b
− 1T′1
1
T′1
=
1
T1t
+
f
λ
where δ is the arterial transit time (ATT), α is labelling efficiency, τ is the duration
of the delivery of labelled blood, λ is the tissue/blood partition coefficient of
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water and T1b and T1t are the spin lattice relaxation times of blood and tissue
respectively.
The signal for continuous ASL can be described as:
DM(t) = 0 0 < t < δ (a)
= 2M0bfT′1αe
−δ
T1b qss(t) δ < t < τ + δ (b) (4.4)
= 2M0bfT′1αe
−δ
T1b e
−(t−τ−δ)
T′1 qss(t) τ + δ < t (c)
where
qss(t) = 1− e
−(t−δ)
T′1 δ < t < τ + δ
1− e
−τ
T′1 τ + δ < t
4.3.2 Producing Theoretical Graphs Using the Buxton Model
By varying different parameters in the kinetic model, Buxton showed their effect
on the overall signal. Figures 4.1 and 4.2 replicates the parameters Buxton used
in his paper using the PASL and CASL standard models (Buxton et al. 1998). These
graphs were produced using MATLAB code produced by myself for this study. The
decay of the signal in CASL depends on τ , which Buxton defined as the labelling
duration. With a long labelling duration a plateau of signal is reached before a
decay after labelling is stopped (Figure 4.2d). This is in contrast to PASL, which
shows no plateau, as only a single inversion pulse is applied (Figure 4.1d). Variation
of the value of T1 tissue showed minimal effect on the signal from PASL and CASL.
The magnitude of the signal increased as the value of CBF increased. Delta also
makes a similar effect on both sequences, with an increase in delta showing a
delayed arrival of signal compared to a short value of delta, and a loss of signal
from T1 relaxation.
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Figure 4.1: Theoretical Buxton signal graphs for PASL
Theoretical graphs produced using the Buxton standard kinetic model for PASL. Graphs show the signal against time (s). The
(green) line parameters are: f = 0.8, δ = 0.5s, τ = 1s and T1 tissue = 1s. The top left graph shows an increase in signal as
CBF increases. The top right shows by varying δ, the arrival of labelled blood and signal changes. The bottom left shows
the effect of changing the T1 of tissue and the bottom right shows the distribution of signal change as τ increases.
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Figure 4.2: Theoretical Buxton signal graphs for CASL
Theoretical graphs produced using the Buxton standard kinetic model for CASL. Graphs show the signal against time (s). The
(green) line parameters are: f = 0.8, δ = 0.5s, T1 tissue = 1s and τ = 3s. The top left graphs demonstrates the increase in
overall signal as CBF increases, with the shape of the curve staying the same. The top right shows that by increasing delta,
the signal arrives later and the overall signal is lower than when a shorter value of delta is used. The bottom left shows the
effect of changing the T1 of tissue and the bottom right shows as τ increases, the start of the decay of signal shifts.
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4.3.3 A mbASL Kinetic Model
The mbASL sequence has similarities to both pCASL and PASL, but cannot be fully
described by either model. mbASL is different to pCASL as it uses a large inversion
slab for labelling compared to the thin labelling slice used in pCASL. The mbASL
sequence is different to PASL as it uses multiple inversion pulses (instead of a single
inversion pulse) which are applied in the neck region, similar to pCASL. Overall,
the mbASL sequence is most similar to PASL because of the thick labelling slab
and therefore mbASL can be described as a multiple PASL. The value of Li, the
distance from the edge of the labelling plane to the edge of the imaging plane,
and the thickness of the labelling slab Linv can be varied dependent on the species
of animal being imaged (Figure 4.3). For the following study, the value of Li was
kept constant and Linv varied for experimental comparison.
Labelling slice Imaging slice
Li 
Linv
Figure 4.3: mbASL slice setup
The labelling slab is placed in the neck region for mbASL. The distance between the labelling and imaging plane (Li) is kept
constant. The labelling slab thickness (Linv) can varied with the slab being extended backwards.
Similar to Buxton’s standard kinetic model, multiple assumptions have been made
in our model of mbASL. A uniform plug flow was assumed, where the mean velocity
of labelled blood was calculated as:
Vblood =
Linv × np
CI (4.5)
where CI is the labelling time. The assumption was made that if enough labelling
pulses are used a continuous style arrival of labelled blood into the imaging plane
will occur, as seen in CASL or pCASL. Hence, Vblood is calculated as the mean veloc-
ity of blood crossing the total labelling slab distance during the labelling time. A
value for the T1 relaxation of arterial blood was assumed using the literature. For
the value of tissue T1, this was measured using a T1 mapping sequence for in-vivo
experiments and assumed for theoretical predictions. By using a RARE sequence
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with a varying TR, the signal from each image voxel is fitted to Equation 2.24 and
gives a value of T1 for each brain voxel. For τ , Buxton defined this as the duration
of arrival of labelled blood. For mbASL, the optimal number of pulses for imaging
will give a pseudo-continuous labelling and is a condition that is assumed. How-
ever, due to the fragmented description of mbASL, tau is defined as the time taken
for the labelled blood of one pulse to cross both Linv and Li:
τ =
Linv + Li
Vblood
(4.6)
The ATT is defined as the time it takes for labelled blood to cross the distance
between the labelling slab and imaging slice, Li, and is calculated as:
ATT = LiVblood
(4.7)
To describe the overall DM signal produced by mbASL, a fragmented description
was used, hence the mbASL model can be described by:
DMmbASL(t) = f
np∑
i=1
DMi,PASL(t) (4.8)
With DMi(t) being the magnetisation from pulse i, and DM being described by the
standard kinetic model for PASL (Equation 4.3).
4.3.4 Producing Theoretical Graphs Using the mbASL Model
Using the mbASL kinetic model described in Section 4.3.3, theoretical predictions
were made of the signal curves (Figure 4.4). The similarity of the shape of the
signal curve in mbASL to CASL when using a long labelling duration and a sufficient
number of labelling pulses is clearly demonstrated. At a low number of pulses, the
peak of the signal from each pulse can be seen, showing that an optimal value of
pulses has not been reached. As the number of pulses increases, the overall signal
curve will smooth and becomes similar to CASL. Experimentally, the signal would
not continue to increase with the number of pulses, due to multiple inversion. By
increasing the labelling thickness, the number of pulses needed to achieve contin-
uous labelling decreases. This can clearly be seen with the comparison of of np =
16 between Figure 4.4 (a) and (b).
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Figure 4.4: Theoretical mbASL signal graphs
Theoretical signal predictions from the mbASL kinetic model, with comparison to PASL and CASL. For all graphs f = 1, λ =
0.8, ATT = 50ms, T1 tissue = 1.76s and T1 blood = 2.1s. For the top left and right graphs CI = 5s and the number of pulses
were varied for two different labelling slab thicknesses. The top left graph shows that at a short labelling thickness, more
pulses are needing to obtain continuous labelling when compared to the top right graph. The bottom left graph shows a
PASL signal curve and the bottom right a CASL signal curve. As the number of pulses increase in the top graphs the signal
curve represents the CASL signal.
By changing the value of CI, the signal distribution from mbASL can be made to
reflect a CASL or PASL distribution. Using a short CI of 500ms (Figure 4.5a) shows
the signal as a PASL distribution with the peak of the signal shifting as the labelling
thickness increases. The number of pulses needed for continuous labelling also
decreases as the labelling thickness increases. When using a labelling duration of
5s (Figure 4.5b), the signal resembles a CASL distribution and shows a plateau of
signal before the signal decays after labelling stops. This demonstrates the hybrid
nature of the mbASL sequence with the signal replicating both PASL and CASL,
whilst using a range of labelling slab thicknesses and number of pulses.
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Figure 4.5: Comparison of mbASL signal at different CI values
Comparison of the mbASL signal at two different labelling durations. Both graphs use the same number of pulses (80, 40
and 20) and labelling thicknesses (Linv = 6mm, 12mm and 24mm). Figure a) shows the signal at CI = 0.5s with a higher signal
seen the at the short labelling thickness of 6mm and the peak of the signal shifting towards the right for the larger labelling
thicknesses. Figure b) shows the same parameters but using CI = 5s. The signal curve resembles a more CASL distribution
with a higher signal seen for the short labelling thickness. The graph demonstrates that more pulses are needed for the
24mm labelling thickness to produce continuous labelling.
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4.4 Experimental Validation
To validate the mbASL quantification, multiple experiments were performed using
three rodent strains: CD-1 mice, C57 mice and SD rats. The experiment was con-
ducted in two parts: the first part consisted of all experiments being performed
on SD rats and CD-1 mice. Following analysis of the initial results, a second part of
the experiment involved performing the experiments using C57 mice to examine
if changes between mouse strains could be detected. Experimental parameters
were altered accordingly. Each strain underwent the following experiments:
1. Varying the number of pulses and thickness of the labelling slab to find the
optimal number for each rodent strain
2. Examination of the distribution of signal for each labelling slab thickness at
multiple inversion delays to confirm theoretical predictions
3. Using optimal parameters from the experiments described above, CBF is mea-
sured by fitting of data to the mbASL kinetic model
4. Comparison of the signal from mbASL against the standard FAIR sequence,
demonstrating the high SNR of the sequence
4.5 Methods
4.5.1 Animal Set Up
All experiments were carried out in accordance to the local ethics review panel
and the UK Home Office Animals (Scientific Procedures) Act 1986. Experiments
were performed on C57 black mice (n = 5, weight = 20 ± 1g), CD-1 white mice (n =
6, weight = 35 ± 3g) and SD rats (n = 6, weight = 465 ± 8g). All animals originated
from Charles River Laboratories, Glasgow, UK. The animals were anaesthetised in a
chamber using 5% isoflurane and a 30:70 O2/NO2 ratio before being transferred to
the MRI scanner. The animals were positioned in an adapted cradle for rodents with
a hot-water jacket used to regulate physiological temperature (36.5°C− 37.5°C).
The head of the animal was kept central with ear bars placed in the ears and
a nose cone used to deliver anaesthetic gas. The animals were spontaneously
breathing using isoflurane levels of 1% - 3% and 30:70 O2/NO2 ratio at a constant
flow of 1Lmin−1. The isoflurane concentration was varied for each animal to keep
a stable respiration rate of 40 - 70 breaths per minute for mice and 60 - 90 breaths
per minute for rats. To measure the respiration, a pressure sensor connected to
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an air-filled balloon was placed under the animal’s abdomen (Biotrig 1.03, Bruker
Biospin, Ettlingen, Germany).
4.5.2 Scanner Set Up
Experiments were performed on a horizontal 7 T Bruker PharmaScan Avance III sys-
tem (300 MHz). A Bruker BGA9 imaging gradient insert (300 mT/m) was used to
provide linear magnetic field gradient pulses. A 72mm diameter, 110mm length
birdcage Radio-Frequency (RF) volume resonator was used to transmit, with a four-
channel phased array receive only head coil used to detect the signal (22mm length
for mice and 35mm for rats (Rapid Biomedical GmbH, Rimpar, Germany)). Exper-
iments were performed using either the mbASL sequence or the manufacturer’s
standard FAIR pulse sequence (Bruker Paravision 5.0). The imaging acquisition
module was echo planar imaging (EPI). For direct comparison of methods, iden-
tical imaging parameters were used. All scans used a matrix of 96×96, with mice
having an imaging slab thickness of 1mm, positioned 4mm posterior from the rhi-
nal fissure and for rats a thickness of 1.5mm, positioned 7mm posterior. Labelling
slab and imaging slice positions are shown in Figure 4.3. For mice the field-of-view
(FOV) = 2.5×2.5cm and for rats the FOV = 1.76×1.76cm. The mbASL-EPI method
was implemented by pre-weighting an EPI sequence with a train of slice-selective
hyperbolic secant (HS) inversion pulses. For each rodent, the distance between
the edge of the labelling slab and imaging slice (Li) was varied. Multiple labelling
slab widths (Linv) were used in the experiment (Table 4.1).
4.5.2.1 Number of Pulses
To achieve optimal pseudo continuous labelling, the number of pulses needed will
vary for each labelling thickness. To optimise the number of inversion pulses
needed, scans were performed using a single shot mbASL-EPI sequence with the
following parameters: continuous inversion time (CI) = 5000ms, inversion delay
(TI) = 50ms, TR = 7000ms, NA = 8. The experimental parameters are given in Table
4.1. The inversion pulses were spread evenly over the inversion time.
4.5.2.2 Varying the Inversion Time
A short labelling duration and various inversion delays were used to examine the
distribution of signal for each labelling slab thickness. Single shot mbASL was used
with CI = 500ms and a variable TI with overall TR kept at 7000ms (TI+TR) (Figure
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Strain Inversion length (mm) Li (mm) Number of Pulses (np)
CD-1 3 5.5 2, 4, 8, 16, 32, 34, 36, 38, 40, 42, 44
CD-1 6 5.5 2, 4, 8, 16, 24, 32, 34, 36, 38
CD-1 12 5.5 2, 4, 8, 16, 20, 24, 32, 34
C57 4 11 2, 3, 4, 5, 6, 7, 8, 9
10, 11, 12, 13, 14, 15, 16, 17
C57 8 11 2, 3, 4, 5, 6, 7, 8, 9, 10
C57 16 11 2, 3, 4, 5, 6, 7, 8
SD Rat 6, 12, 36 24.25 10, 15, 20, 30, 40, 50, 60
Table 4.1: Number of pulses used for the optimisation of pulses experiment for mice and rats.
4.6). The number of pulses used for each thickness was chosen based on the pre-
vious optimisation of pulses 4.5.2.1. For mice this was np = 8, 4 and 2 for Linv = 4,
8 and 16 mm for C57 mice and np = 12, 6, 3 for Linv = 3, 6, 12 mm for CD-1 mice.
For rats, np = 5, 3, 2, 2 for Linv = 6, 12, 24 and 36 mm respectively. To calculate
values of ATT for each labelling slab thickness, the signal curve for each thickness
was averaged and fitted to the mbASL kinetic model using in-house MATLAB code.
Labelling (500ms)
EPI Readout
500ms
500ms
50ms
Labelling (500ms)
EPI Readout
50ms
500msLabelling (500ms)
EPI Readout
50ms
Figure 4.6: Simplified diagram of the inversion time experiment for mbASL
For each scan, the labelling time was kept constant at 500ms. The inversion delay to allow labelled blood to travel to the
imaging plane was increased by 500ms for each scan. The delay increased from 50ms to 4050ms, with the overall TR value
decreased each time to keep a constant TI + TR = 7s.
4.5.2.3 CBF Maps
For full quantification of mbASL, high SNR 4-shot mbASL images were obtained
using TI = 50ms, CI = 5000ms, TR = 2000ms, NA = 10. For C57 mice np = 20, 10, 5
for Linv= 4, 8, 16mm and for CD-1 mice np = 45, 30, 15 for Linv = 3, 6, 12mm. For
the rats, np = 50, 30, 20 for Linv = 6, 12, 24, 36mm. A T1 map was obtained for
each animal using NA = 8, TE = 12.29ms, TR = 916ms. Seven slices were used with
a RARE factor of 4. For comparison of mbASL with FAIR, the Bruker instruments
(Paravision 5.0) standard FAIR EPI method was used, with the same TR, imaging
parameters and scan time as mbASL. A 12mm slice thickness was used for both
mice and rats, with an inversion pulse of 5ms and delay between inversion and
imaging of 1750ms.
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To calculate quantitative cerebral blood flow maps, a quantitative model of CBF
was used:
CBF = 6000 DMmbASL∑np
i=1 Mi(t)
(4.9)
where Mi(t) is:
Mi(t) = 2Mb0τα
e
−t
T1b ekte−kδ − e−k(τ+δ)
kτ (4.10)
with T1b = 1.65s for 7T, α = 0.96, λ = 0.9. The modification of Mb0 was used due to
using a TR of less than 5s (Alsop, Detre, et al. 2015). τ , δ and k were calculated
for each species as per the definitions above. DMmbASL is the signal obtained from
subtracting the control and label images and a factor of 6000 is used to convert the
CBF values into units of mL/100g/min. CBF values were calculated per voxel with
a map produced for each animal. ROIs were taken for the full brain and cortex
region for quantitative comparison between ASL methods and labelling thickness.
For qualitative comparison of signal between the mbASL and FAIR images, the same
scale is used.
4.6 Results
Two species of rodents were used to experimentally validate mbASL: mice and rats.
Furthermore, two strains of mice were used: C57 mice and CD-1 mice. Parameters
were optimised for each rodent/strain with mbASL images and CBF maps produced.
4.6.1 Optimal Number of Pulses to Maximise Signal
The optimal number of pulses varied with the thickness of the labelling slab (Figure
4.7). Three animals were used for each species with all scans taking place in the
same scanning session. For the SD rats, a plateau of signal was seen for Linv =
12mm starting at 30 pulses, with a decrease in signal observed when more pulses
were used. For Linv = 36mm, although a peak was seen at 50 pulses, the data
suggests that after 20 pulses, the plateau of signal has began. For Linv = 6mm, a
maximum of 60 pulses was used, but a plateau was not seen. Experiments using
Linv = 24mm in SD rats were performed in a different session with no number of
pulses optimisation performed.
In the C57 mice, the optimal labelling thickness fell between the Linv = 8mm and
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Figure 4.7: Number of pulses optimisation for SD rats
A range of labelling pulses between 10 and 60 were used to optimise the signal seen for SD rats for different inversion slab
thicknesses. The data were plotted as a percentage of the maximum signal at each value of pulses. N = 3 animals were
used and error bars were calculated as the standard deviation.
16mm thicknesses (Figure 4.8a). The peak number of pulses was five pulses for
the 8mm thickness and four pulses for the 16mm thickness. The optimal number
of pulses was not reached for Linv = 4mm, but the curve suggests that the plateau
was nearly reached at seventeen pulses, with a suggested optimal of around twenty
pulses. In the CD-1 mice, the optimal number of pulses needed was higher than
the number of pulses used in the C57 mice (Figure 4.8b). The peak number of
pulses was 20 for Linv = 12mm with a plateau of signal seen for Linv 6mm from 32 -
38 pulses. For Linv = 3mm, a maximum of 44 pulses were used, with a plateau not
reached.
The number of inversion pulses used was limited due to the RF duty cycle (∼
2.5mW) of the surface coil and SAR restraints. The full range of pulses used are
presented in Table 4.1.
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Figure 4.8: Number of pulses optimisation for mice
a) For 4mm, the plateau in signal was not reached but the trend suggests this would happen at approximately 20 pulses.
The optimal signal was seen at five pulses for Linv = 8mm and four pulses for 16mm with a drop in signal seen after this.
The data are presented as a percentage of the maximum signal reached. b) The optimal signal was not reached for the
smallest labelling slab (Linv = 3mm) with the signal still increasing at 44 pulses. For Linv = 6mm, a plateau was reached after
30 pulses. The signal peak was seen at 20 pulses for Linv = 12mm with the signal dropping after this. N = 3 mice were used
in each experiment and error bars were calculated as the standard deviation.
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4.6.2 ATT Measurement
The mean velocity of blood crossing the labelling slab and hence mean ATT was
calculated using Equation 4.7 for each value of Linv. The distance Li was 24.25mm
for rats, 11mm for C57 mice and 5.5mm for CD-1 mice. Values of np were chosen
based on when continuous labelling was reached in the data produced from Section
4.6.1. As the optimal number of pulses was not reached for the smallest labelling
thickness in all species, these ATT values were not considered to be accurate (Table
4.2).
SD Rats C57 Mice CD-1 Mice
6mm 12mm 36mm 4mm 8mm 16mm 3mm 6mm 12mm
Vblood (mm/s) 60 72 144 11.2 9.6 12.8 24 36 48
ATT (s) 0.40 0.34 0.21 0.98 1.1 0.859 0.23 0.152 0.114
np 50 30 20 14 6 6 40 30 15
Table 4.2: ATT values from the mbASL study
4.6.3 Fitting mbASL Data to the Kinetic Model
4.6.3.1 Graphs
The signal obtained at the varying inversion times (TI) was fitted to the mbASL
kinetic model and plotted for each value of Linv, for all species. Figure 4.9 demon-
strates the fit for the SD rats. The peak of the signal is at 50ms for Linv = 6mm
and shifts to 1000ms for Linv = 12mm. For the larger slabs, Linv = 24mm and 36mm,
multiple peaks appear across the four second inversion time, with more variance
in the data. The quality of the fit of data to the model was high for the smaller
values of Linv = 6mm and 12mm (R2 = 0.92 and 0.82), but was poor for the larger
Linv values of 24mm and 36mm (R2 = 0.46 and 0.011).
For the CD-1 mice, although the labelling thickness was varied between 3mm and
12mm, no change in peak signal was seen between the curves. This is assumed to
be from using a smaller value of Li, compared to the C57 mice (Li = 5.5mm for CD-1
in comparison to Li = 11mm for C57 mice). The peak signal was at 50ms for each
curve. The fitting of data to the mbASL model for 3mm, 6mm and 12mm resulted
in R2 values 0.98, 0.98 and 0.62. For the C57 mice, a shift in the peak of the signal
at each labelling thickness was seen after a 50ms delay for Linv = 4mm, but shifted
to one second for Linv = 8mm and 1.5 seconds for Linv = 16mm (Figure 4.10a). The
fitting of data to the mbASL model for 4mm, 8mm and 16mm resulted in an R2
value of 0.96, 0.96 and 0.96.
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Figure 4.9: Variable TI data for SD rats fitted to the mbASL kinetic model
The thinner slabs had a high R2 fitting value for the mbASL model (R2 = 0.92 for Linv = 6mm and 0.82 for Linv = 12mm). For
the larger 24mm and 36mm labelling slabs the signal is lower from being outside of the homogeneous region of the magnet.
This results in a poorer fit to the model (R2 = 0.46 for Linv = 24mm and 0.01 for Linv = 36mm). N = 6 rats were used and error
bars were calculated as the standard deviation.
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(a) Variable TI data fitted to the mbASL kinetic model for C57 mice
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(b) Mean signal for variable TI data from CD-1 mice fitted to the mbASL kinetic model.
Figure 4.10: mbASL data fitted to the kinetic model for mice
a) Each labelling thickness displayed a different distribution of signal, with the peak of the signal shifting to a higher TI
value as the labelling thickness increased. b) The signal curve seen at all three labelling thicknesses showed the same
distribution of signal, with the peak signal seen at 50ms. N = 6 C57 or CD-1 mice were used and error bars were calculated
as the standard deviation.
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4.6.3.2 Obtaining ATT Values from the Fitted Data
Values of ATT found from fitting the variable TI data to the mbASL, PASL and CASL
kinetic models (Table 4.3) were compared with values found in Section 4.6.2. Val-
ues of ATT were only considered comparable if a sufficient R2 fitting values was
found (R2 > 0.75).
SD Rats C57 Mice CD-1 Mice
6mm 12mm 4mm 8mm 16mm 3mm 6mm 12mm
ATT (s) 0.4 0.34 0.98 1.1 0.86 0.23 0.15 0.11
ATT (s) mbASL 0.24 0.6 0.96 1.13 0.9 0.036 0.073 -
ATT (s) PASL 0.24 0.08 0.09 0.11 0.1 0.08 0.08 0.08
ATT (s) CASL 0.84 - - - - - - -
Table 4.3: ATT values from fitting to the mbASL, PASL and CASL kinetic models.
Only values were the R2 value is >0.75 are displayed, with values <0.75 considered not accurate. The top line represents
the ATT values that were previously calculated in Section 4.6.2
4.6.4 Comparison of DM mbASL to DM FAIR
The mean DM signal from different brain regions was compared between images
produced using the mbASL sequence and the Bruker FAIR sequence. For the SD rats,
the mbASL images had a much higher DM signal compared to FAIR for all labelling
slab thicknesses (Figure 4.11). For a full brain ROI, the DM signal was 375% of the
DM FAIR signal for Linv = 12mm. A similar increase was seen for the cortex with a
value of 365% of the FAIR signal.
A large DM signal increase was seen in the brain for C57 mice compared to FAIR.
The comparison of DM mbASL to FAIR was 467% and 546% in the full brain for Linv
8mm and 16mm respectively. In the cortex, the comparison was 428% and 510%.
The large increase in DM signal can be attributed to a low overall signal from the
FAIR images. The DM mbASL signal for CD-1 mice showed higher signal than FAIR at
all labelling slab values. The highest DM signal increase was seen for Linv = 16mm
at 162 %. For the 12mm slab thickness, the mean signal was 128 % of FAIR. An
increase in DM signal was seen for each labelling thickness for CD-1 mice. For Linv
= 6mm and 12mm, the ratio of mbASL DM signal to FAIR in the whole brain was
128% and 162%. In the cortex ROI, the DM signal was 133% and 165%.
4.6.5 Calculation of CBF Maps using the mbASL Kinetic Model
An optimal labelling slab thickness was chosen for each strain. This was based on
the fitting of the signal to the mbASL kinetic model and if a plateau of signal had
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been reached when optimising the number of labelling pulses. For SD rats, this
was Linv = 12mm, Linv = 8mm for C57 mice and Linv = 6mm for CD-1 mice.
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Figure 4.11: mbASL images and CBF maps for all strains
An mbASL image and corresponding CBF map (presented in units ml/100g/min ± standard deviation) at the optimal labelling
slab thickness are shown for each rodent strain. A FAIR image is shown as a comparison for mbASL. mbASL and FAIR images
are shown with arbitrary units. For SD rats at Linv = 12mm, the mean CBF value was calculated to be 120 ± 14 ml/100g/min
using a whole brain ROI and 138 ± 28 ml/100g/min in the cortex. A value of Linv = 8mm for C57 mice gave a mean value of
CBF as 110 ± 9 ml/100g/min for the full brain and 128 ± 8 ml/100g/min in the cortex. For CD-1 mice, the optimal labelling
thickness was Linv = 6mm, with a CBF value of 172 ml/100g/min ± 31 in the full brain and 195 ± 44 ml/100g/min in the
cortex.
CBF maps were calculated for each strain using the mbASL kinetic model, mbASL
images and T1 maps. In the SD rats, a mean CBF value of 120 ± 14 ml/100g/min
was calculated for the full brain ROI and for the cortex as 138 ± 28 ml/100g/min.
For the C57 mice, the mean value of CBF produced was 110 ± 9 ml/100g/min
for the full brain. Using an ROI in the cortex, the mean CBF value was 128 ± 8
ml/100g/min. The CD-1 mice had a higher mean CBF value with 172 ml/100g/min
± 31 in the full brain and 195 ± 44 ml/100g/min in the cortex.
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4.7 Discussion
The aim of this work was to produce a kinetic model for the mbASL sequence,
which was used to generate CBF maps. A modification to Buxton’s kinetic model
showed the mbASL signal could be accurately described mathematically. Using this
model, the effects of np and Linv on the mbASL signal were theoretically assessed
and in-vivo experimental validation of the sequence undertaken.
4.7.1 Quantification
As mbASL uses a train of adiabatic pulses paired with a thick labelling slab, it is
better described as a multiple PASL, rather than a pCASL sequence, which uses
a thin slice for labelling. Our mbASL kinetic model therefore made the same as-
sumptions and had the same limitations of the original Buxton model. The mbASL
model assumed that all the blood in the labelling slab is inverted during the in-
version time. The assumption that the labelled blood has travelled to the imaging
slice when imaging takes place was also used. For the larger slabs this may not
be true, as seen when increasing the labelling slab thickness the peak of the sig-
nal shifts. Another assumption was made that if a sufficient number of pulses are
used, then continuous labelling will be reached, and the signal would compare to
CASL. The model was examined theoretically, by changing the number of inversion
pulses and the size of the labelling slab (Figure 4.4). If a small number of pulses are
used, the peak of each signal can be seen and continuous labelling is not reached.
Furthermore, the importance of the size of the labelling slab is shown, with the
model demonstrating that less pulses are needed to reach continuous labelling for
the larger slab (Linv = 36mm) compared to the thinner slab (Linv = 6mm). The hybrid
nature of the sequence was shown in two ways. First between Figure 4.4 where a
long CI value was used and Figure 4.5 where a short value was used. By using a long
CI the demonstration of the CASL curve is seen and a plateau of signal reached with
enough inversion pulses. Using a short CI demonstrates the typical mbASL signal
curve which is similar to PASL. Figure 4.5 also demonstrates that by changing the
size of the labelling slab, the peak of the signal will shift.
4.7.2 Experimental Validation
To experimentally validate the mbASL sequence and explore the theoretical pre-
dictions, multiple in-vivo experiments were performed on SD rats and two strains
of mice. This was for two reasons: to explore if any major differences were seen
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between the mouse strains and to further validate the quantification of mbASL by
showing its ability to produce CBF values for multiple strains.
4.7.2.1 Number of Pulses
The number of pulses needed for each labelling thickness was optimised to produce
a continuous labelling. This optimisation was able to show that using a larger
labelling slab generally needed a lower number of pulses to label the arterial blood.
The number of pulses used were limited for the thinnest slabs for each species due
to the duty cycle of the coil and SAR levels. The number of pulses needed for rats
was higher than in mice. This confirms what was previously described by Vallatos
et al. (Vallatos et al. 2018), where similar results were produced with rats needing
more pulses overall to label the blood compared to mice.
The mbASL model assumed that a sufficient number of pulses are used to create
continuous labelling. If the number of pulses chosen is not from the plateau re-
gion, this may violate this assumption, resulting in a non-continuous labelling and
overall lower SNR. The curves produced for the larger labelling thickness in both
rodents showed that using too many pulses would also produce a detrimental ef-
fect and the overall DM signal, which will decrease due to over-labelling of the
arterial blood. Furthermore, optimisation of the number of pulses avoided un-
necessary pulses being used, especially in the smaller labelling thicknesses. The
difference in optimal pulses between the CD-1 and C57 mouse (Figure 4.8a and
Figure 4.8b) demonstrates the importance of not only optimising for each rodent
but also for different strains. Furthermore, it demonstrates there is a minimum
labelling thickness that can be practically used for mbASL.
4.7.2.2 Obtaining ATT values
As the mbASL protocol is novel to other ASL sequences (Figure 4.3), it was con-
sidered that literature values of ATT would be inappropriate. Hence, ATT was
calculated from the number of pulses optimisation (Section 4.6.1. A simplified
approach was used, with the optimal number of pulses found from the pulse op-
timisation graphs and Equation 4.7. This gave sensible results compared to the
literature. Hirschler et al. reported a range of measured ATT values across the
brain in mice from 169ms in the hippocampus to 284ms in the cortex (Hirschler
et al. 2018). Thomas et al. measured the ATT in rats used CASL with a range of
177ms for the caudate putamen to 339ms in the visual/auditory cortex (Thomas
et al. 2006). Similar values were also reported by Wells et al. with a transit time
of 240ms (Wells, Siow, et al. 2013). The ATT for rats in this experiment generally
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matches well with our value in rats being 340ms (Section 4.6.2). In CD-1 mice a
range of ATT values between 110ms and 230ms were calculated. These again agree
with what has been seen in the literature. For the C57 mice, much longer ATT times
were found, with over one second for Linv = 8mm. This has been attributed to the
long distance between the labelling and imaging slice planes, relative to the size
of the animal being imaged. The velocity in these mice was lower than the CD-
1, which was perhaps to be expected as the mice were smaller. Furthermore, a
lower number of pulses was needed to label the blood. Further studies of the C57
mice using a large group of animals would be useful to explore the accuracy of
these results, as from Figure 4.10, labelled blood has arrived after a CI of 500ms
labelling.
4.7.2.3 Fitting to the Kinetic Model
To examine the hybrid nature of the mbASL sequence, data were acquired at multi-
ple TI values using a short labelling duration of 500ms. For small values of Linv, the
peak of the signal was seen after a delay of 50ms, with the signal curve mimicking
the decay of signal seen in a pCASL experiment (C57 mice (Figure 4.10a) and rats
(Figure 4.9)). The lack of a peak shift for the CD-1 mice was believed to be due
to the small distance chosen between the labelling and imaging slice and, hence,
the peak signal was seen at 50ms for all Linv. This was one of the reasons a second
strain of mouse was included in the experiments as previous research (Vallatos et
al. 2018) had shown for C57 mice the peak occurred at a time point larger than
50ms with similar experimental parameters. Double peaks seen in the 24mm and
36mm data produced from the rats. This could result for two potential reasons.
Either the recirculation of the heart causes the labelled blood to take longer to
reach the imaging slice or the number of inversion pulses were too low. A similar
effect was seen from the theoretical predictions when using similar values (Figure
4.4). The overall DM signal for these thicker slabs were lower than for the smaller
slab thicknesses. This may be due to part of the inversion slab being outside of the
homogeneous region of the RF coil, stressing there is a limit beyond which mbASL
will not produce optimal results. In addition, a lower DM signal will be produced
when using a large labelling slab due to T1 relaxation effects.
The variable TI data were fitted to the mbASL model to see if an accurate value
of ATT could be produced. In addition, the data were also fitted to the PASL and
CASL models, to examine if ATT values would change between the three models
depending on the labelling slab thickness. In rats, the PASL models produced values
that resembled the literature, but differed from the values calculated in Section
4.6.2. For mbASL, a longer value was found from fitting with the 12mm thickness
than from the calculated value. In the C57 mice, the CASL fitting value was low for
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all labelling thicknesses. This is most likely due to the longer distance of Li used
compared to a standard CASL or pCASL sequence. Only one value was obtained with
a high fitting R2 value for mbASL. This did not agree with either the calculated ATT
or PASL. Overall this suggests that when too large an Li or Linv is used, the ATT
values are not accurate. PASL fitting values were similar to literature but were
vastly different from the calculated ATT. In CD-1 mice, the fitted mbASL values
were higher than the calculated values, but were still within literature range.
Overall this research has shown that accurate values of ATT cannot be obtained
by fitting to the mbASL kinetic model. This will be due to the model not taking a
number of factors into consideration, including the heart circulatory system and
considering the labelled blood to travel with a constant velocity, with further work
on the model needed to be able to obtain similar ATT values from both a calculation
(Section 4.6.2) or fitting to the model.
4.7.2.4 CBF maps
Cerebral blood flow maps were produced for each animal, using the ATT values
found using Equation 4.7 (Section 4.6.2). The mean CBF seen across all the subject
groups were within the literature range (Duhamel et al. 2012; Baskerville et al.
2012; Larkin et al. 2019; Buck et al. 2018). For SD rats, the mean CBF value was
120 ml/100g/min. Larkin et al. reported values of 111 ml/100g/min using a pCASL
sequence. Wells et al. also reported similar results with a value of CBF as 123
ml/100g/min using a FAIR sequence (Wells, Siow, et al. 2013). For mice, the mean
CBF was higher for the CD-1 mice compared to the C57 mice (172 ml/100g/min
compared to 110 ml/100g/min). This was expected as the CD-1 mice were larger
in size and weight and hence needed a larger number of labelling pulses to reach
a plateau of signal. This suggests these mice had a faster blood velocity than the
C57 mice and hence a higher CBF. Both values compared to what is reported in
the literature. Buck et al. reported CBF values of 96 ml/100g/min using BALB/c
mice (Buck et al. 2018). Duhamel measured values of CBF of 116 ml/100g/min
on C57 male mice, comparing well to the values found for C57 mice. Although in
rats, Baskerville et al. reported values of 157 - 177 ml/100g/min using a pCASL
sequence, showing our results fall within a range seen in the literature using both
pCASL and FAIR. Most models of CBF (Larkin et al. 2019; Alsop, Detre, et al. 2015)
use a simplified model to calculate the maps. This work has shown that the mbASL
kinetic model can be used to produce accurate CBF values that agree with values
in the literature and can account for differences between strains.
86
4.7.2.5 Comparison of mbASL and FAIR DM Signal
The mean signal from the DM mbASL images was compared to the values in the FAIR
images under the same conditions. It should be stressed that it was attempted to
keep as many parameters the same for both sequences; overall scan time, FOV,
matrix size, labelling duration and receiver gain. Both scans were also performed
in the same imaging session. An increase in DM signal was seen in multiple brain
ROIs, for all animals over FAIR, and confirms what was presented previously for
mbASL (Vallatos et al. 2018). In both mouse species, the largest increase in DM
signal was seen in the thicker slabs (Linv = 12mm CD-1 and Linv = 16mm C57), with
an increase between 300 % and 500 % in the C57 mice. This is much higher than a
mean increase of 130 % over FAIR for the CD-1 mice. This large difference is mainly
due to the poorer quality FAIR images in the C57 mice. For the rats, an increase
of 200 % - 300 % of the FAIR signal is seen. The highest increase in DM signal is
seen for Linv = 12mm, with the lowest signal seen at Linv = 36mm. This data shows
overall that mbASL can consistency produce higher DM signal than FAIR for both
mice and rats.
4.7.2.6 Comparison to other ASL sequences
The mbASL sequence has been qualitatively compared to FAIR, showing a much
higher signal for all values of Linv. A quantitative comparison was not suitable for
this study due to the scan parameters chosen for the FAIR used. Furthermore, the
discrepancies shown between FAIR and pCASL by Duhamel (Duhamel et al. 2012),
demonstrates a straight comparison of values may not be suitable. A better com-
parison for mbASL would be to compare the signal, SNR and CBF between mbASL
And pCASL on the same animals. The pCASL sequence has a higher SNR that PASL
and could be a fairer comparison in overall signal and SNR of ASL sequences. How-
ever, as shown previously (Alsop, Detre, et al. 2015) there are many variations of
pCASL, making comparison more difficult.
4.7.2.7 Limitations
The mbASL kinetic model makes multiple assumptions in the fitting of the TI data.
It is assumed that a constant blood velocity takes place for the labelled spins trav-
elling from the labelling slab to the imaging slice. The original Buxton model as-
sumes a constant velocity with a plug flow. A further variation of the mbASL model
would be to include a varying velocity when obtaining a value of ATT. The mbASL
sequence has a limited thickness range which varies not only between animals, but
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between species. Paired with the drastically different amount of labelling pulses
needed, this means optimisation of the sequence is needed before it can be used.
This study used only a small number of animals, in keeping with the 3Rs guidelines.
A larger experimental group however would provide much needed data for better
fitting to the mbASL kinetic model.
4.8 Conclusions
A quantitative model for mbASL has been developed and validated successfully,
allowing high quality CBF maps to be produced. By optimising the number of pulses
and showing how crucial the labelling thickness is in calculating ATT values, the
hybrid nature of mbASL has been shown. The kinetic model is able to describe the
signal seen from mbASL in different rodents using a varying labelling thickness,
which has not been seen in the literature previously.
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Chapter 5
Development of Diffusion Weighted
Multiple Boli Arterial Spin Labelling
5.1 Abstract
The mbASL sequence, described in Chapter 4, was combined with a pair of gradient
pulses to develop a diffusion weighted mbASL sequence (DWASL). The aim of this
chapter was to develop the DWASL sequence to be sensitive to changes in water
exchange in the brain. Furthermore, the sequence was altered to examine the
effect of the observation time between the gradient pulses, D, on the signal when
the same b-values were used. Multiple experiments were designed to test and
validate the diffusion weighted mbASL sequence.
5.2 Experimental Setup
Animal ethics, scanner set up and protocols have been previously described in
Chapter 4. Animals used in the development of DWASL were female CD-1 mice,
weight = 30 - 40g. Specific sequence parameters are defined in each section. All
data were analysed using in-house MATLAB code written by myself (Mathsworks,
Inc).
The equation for bi-exponential fitting is shown below, where A1 and A2 represent
weightings and Dcap and Dtis (mm2/s) are the apparent diffusion coefficient of the
capillary and tissue water respectively. S represents the signal and b is the b-value,
measured in s/mm2.
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S(b)
S0
= A1eDcap · b + A2eDtis · b (5.1)
5.3 Initial Development of DWASL
To develop the mbASL sequence into a DWASL sequence, initial studies used a
phantom of CuSO4 solution. Further studies were applied in-vivo, with CD-1 mice.
5.3.1 Qualitative Development of Readout Module
A comparison of readout methods was undertaken as the first part of the project,
before the research in Chapter 4 and prior to the addition of diffusion gradients.
A RARE readout after ASL labelling was qualitatively compared to an EPI readout.
Parameters for the RARE readout were: NA = 24, slice thickness = 1.5mm, np =
25, matrix size = 64×64. Parameters for the EPI readout were: NA = 10, np =
35, matrix size = 96×96. To determine the overall signal and SNR of the images,
pair-wise subtraction of the label and control images was undertaken. A full brain
ROI was used and the signal averaged. Figure 5.1 shows the images obtained from
both sequences. The matrix size was increased from 64×64 in the RARE images to
96×96 in the EPI images for qualitative comparison, with a decrease in the number
of averages used for EPI lowering the overall scan time.
Figure 5.1: Comparison of ASL images acquired using a mbASL-RARE and mbASL-EPI sequence
A DWASL-RARE and DWASL-EPI image with b = 0 s/mm2 shown with arbitrary units. A higher signal and SNR were seen when
using DWASL-EPI compared with DWASL-RARE. This higher SNR meant a larger matrix of 96×96 was able to be used for the
DWASL-EPI, with more detail able to be seen when using DWASL-EPI.
Following the results of this study, it was decided to use EPI for the remainder of
the experiments in this thesis. The RARE readout showed an overall low SNR and
signal, with a lack of structural detail in the images.
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5.3.2 Interleaved Readout Module
In anticipation of adding diffusion gradients to the mbASL sequence, multiple
changes were made to the acquisition module. This involved modifying the looping
structure and changing the user interface and pulse programme.
5.3.2.1 Looping Structure
In a conventional Bruker EPI sequence, the order of looping is: number of slices,
number of averages, number of shots and number of repetitions. As the mbASL was
a modification of the Bruker FAIR EPI sequence, the mbASL looping order was: pulse
train, number of slices, number of averages, number of EPI shots and number of
repetitions (Figure 5.2). As the number of averages and number of EPI shots comes
before the number of repetitions, all the label ASL averages are acquired before
all the control ASL averages. This was acceptable for short acquisitions, but for
the DWASL sequence with multiple b-values, the images could be affected by phys-
iological parameters from longer scan times. A single shot EPI readout module was
used to shorten the scan time, however, multiple physiological parameters could
change throughout the scan, for example the heart rate, breathing and anaesthetic
levels for the animal, in addition to changes in CBF. To try to minimise the effects
of these physiological parameters, the looping structure was changed (Figure 5.3),
by rewriting the source code. The definition of the number of repetitions (NR) was
changed so that:
Number of repetitions = 2 ∗ Number of Averages (5.2)
The looping was changed to: pulse train, number of slices, number of EPI shots,
number of repetitions.
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Start
Figure 5.2: Looping structure of conventional DWASL
The looping structure originates from Bruker’s EPI sequence. Following the addition of a pulse train and diffusion gradients,
the structure of the sequence, where the number of averages of each EPI shot for the label image are acquired before the
control image, can lead to physiological effects in the images.
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Figure 5.3: Looping structure of modified DWASL
Modifying the looping structure so that the number of EPI shots for a label and a control image are acquired before the next
average allowed the physiological effects on the images to be minimised.
5.3.2.2 Modification of the Paravision User Interface
For the initial development of DWASL, the addition of diffusion gradients meant
only a single diffusion value could be used in each scan. For user convenience, the
pulse programme was altered so the user interface included the option to acquire
multiple b-values during the same scan (Figure 5.4). The b-value of the sequence
was controlled by changing the strength of the gradient. For this DWASL sequence,
this involved calculating a percentage (G%) of the maximum gradient Gmax:
G =
√√√√ b
γ2δ2(D− δ3)
G% = GGmax
(5.3)
Where γ = 42.6 MHz/T and Gmax = 2.94× 10−4 mT/m.
Additional parameters include the number of inversion pulses used for the mbASL
labelling (Npul), the length of labelling (InvTime) and the delay between the la-
belling and imaging (TrainDelay). The time between the inversion pulses (SepTime)
was calculated by the pulse programme dependent on the value of Npul and In-
vTime.
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Figure 5.4: DWASL user interface
The menu for the mbASL labelling pulses was modified to include diffusion values for the diffusion weighting and the option
for the number of averages and diffusion values used for interleaving the sequence. By setting NAverage and NDiffGrad, the
subsequent images produced by the DWASL sequence can be combined in MATLAB. The value of b for diffusion weighting is
entered as a percentage of the maximum gradient.
5.3.2.3 Combining Multiple b-values and Interleaved Readout Module
The original mbASL looping structure acquired all averages of the label image be-
fore acquiring all the averages of the control image. The modifications made to
the looping structure meant one average of a label and control image were ac-
quired in an interleaved fashion before moving to the next average. The number
of images acquired for DWASL was:
Images = 2 ∗ NAverage ∗ NDiffGrad (5.4)
This resulted in a one average pair of DWASL images for every b-value. These im-
ages were then exported in a DICOM format to MATLAB where in-house MATLAB code
was used to combine the images into the conventional one label and one control
ASL image set. Figure 5.5 shows the original looping structure. For the interleaved
modification, the label and control k-spaces were collected in a different order
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from the original method (Figure 5.6). Each k-space was Fourier transformed into
a one average image. These one average images were combined using MATLAB
code post-imaging.
1 2
3 4
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7 8
Control
Averages
Label 
Averages
Image = Average 
5 + 6 + 7 +8
Image = Average 
1 + 2 + 3 +4
Figure 5.5: Schematic of original acquisition of DWASL data
The method of collecting the images from the original Bruker looping structure is to collect all the averages of the label
image before collecting all the averages of the control images. This is shown in the above figure with the numbered k-
spaces, where 1, 2, 3 and 4 are collected first before 5, 6, 7 and 8. These k-spaces are acquired and combined to provide
two images for the user.
1 3
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2 4
6 8
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1 + 3 + 5 +7
Figure 5.6: Schematic of modified acquisition of DWASL data
The modified image acquisition sees the label and control images acquired in an interleaved fashion. These are produced
as one average images. As in the figure above, the user will acquire eight of these images and will then combine them using
MATLAB software. The label image is combined from images 1, 3, 5 and 7. The control image is combined from images 2,
4, 6 and 8.
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5.3.3 Adding Gradients to the mbASL Sequence
After altering the pulse programme and adding the interleaving option, the inter-
leaved mbASL sequence was made diffusion weighted by adding a pair of gradient
pulses (Figure 5.7). Multiple development tests were performed to ensure the
sequence was producing labelling of spins and measuring accurate diffusion coef-
ficients.
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Figure 5.7: A schematic of the DWASL sequence
The DWASL sequence used in this thesis is based on a spin-echo EPI sequence pre-weighted with a train of adiabatic pulses
(mbASL). Between the labelling train and the imaging module, a gradient pair was used to attenuate the signal. The first
gradient dephases the signal with the second gradient pulse after the 180° pulse used to rephase the signal from the labelled
spins. A single-shot spin-echo EPI readout module was used to acquire the imaging data.
5.4 Testing and Validation of DWASL
To confirm the DWASL sequence produced the expected signal attenuation, exper-
iments were performed using phantoms and in-vivo using mice.
5.4.1 Validating Diffusion Gradients with a Phantom
Images of the CuSO4 phantom were acquired using a diffusion gradient strength of
zero to test the stability of DWASL against the previous mbASL sequence. Twenty
image pairs were acquired with NA = 2 and G = 0. The matrix size was 96×96 with
np = 20 and CI = 5s. The control image for each pair was used for analysis, with a
ROI taken near the top of the phantom where the highest signal was seen. Analysis
of the signal for each ROI gave a coefficient of variation of 0.37%, indicating that
any changes in signal were not due to the DWASL sequence (Figure 5.8).
To test that the DWASL sequence produces diffusion values that correspond to the
literature, varying b-values were acquired on a phantom, n = 1. Figure 5.9 shows
the corresponding data plotted on a log scale. The average diffusion value was
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Figure 5.8: Multiple scans using G = 0 on a phantom model
The stability of the DWASL sequence using no gradient was tested using multiple value of b = 0 s/mm2 on a phantom. The
coefficient of variation was 0.37 %. The data were normalised to the first signal value before being plotted.
D = 2.26× 10−3 mm2/s which matches with literature values for water diffusion
(2.2 × 10−3 mm2/s (Tanaka 1978)). Further tests (not shown) used gradients in
different orders, rapid switching between high and low b-values and multiple rep-
etitions of the same b-value. These tests were designed to check that the MRI
system could cope with high gradient strength, the rapid switching between high
and low gradient strengths and produce results consistent with the zero gradient
measurement.
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Figure 5.9: Diffusion of a water phantom using the control image of a DWASL sequence
The diffusion of water was tested using varying b-values between b = 0 and b = 500 s/mm2 and plotted using a log-linear
scale. The signal from the control image acquired at each b-value was plotted and the value of ADC found by fitting to a
mono-exponential. The value of diffusion found was D = 2.26× 10−3mm2/s.
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5.4.2 Validating Diffusion Gradients In-Vivo
After successfully obtaining an accurate value of the diffusion of water using a
phantom, the sequence was applied in-vivo. Only limited information could be ob-
tained from a phantom, with an in-vivo model making development more realistic.
To examine any changes in the image signal in-vivo, both the control image and the
subtracted DWASL images were examined using one mouse with a full brain ROI. Six
averages were used, with the same parameters as previously. Five image pairs were
taken for the experiment. A variation of 0.10% was seen between the signal from
the control image ROIs and 3.97% between the subtracted DWASL image ROIs. A
higher variation coefficient was seen in the DWASL images due to lower SNR. Figure
5.10 shows the normalised signal from the subtracted image ROI. Similar gradient
tests to the phantom experiments were performed as described above in Section
5.4.1.
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Figure 5.10: Variation of the DWASL sequence in-vivo
The variation of the DWASL was tested in-vivo using a single mouse. The normalised data shows a change of ∼ 4% over the
first value of DM. A larger variation is expected from the subtraction of in-vivo images. Error bars depict the SD from the
signal from all scans.
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5.4.3 Proof of Concept Study
Two different experiments were performed as a proof of concept for DWASL. Thie
first experiment used n = 6 mice, with varying b-values from b = 0 to 500 s/mm2
used with the same parameters as above with NA = 10. A full brain ROI was used and
the signal from each image plotted. Figure 5.11 shows the DWASL signal from the
obtained data fitted to a bi-exponential model with the signal from the correspond-
ing control image plotted as a reference. The control image has no labelling and
thus provides a diffusion weighted image. The drop in the signal is from the atten-
uation of the labelled blood in the capillaries. This attenuation happens because
of flow dispersion and the diffusion gradients. As the b-value increases, a slower
decay of the signal is observed. The signal from images with higher b-values comes
from the labelled water in the tissue. The labelled water in the tissue travels at
a slower rate due to the restricted diffusion of the tissue (in comparison to the
unrestricted capillaries). The signal from labelled tissue water matches the same
signal attenuation seen for a DWI image, represented on the graph by the control
signal, showing the change between labelled water in the IV or EV compartments.
The results from fitting the signal from the control signal and the DWASL signal to
a bi-exponential model are seen in Table 5.1.
Image type A1 ADCcapillary (mm2/s) A2 ADCtissue (mm2/s)
Control 0.05 1.7× 10−2 0.95 7.4× 10−4
DWASL 0.13 1.1 0.87 9.3× 10−4
Table 5.1: Fitting values for the DWASL proof of concept study.
Fitting results from the DWASL images and control images for the proof of concept DWASL study. The control image from
the label-control pair provides a DWI image, for comparison to the DWASL signal. R2 = 0.99 for the control signal and R2 =
0.99 for the DWASL signal to the mono-exponential and bi-exponential models respectively.
For the second experiment, the signal at three different b-values were compared
at varying inversion times. The inversion time controls the fraction of labelled
arterial spins that exchange from the capillaries into the tissue (Figure 5.12). By
increasing the inversion time, it was expected that the ratio of the labelled spins
in the intravascular (IV) and extravascular (EV) compartments would change when
compared at each b-value. Three mice were used with multiple TI values. As the
TI value increased, the ratio of the signal from the tissue component increased,
with the signal from the DWASL control image used for comparison. At b = 50
s/mm2, there was a significant difference (p<0.05) between TI = 10ms and 300ms
(p = 0.045), TI = 10ms and 600ms (p = 0.015) and TI = 10ms and the control signal
(p = 0.0033). For b = 75 s/mm2, a significant difference was seen between TI =
10ms and the control signal (p = 0.028) but not between TI = 10ms and 300ms (p =
0.079) or TI = 10ms and 600ms (p = 0.056). At b = 100ms, there was a significant
difference between TI = 10ms and 600ms (p = 0.046) Overall, this confirms that
by increasing the exchange time, TI, this will result in a significant increase in
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Figure 5.11: In-vivo DWASL data fitted to a bi-exponential model
The DM signal and control signal from DWASL was fitted to the bi-exponential model and plotted using a log-linear scale for
n = 6 mice. The difference between the signal for the IV and EV spins can be seen in the DWASL graph with a sharp drop
before the signal decays at the same rate as the signal from the control image.
exchange of arterial blood water with tissue water.
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Figure 5.12: Comparison of the DM signal using different TI values
The signals for n = 3 mice at different TI values were compared on a log-linear scale. Error bars are the standard deviation.
As the TI increased from 10ms to 600ms, the ratio of IV to EV signal changed, with a larger number of labelled spins diffusing
into the tissue when using a longer TI value. The control image signal was plotted for comparison. There was a significant
difference (p<0.05) between the signal for TI = 10ms and the longer TI values and control signal.
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5.5 Modifying DWASL to Incorporate a Bi-Polar Diffu-
sion Gradient Pair
It was shown in Section 5.4.3 that from b = 25 s/mm2 the signal seen was from
labelled spins in the tissue (EV compartment) rather than the capillaries (IV com-
partment). At low b-values we speculated there was instability in the signal due to
the low diffusion gradients needed. This was important as the signal is normalised
to b = 0 s/mm2. To address this instability and to allow for more low b-values,
a suggestion was to decrease the value of D which, in turn, increased the value
of gradient needed to give the same b-value. To do this, we moved the second
diffusion gradient to before the spin echo pulse, in a bi-polar configuration (Figure
5.13). This modification of DWASL was termed single sided diffusion weighted ar-
terial spin labelling (SS-DWASL). To test this new sequence and develop the optimal
value of D, multiple phantom and in-vivo experiments were performed.
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Figure 5.13: A schematic of single sided DWASL
The main difference between DWASL and single sided DWASL is the moving of the gradient pair. By moving the gradients to
create a bipolar pair before the 180 ° pulse, this shortens D and increases the strength of gradient needed.
5.5.1 Testing SS-DWASL Using a Phantom
To test what effect moving the diffusion gradients would have on the signal, three
different phantoms were used: CuSO4, ethanol and 2-butanone. One signal aver-
age was acquired with varying b-values. Figure 5.14 shows the plotted data set.
Both DWASL and SS-DWASL signal attenuation were used to evaluate the diffusion
value of water. Table 5.2 shows the average diffusion value calculated for each
phantom using a single exponential fit. All phantoms had an R2 value of 0.99. A
literature value for each liquid is shown for comparison (Tanaka 1978; Hurle et al.
1985; Zhu et al. 1992).
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Figure 5.14: Diffusion plot using DWASL and multiple phantoms
The SS-DWASL sequence was compared against the DWASL sequence using a water phantom. The data were plotted using
a log-linear scale. Both sequences produced the same diffusion values (2.20× 10−3 mm2/s and 2.23× 10−3 mm2/s). SS-
DWASL was also used to measure the diffusion of Ethanol an 2-butanone with the diffusion values matching the literature
(1.08× 10−3 mm2/s and 3.58× 10−3 mm2/s respectively).
Phantom Average Diffusion (×10−3mm2/s) Literature (×10−3mm2/s)
H2O (DWASL) 2.2 2.3
H2O (SS-DWASL) 2.2 2.3
Ethanol 1.1 1.1
2-butanone 3.6 3.6
Table 5.2: Diffusion values for multiple phantoms determined using DWASL and SS-DWASL, acquired
at room temperature (22 °C)
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5.5.2 Varying the Value of δ and D
The variation of δ and D on the signal attenuation was tested on a phantom. It
was expected that the same attenuation would be produced. Figure 5.15 shows
the signal produced for D = 11.2, 13.2 ms and δ = 3.2, 5.2, 7.2 ms. The sequence
showed signs of variance when using a large gradient. Overall, at b-values less than
b = 300 s/mm2, all values of D and δ produced nearly identical signal attenuation.
For further studies, it was decided a value of δ = 3.2 ms was kept the same as the
original DWASL sequence and a value of D = 9.2 ms was chosen.
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Figure 5.15: Comparison of varying D and δ in SS-DWASL
Values of D and δ were varied whilst maintaining the range of b-values between 0 and 500 s/mm2. Slight deviation was
seen at high b-values when a large gradient was needed. The graph is plotted using a log-linear scale.
To check the stability of the sequence, the sequence was run with b = 0 s/mm2 for
10 repetitions and NA = 1. The same gradient tests in Section 5.4.1 were performed
to test the reliability of SS-DWASL. All tests produced the expected results that
were seen in DWASL.
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5.5.3 Optimising Diffusion Gradients In-Vivo
To examine the effect of bipolar gradients in-vivo, six mice were used. b-values and
parameters were the same as in Section 5.4.3. Diffusion gradient strengths were
set to values that corresponded to b-values between 0 and 500 s/mm2. The signal
attenuation from the control and SS-DWASL images are shown in Figure 5.16. The
fitted curve shows a smoother line for the SS-DWASL signal, with the same decay of
signal seen as the control signal from b = 200 s/mm2. Coefficients from the fitting
are displayed in Table 5.3.
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Figure 5.16: Signal at various b-values using SS-DWASL in-vivo
The fitting of the SS-DWASL signal to the bi-exponential model shows a smooth curve than the fitting curve seen in DWASL.
The graph is plotted using a log-linear scale, error bars are the standard deviation and n = 6 mice were used. From b = 200
s/mm2, the curve follows the same decay as the control signal fit.
Image type A1 ADCcapillary (mm2/s) A2 ADCtissue (mm2/s)
Control 0.093 5.9× 10−3 0.99 8.7× 10−4
SS-DWASL 0.12 1.6× 10−2 0.88 8.6× 10−4
Table 5.3: Fitting values for SS-DWASL from Figure 5.16
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5.6 Comparing DWASL and SS-DWASL In-Vivo
The data collected in Sections 5.4.3 and 5.5.3 for DWASL and SS-DWASL are com-
pared below in Figure 5.17. A difference between the two sequences was seen,
with the sharper drop in signal for DWASL and a more subtle drop for SS-DWASL.
Both sequences showed a similar value for ADCtissue compared to each other and
both control image values (8.29× 10−4 mm2/s for DWASL and 8.64× 10−4 mm2/s
for SS-DWASL). A large difference was seen in the ADCcapillary values.
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Figure 5.17: Comparison of DWASL and SS-DWASL pilot data
Comparison of the two fitting curves for DWASL and SS-DWASL shows a qualitative difference in shape in addition to different
ADC values for the capillaries (1.052 for DWASL and 1.62 × 10−2 for SS-DWASL). The ADC values for tissue were similar
between DWASL, SS-DWASL and the control ADC value. The graph is plotted using a log-linear scale, error bars are the
standard deviation and n = 6 mice used for both signals.
A study group of n = 6 mice was used to further compare DWASL and SS-DWASL
by examining if SS-DWASL was a viable alternative to DWASL. Both DWASL and SS-
DWASL were used in the same scanning session. The same parameters and b-values,
as described above, were used. The results of this study showed no clear difference
between the two sequences (Figure 5.18). Fitting data to the bi-exponential model
(Equation 5.1) produced very similar values for ADCtissue with 7.9× 10−4 for DWASL
and 7.1× 10−4 for SS-DWASL (Table 5.4). Above b = 200 s/mm2 the two curves
followed the same signal attenuation. The values for ADCcapillary are closer than
the values produced in the pilot study, with 3.5× 10−2 for DWASL and 1.4× 10−2
for SS-DWASL.
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Image type A1 ADCcapillary (s/mm2) A2 ADCtissue (s/mm2)
Control 0.027 4.3× 10−2 0.97 6.4× 10−4
DWASL 0.10 3.5× 10−2 0.90 7.9× 10−4
SS-DWASL 0.13 1.41× 10−2 0.87 7.1× 10−4
Table 5.4: Fitting values from DWASL and SS-DWASL from the comparison study of both sequences
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Figure 5.18: Comparison of SS-DWASL and DWASL in a group of mice
A group of n = 6 mice were used to compare the two sequences. Both DWASL and SS-DWASL produced similar fitting curves,
with the same signal attenuation seen from b = 200 s/mm2. The graph is plotted using a log-linear scale and error bars are
the standard deviation.
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5.7 Discussion
5.7.1 DWASL
The purpose of this chapter was to convert the mbASL sequence into a diffusion
weighted mbASL sequence that could probe capillary water exchange in the brain.
As over 95% of the signal in an ASL sequence is lost due to subtraction, it is im-
portant to have a high SNR sequence that is sensitive to changes in the brain.
After preliminary experiments, a single shot EPI readout was chosen for all DWASL
scanning.
The modification of the looping structure of DWASL was designed to minimise the
physiological effects the longer DWASL scans. A one shot one average EPI scan
takes only a few seconds to acquire meaning any physiological parameter changes
will make minimal difference to the acquired data. The DWASL sequence with
the addition of the pulse train and multiple b-values increased the overall scan
time significantly. A ten average DWASL sequence with ten b-values takes ∼ 20
minutes, where multiple changes including scanner drift, anaesthetic changes, CBF
changes and animal movement can occur during this time. We proposed changing
the structure of the sequence, where the acquisition of a label and control image
was interleaved before the next average, in contrast to collecting all averages of
the label image before the control image.
In addition we added the option of acquiring multiple b-values in the same scan.
This involved multiple changes to the Bruker source code to define new param-
eters and modifying the looping of the scan repetitions. The resulting sequence
produced separate one average images which were combined in MATLAB to create
a label and control image. A limitation of this method of collecting images and
manually combining them them could lead to increased noise in the final image.
A further improvement to this method would be to combine the k-space of each
image rather than the magnitude image. This was too complex to complete in the
time-frame available but would be a future progression of this new interleaved
method of acquisition. This modified looping structure is more suitable for pre-
clinical imaging where scan times are typically longer for developmental studies.
A number of steps were taken to develop mbASL into a diffusion weighted sequence
that could detect changes in the IV and EV compartments. By first performing
experiments with no diffusion gradient, this tested the variability of the sequence
which was shown to be very low, at a 0.37% change in signal demonstrating the
stability of the sequence. The sequence was examined in-vivo by using a range of
b-values to examine the signal attenuation. A sharp drop in signal was seen for low
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b-values before the drop in signal became smoother at high b-values, similar to the
signal seen from the tissue. This effect (Figure 5.11) has been seen in the literature
previously, where Wang (Wang, Fernandez-Seara, et al. 2007) demonstrated the
separation of the signal from the IV and EV departments in humans at different
labelling delays.
The proof of concept study of the DWASL sequence was important to show that our
DWASL sequence would be able to detect changes in the ratio of IV to EV signal in
the brain. Comparison was made at three different b-values using three different
inversion times. By using different TI values, this allowed less or more time for
the labelled arterial water spins to exchange into the brain tissue. This would
change the ratio of IV to EV spins in the imaging plane. It was hypothesis that
the ratio of IV to EV signal would change as the TI was increased. At the lower
value of b = 50 s/mm2 it was expected there would be a larger difference between
the data points compared to the higher values of b = 75 and 100 s/mm2. This is
because the increased attenuation of the signal would mean the majority of the
signal would come from the EV compartment. It was shown (with p < 0.05) that at
b = 50 s/mm2 there was a significant difference between the signal value at each
inversion time. This is similar to the experiment reported in Wang’s article on
DWASL (Wang, Fernandez-Seara, et al. 2007), where the signal at three different
inversion times in clinical patients showed a significant difference between the
signals. This has not been shown in the mouse brain until now. Limited data
exists for demonstrating the effect of the post label delay in rats with Kim et. al
showing the contribution of arterial blood to the image signal decreases as the
post label delay increases (Kim and Kim 2006). This study uses the concept of IVIM
but demonstrates that a significant difference can be detected in the IV and EV
compartments by changing the post label delay.
Other methods have been used to non-invasively image changes in the water ex-
change in the brain. A multiple echo time ASL has been developed at UCL (Wells,
Thomas, et al. 2017; Ohene et al. 2019). By varying the echo times, the perme-
ability of the blood-brain interface can be examined. Ohene’s study focused on
examining the water transport due to using AQP4 deficient mice, with a change in
exchange time seen between the deficient mice and a wild type group. This sig-
nifies the importance of having non-invasive methods of imaging BBB permeability
and water exchange.
One of the main limitations at this stage is the need for a quantitative model of
the DW mbASL sequence. Although Chapter 4 has shown we have quantified the
mbASL sequence, the use of diffusion gradients to suppress the signal means that
the model would not be able to reflect the signal that we receive from DWASL im-
ages. The overall low levels of signal and SNR in any pre-clinical ASL MRI are always
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a limitation. By using a high SNR ASL sequence such as mbASL, we have managed to
increase the resolution and produced a high quality pre-clinical DWASL sequence.
Although DWASL has been applied in rats previously (Wells, Thomas, et al. 2017;
Tiwari et al. 2017), there have been no reports in the literature on its applica-
tion on mice. It has been shown previously that there is a dependence on the
direction of the DWASL gradients (Wells, Thomas, et al. 2017). This thesis used a
single direction for all DWASL scanning. Developmental work (not presented) was
undertaken to examine the difference in signal using different directional gradi-
ents, with the highest overall signal direction chosen. Further work would be to
implement a multi-directional DWASL, in addition to an option for multi-slice imag-
ing. This chapter has focused on the separation of the signal from the IV and EV
compartments. The sequence can, however, be used to examine the permeability
of the brain by the use of a ratio of the signal from a diffusion weighted and non
diffusion weighted ASL image.
5.7.2 SS-DWASL
Current DWASL literature uses the traditional method of a small gradient to sup-
press the intravascular signal. A novel change has been made to DWASL by changing
the timing of the gradients in the DWASL sequence. This increased the gradient
strength that was used in the conventional DWASL sequence and was achieved by
moving the gradients together rather than either side of the 180° spin echo pulse.
This was primarily to increase the stability of the sequence. A larger number of
points at low b-values would be useful to further explore the IV signal (as seen in
(Silva et al. 1997)), but the sequence needed to be altered to have b-values lower
than 25 s/mm2, as the value of G needed to be larger for this to happen. Multiple
experiments were performed both in-vivo and on a phantom to test the diffusion
values produced. SS-DWASL was able to produce accurate diffusion values for mul-
tiple substances that corresponded to literature values. The same H2O diffusion
values were obtained using both DWASL sequences. Further tests proved that by
varying the values of D & δ, the same diffusion values were produced for the same
b-value.
Using SS-DWASL in a pilot in-vivo study, the data collected showed a difference
in the bi-exponential fit compared to conventional DWASL. When a further study
was performed that compared both sequences, very similar results were produced,
with the results achieved in the pilot study not being replicated. A comparison was
made between both sequences, to examine whether a difference in the A1 fitting
value would be seen. The value for A1 was very similar between both sequences
(p > 0.05), suggesting that changing the gradients made no difference to the over-
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all output of the SS-DWASL sequence. There could be multiple reasons why this
occurred, including poor labelling and artefacts in the images, or physiological
changes in the mouse. Further research is needed into SS-DWASL to examine if it
is a viable alternative to DWASL for imaging water content in the brain.
5.8 Conclusion
To summarise, a diffusion weighted mbASL sequence was successfully developed
to probe water changes in the brain. By using a pair of diffusion gradients, the
signal from labelled spins was suppressed and a ratio between the spins in the
intravascular and extravascular compartments was shown. Using a high SNR ASL
sequence as the base, high resolution pre-clinical images, which are able to chal-
lenge DWASL data that are currently in the literature, were produced. The DWASL
sequence was able to significantly image changes in the ratio of labelled spins by
changing the inversion time of the sequence. Further implementation of this se-
quence could lead to applications in animal models of disease, specifically where
there is damage and permeability changes to the blood brain barrier.
The effect of moving the gradient pair to change the D time was explored. Al-
though promising phantom data were found from pilot studies, in-vivo experiments
failed to deliver the changes in intravascular and extravascular signal that were
expected. Further research is needed to optimise the sequence so it is viable for
further research.
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Chapter 6
Applying DWASL to a Trypanosome
Mouse Model
6.1 Introduction
This chapter demonstrates the use of diffusion weighted arterial spin labelling to
image changes in the permeability of the BBB for mice infected with human African
trypanosomiasis.
Study 1: Diffusion weighted ASL was used to probe BBB permeability in early stage
HAT in mice. Multiple time points and separate groups of mice were imaged, with
the end point set as day fourteen post-infection, based on previous time points in
the literature.
Study 2: A serial study was designed to examine changes in BBB permeability in
one group of mice over the course of infection, with time points in the early and
late stage of the disease.
Study 3: To investigate whether water permeability changes occur at the later
stage of the disease, the experimental dates were extended forward to include
multiple later stage data points.
Study 4: The wet-dry method was used to compare the water content in the mouse
brain for healthy and infected mice.
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6.2 Methods
6.2.1 Stabilate GVR 35
The T. b. brucei trypanosomes were originally isolated from an infected wildebeest
from the Serengeti National Park in 1966. This stabilate was sent to the London
School of Hygiene and Tropical Medicine where the stabilate LUMP 22 was produced
by passaging the parasite in rats. Another passage using parasites from LUMP 22
produced LUMP 1001. Dr Frank Jennings at the University of Glasgow obtained
a clone of LUMP 1001. This clone was passaged through sub-lethally irradiated
mice and named GVR35/C1. The stabilate is stored in liquid nitrogen. Working
stabilates are produced from the reserve stabilate GVR35/C1.1 using passage mice.
Throughout this project, the working stabilate GVR35/1.9 was used to establish
infections in mice.
6.2.2 Animals
For all studies, female CD-1 mice were purchased from Charles River Ltd, Margate,
England. Animals were between 30 - 40g in weight and 6 - 8 weeks in age. All mice
were allowed to acclimatise to the animal unit in the University of Glasgow for at
least one week before any procedures were carried out. Mice were stored in a mix
of standard caging and individually ventilated cages with free access to water and
food. Group sizes in cages varied between two and four dependent on experimental
numbers. The mice were maintained with a temperature range between 19-23 °C,
a humidity of 45 ± 10 % and a light/dark cycle of 12 hours light and 12 hours dark.
6.2.2.1 Animal Infections
For each experiment, two passage mice were infected with T. b. bruceiGVR35/C1.9
described above. These mice were used to generate trypanosomes for infection of
the larger groups of experimental animals. To initiate the infection, a small sec-
tion of the frozen stabilate was mixed with phosphate buffered saline plus glucose
(PBGS), pH 8 (recipe in Appendix A). A dilution containing 2-trypanosomes per field
was used for infection of the passage mice. A volume of 0.1-0.3ml of the diluted
stabilate was injected intraperitoneally (IP) into the mice. The development of
the trypanosome infection was monitored by wet blood films under the light mi-
croscope using a x400 magnification. This was achieved by removing <0.5mm from
the end of the mouse tail using sharp scissors. A drop of blood was then placed
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onto a glass microscope slide and covered with a 6mm circular slip. The level of
the parasitemia was estimated using a modified Herbert scale and Lumsden scale
(Herbert et al. 1976). The number of trypanosomes per field were scored using
the scale seen in Figure 6.1. This method was employed to monitor parasitemia in
both passage and experimental animals.
1 trypanosome / 5 fields ±
1-2 trypanosomes / f ield +
Figure 6.1: Modified Herbert and Lumsden scale
The number of trypanosomes present in a wet blood film under a light microscope was examined. By using a modified
Herbert and Lumsden scale, the number of trypanosomes were estimated in each visual field and graded.
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6.2.2.2 Infection of Mice
When the first peak of parasitemia was seen in the passage mice, the mouse was
culled by overdose of anaesthetic with a neck dislocation to confirm death and
blood taken by cardiac puncture. The blood was diluted to 1 - 2 trypanosomes per
field with the PBGS solution described above and used to infect the experimental
mice. To establish infection 0.1ml of the diluted blood was injected intraperi-
toneally and the developing parasitemia monitored as described above.
6.2.3 Scanning
6.2.3.1 Animal Preparation for MRI
Animals were anaesthetised using 5% isoflurane in a mixture of 70:30 NO2:O2, and
then reduced to 1 - 2% isoflurane for maintenance. For injection of the contrast
agent, cannulation of the tail vein was performed using a 26 gauge × 19mm can-
nula. The animal was placed in a mouse cradle designed for pre-clinical imaging.
The animal was restrained using tooth and ear bars with the animal’s head placed
in the same position for each scan. The respiration rate was measured throughout
the experiment, along with the body temperature via a rectal probe. The body
temperature was maintained by using a water jacket and the anaesthetic adjusted
according to temperature and respiration rate.
6.2.3.2 Scanner and Sequence Setup
Experiments were performed on a horizontal 7T Bruker PharmaScan Avance III sys-
tem (300 MHz). A Bruker BGA9 imaging gradient insert (300 mT/m) was used to
provide linear magnetic field gradient pulses, a 72mm birdcage Radio-Frequency
(RF) volume resonator was used to transmit and a 4-channel phase array coil to
receive.
A DWASL sequence (developed in Chapter 5) was used throughout the first three
studies. The parameters associated with each study are shown in Tables 6.1 and
6.2. Further parameters unique to each study are described in the appropriate
section.
For contrast enhanced MRI, a T1-MSME sequence was used with the following pa-
rameters: FOV = 25×25mm, TE = 12.28ms, TR = 800ms, slice thickness = 1.5mm,
matrix size = 176×176, NA = 16. A single imaging slice in the centre of the brain
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was taken. The T1-MSME sequence was performed before the injection of the con-
trast agent, diethylenetriaminepentaacetic acid (Gd-DPTA Magnevist). A volume
of 0.1ml containing 50µL Gd-DPTA Magnevist and 50µL of sterile water via the can-
nulated tail vein was used. Following a five minute delay, to allow the contrast
agent to travel to the brain, the T1-MSME was repeated.
Study CI (ms) TI(ms) TR(ms) TE(ms) np NA Label slice (mm)
1 (RARE) 5000 50 3000 7.26 20 16 8.5
1 (EPI) 5000 200 7000 18.4 35 10 9
2 5000 500 7000 15.1 20 10 1
3 5000 50 7000 27.33 20 10 10
Table 6.1: Table of parameters for DWASL
The major parameters used in each DWASL study. These are labelling time (CI), delay time (TI), repetition time (TR), echo
time (TE), number of pulses (np), number of scan averages (NA), labelling slice thickness (mm).
Study b-value (s/mm2)
1 (RARE) 0, 448
1 (EPI) 0, 448
2 0, 12, 18, 41, 73, 165, 292, 458, 659
3 0, 25, 50, 75, 100, 200, 300, 400, 500
Table 6.2: b-values used in each DWASL study
6.2.4 Data Processing of MRI Images
All processing of images was completed using in-house MATLAB (Mathworks, Inc)
code. Data were transferred from Paravision to MATLAB via DICOM format. All
images were normalised by dividing each image by its respective reco_map_slope
value. DWASL images were processed as described previously (Section 5.4.3) and
pseudo-permeability maps calculated. No image manipulation was performed.
6.2.4.1 Processing of CE-MRI Images
The percentage signal change seen by the subtraction of the post-contrast and
pre-contrast images was calculated using the following equation:
% Signal change = post contrast image− pre contrast imagepre contrast image × 100 (6.1)
The mean signal for each brain slice was calculated by selecting the full brain area
as the ROI and averaging the signal. Using this information, signal change maps
were produced.
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6.2.4.2 Statistics
Data were processed using MATLAB (described above) and statistical analysis per-
formed using Minitab 17 (Minitab Inc). Differences between the means of groups of
mice were investigated across experiments using the general linear model proce-
dures and the randomised block analysis of variance (ANOVA) and groups compared
using Tukey’s comparison test. Statistical significance was considered for p-values
< 0.05. Log transformations of data were performed where appropriate. Means,
standard errors (SE) and 95% confidence intervals (CI) are provided as summary
statistics.
Where appropriate, DWASL data were fitted to a bi-exponential model:
S = A1 eb·Dcap + A2 eb·Dtis (6.2)
where S represents the signal and b is the b-value. A1 and A2 represent weightings.
Dcap and Dtis are the apparent diffusion coefficient of the capillaries and tissue
respectively, measured in mm2/s.
For estimation of pseudo-permeability, two DWASL scans were used, with and with-
out diffusion gradients. For studies two and three, a b-value of b = 74 and 75
s/mm2 respectively were chosen. This method is based on (St Lawrence, Owen,
et al. 2012) where a b-value was chosen that would have minimal effect on the
tissue component but suppress the intravascular signal.
6.2.5 Preparation of Brains for Histology
All mice were euthanised using an overdose of anaesthetic at the end of scan-
ning. Brains were removed for histological examination and placed in 4% neu-
tral buffered formalin (NBF). Brains were removed from the NBF and processed to
paraffin. Sections (3µm) were cut from the paraffin blocks and mounted on glass
microscope slides. The sections were stained using haematoxylin and eosin (H & E)
so that the severity of the inflammatory response of the brain could be assessed.
All histopathological processes were performed in the University of Glasgow Vet-
erinary Diagnostic Service Histopathology Laboratory. The brain sections stained
with H & E were examined using light microscopy at a magnification of 200 fold. To
measure the inflammatory response, a neuropathological grading scale was used
(Kennedy, Rodgers, et al. 1997). Each brain section was graded by assessing the
severity of the meningitis, the occurrence of perivascular cuffing and the degree
of inflammatory cell infiltration of the brain parenchyma (Table 6.3).
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6.3 Study 1: Examining BBB Permeability Changes at
the Early Stage of HAT Infection
6.3.1 Methods
Twenty-four female CD-1 mice were randomly assigned to eight separate groups
of n = 3 for scanning. Six groups were infected as previously described (Section
6.2.2.2). Two different sequences were used for the DWASL imaging, DWASL-RARE
and DWASL-EPI. Scanning parameters are shown (Table 6.1). Additional DWASL-
RARE parameters are: effective TE = 36.3ms, RARE factor = 32. Scanning took
place on days 8, 10 and 14 post-infection with the two uninfected groups scanned
as controls. Two DWASL scans were performed for each mouse, using b = 0 and
448 s/mm2 plus CE-MRI where possible. CE-MRI parameters are described above
(Section 6.2.3.2).
6.3.2 Results
6.3.2.1 DWASL-RARE
Fourteen DWASL data sets were obtained overall from the potential 24 scans in
the experiment. It was not always possible to collect CE-MRI data and DWASL data
from the same animal.
For the DWASL-RARE sequence, six DWASL scans were obtained and eight CE-MRI
scans (Table 6.4).
Day of Infection DWASL CE-MRI
Uninfected × 3 × 3 3 ×
8 ×× 3 3 × 3
10 3 3 3 3 3 3
14 3 ×× 3 ××
Table 6.4: Scans performed in Study 1 using DWASL-RARE
The number of scans performed using DWASL-RARE and CE-MRI in the first study. Successful scans are denoted 3. In some
instances scans could not be completed or the data were unsuitable for analysis (×).
Two scans were performed for each mouse, with b = 0 and 448 s/mm2. The mean
drop in the DM signal, calculated using a full brain ROI for all DWASL-RARE data
sets, was 36 ± 11 % (Figure 6.2). Comparison of the mean signal change at each
point of infection showed no significant change (p > 0.05). A full brain ROI was
used for comparison due to the low mean signal seen in all images. Unfortunately
no further comparison could be made due to the low number of data sets acquired.
117
Uninfected Day 14
0
44
8
2x105 9x10
4
00 0
4x104
0
9x104
Day 8 Day 10
b-
va
lu
e 
(s
/m
m
2 )
Figure 6.2: DWASL images for n=2 mice
Two images are shown for each mouse, with b = 0 and 448 s/mm2 to suppress signal. A 12% and a 20% reduction in signal
was measured between the two b-values at the uninfected time point and day 14 respectively.
To assess BBB function, the ratio between the images produced using b = 0 and
448 s/mm2 was calculated and used to produce pseudo-permeability maps (Figure
6.3). The maps show no changes in pseudo-permeability between the time points
of infection. The values of permeability found at each time point are detailed in
Table 6.5. Only one data set was able to be obtained for the uninfected, day 8 and
day 14 post-infection groups. There was a large variance in the data with pseudo-
permeability values ranging from 0.31 to 0.91. No conclusions on permeability
could be drawn from this experiment due to the small sample size of data and the
large variation seen between pseudo-permeability values.
Uninfected Day 14 1
0
Day 8 Day 10
Figure 6.3: Pseudo-permeability maps for Study 1 using DWASL-RARE
Pseudo-permeability maps were produced and averaged over the whole brain with values of permeability as 0.91 and 0.86
respectively for day zero and day fourteen post-infection.
Day of Infection Pseudo-permeability
Uninfected × 0.91 ×
8 × × 0.34
10 0.69 0.89 0.31
14 0.86 × ×
Table 6.5: Pseudo-permeability values using DWASL-RARE
To confirm if changes in the BBB function could be seen with a contrast agent,
CE-MRI was performed at each time point and a signal change map produced for
each CE-MRI data set (Figure 6.4). The sequence used a single slice for imaging.
Uninfected Day 8 Day 10 Day 14 1
0
Figure 6.4: Signal enhancement maps produced for Study 1
CE-MRI data showed a signal change of 5.9 %, 6.6 %, 11.6 % and 5.2 % for the uninfected time point, day 8, 10 and 14
respectively. No significant changes were seen between the mean signal measure at each infection time point (p> 0.05).
118
CE-MRI data were collected at all time points (Table 6.6). A single data set was
able to be collected at day fourteen but the low signal change (5.2 %), suggests
a failure of the contrast agent to enter the blood stream. Although an increase
in mean signal enhancement over the whole brain was seen from the different
time points, no significant difference (p > 0.05) was found. The mean percentage
change seen at these time points reflects values seen in previous literature.
Day of Infection % Change of signal Mean % change
Uninfected 6.7 5.2 × 5.9
8 7.8 × 5.4 6.6
10 15.7 7.4 12.6 11.9
14 5.2 × × 5.2*
Table 6.6: CE-MRI data for Study 1 examining DWASL-RARE
Table of % signal change values for the CE-MRI data. No changes were seen between the mean value at each infection time
point (p> 0.05). A * indicates that the contrast agent may not have fully entered the brain.
6.3.2.2 DWASL-EPI
The second experiment in this study was to repeat the first experiment using a
DWASL-EPI sequence. The DWASL-EPI scans obtained in the first study were seven
out of a potential twelve scans. The number of CE-MRI scans that were successful
were five (Table 6.7).
Day of Infection DWASL CE-MRI
Uninfected 3 3 3 3 ××
8 × 3 3 ×× 3
10 3 × 3 ×× 3
15 ××× 3 3 ×
Table 6.7: Scans performed in Study 1 using DWASL-EPI
The number of scans obtained using DWASL-EPI and CE-MRI in the first study. Three data sets were unusable for analysis
(one at day 10 and two at day 15 post-infection).
Images obtained using DWASL-EPI had a substantially higher overall SNR compared
to DWASL-RARE, for approximately the same scan duration. For b = 0 s/mm2, the
SNR for DWASL-EPI was 9 ± 0.8. Regions including the cerebral cortex, hippocam-
pus and external capsule are distinguishable in the images that previously were
not for DWASL-RARE (Figure 6.5). The mean drop in signal using the whole data set
at b = 0 and 448 s/mm2 was 34 ± 7 %.
To examine any qualitative changes in BBB function, the two DWASL-EPI images for
each mouse were used to create pseudo-permeability maps (Figure 6.6). The mean
pseudo-permeability values for the whole brain at each infection point are shown
in Table 6.8. The variability of the permeability values was less for DWASL-EPI than
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Figure 6.5: DWASL-EPI images from Study 1
b-values of 0 and 448 s/mm2 were used to suppress signal from the capillaries. DWASL-EPI scans from an uninfected, day 8
and 10 post-infection mouse are shown. A drop in signal of 34 ± 7 % over the whole brain was seen for the scans using b =
448 s/mm2.
for DWASL-RARE. Comparison of the groups found no significance between any of
the study time points (p > 0.05).
Uninfected Day 7 Day 8 Day 10 1
0
Figure 6.6: Pseudo-permeability maps for Study 1 using DWASL-EPI
Pseudo-permeability maps were produced using DWASL-EPI data with b = 0 and 448 s/mm2. The mean permeability values
over the full brain were 0.68 ± 0.09, 0.75 ± 0.09 and 0.69 ± 0.2 for uninfected, day 8 and 10 post-infection respectively.
Day of Infection Pseudo-permeability Mean
Uninfected 0.75 0.78 0.51 0.68 ± 0.09
8 - 0.83 0.66 0.75 ± 0.09
10 0.46 - 0.91 0.69 ± 0.2
Table 6.8: Pseudo-permeability values found for DWASL-EPI scans performed in Study One
No significant difference was seen between the pseudo-permeability values measured in this study. The range of values
seen compared to the values obtained from DWASL-RARE was smaller.
The contrast maps produced using the CE-MRI data sets showed no significant
changes between any of the groups (p > 0.05). Only one usable data set was
able to be obtained for the control group, day 8 and day 10 post-infection. Two
data sets were obtained for day 15 post-infection (Table 6.9). The signal change
values were similar to the values for the first part of the study. No real comparison
could be made between the time points from the limited data, with no significant
difference seen between them (Figure 6.7).
Uninfected Day 8 Day 10 Day 15 1
0
Figure 6.7: CE-MRI images produced for comparison with DWASL-EPI
Signal enhancement maps produced from CE-MRI data taken during the DWASL-EPI study. There is no significant change in
overall signal between the days of infection.
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Day of Infection % Change of signal Mean % change
Uninfected 8.8 - - 8.8
8 - - 9.6 9.6
10 - - 6 6
15 10.2 11.7 - 11 ± 0.8
Table 6.9: Values of percentage signal change in the brain using CE-MRI
6.3.3 Discussion
This was the first study to attempt to measure changes in water permeability in
trypanosome infected mice using DWASL. Multiple time points were chosen in the
early stage of the infection, to try and detect changes in the brain that could not
be detected using the standard CE-MRI. These earlier time points were chosen due
to the mice becoming sicker in the later stages of the disease. The study was also
used to compare the DWASL-RARE and DWASL-EPI sequences and was conducted at
the beginning of the research project before the experiments in Chapters 4 and 5.
By using a DWASL-RARE sequence, it was possible to avoid the typical ghosting
artefacts associated with an EPI sequence. This study therefore examined whether
a DWASL-RARE sequence was suitable for imaging. The DWASL-RARE images had a
poor SNR and low signal. Low resolution images with no anatomical detail was seen
in both DWASL-RARE images, suggesting the data were of overall poor quality. A
low b-value was required to suppress the signal from the arterial blood water in the
capillaries. For this pilot study, a gradient value of 20 % was chosen as it suppressed
all the intravascular signal and only gave signal from the tissue. Post-experimental
analysis gave b = 448 s/mm2 but previous studies have shown a reduction in arterial
component using b-values of less than 50 s/mm2, suggesting that using such a large
b-value is not recommended.
The mean signal and pseudo-permeability values were calculated for a full brain
ROI, with no smaller ROIs able to be examined. This was due to the lack of detail
in the images and the low SNR. The data demonstrated that high quality DWASL
images could not be achieved and suggested that a RARE readout module was not
suitable for DWASL imaging.
A second experiment was performed using an EPI readout instead of a RARE read-
out. Although the use of EPI typically introduces artefacts into the images the SNR
from the subtracted DWASL images was higher for both sets of images acquired.
The DWASL images were of a higher quality than those obtained with DWASL-RARE
with regions such as the cortex identifiable. Overall, there was no significant issue
with ghosting in the DWASL images.
Pseudo-permeability values from DWASL-RARE had a large range, suggesting the
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sequence was not functioning correctly. The standard deviation in the permeability
values for DWASL-EPI was reduced compared to the RARE sequence, although there
was no statistical changes seen overall between the different points of infection.
These findings suggest that BBB permeability to water may not be altered at this
stage in the infection, or that any changes present are below the detection level
of the DWASL sequence.
Contrast enhanced data for both studies at each time point showed no BBB leakage,
and no significant enhancement of signal was seen at any stage of the disease.
Rodgers et al. reported a significant change at day 14 post-infection (Rodgers,
Bradley, et al. 2017), but not at day 7 post-infection. The limited number of
successful scans at day 14 and 15 post-infection meant no comparison could take
place, but the data obtained at earlier time points further confirmed that no BBB
breakdown could be seen at a time point previous to day 14 post-infection.
This study was designed as a qualitative pilot study to examine whether DWASL
would be able to pick up changes in BBB permeability. The study focused on the
early stage of the trypanosome infection in mice. No image detail could be seen
using DWASL-RARE with the DWASL sequence being of higher quality. The combi-
nation of no significant changes seen in either the pseudo-permeability maps and
CE-MRI contrast maps, meant a further study was conducted to examine the per-
meability of the barrier in the later stages of the disease. The permeability of the
BBB has not been previously explored in HAT, so this was a novel use of DWASL
with no previous comparison. The large variation of pseudo-permeability values
and limited data sets suggested a further developed DWASL sequence was needed
to be more sensitive to any changes that may occur in the permeability of the
BBB in HAT at early stages. It was decided to continue using the EPI readout as it
produced better DWASL images than the RARE readout for the rest of the research
throughout this thesis.
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6.4 Study 2: Examining Permeability Changes in the
HAT Brain using a Serial Study
6.4.1 Methods
Eight female CD-1 mice were randomly assigned to two cages and infected as out-
lined above (Section 6.2.2.2). Each mouse was scanned before infection and then
on days 7, 9, 11 and 14 post-infection. A final scan point was scheduled at day
18 post-infection, however, this was prevented by an unexpected closure of the
MRI centre. A DWASL single shot EPI sequence was used. Scanning parameters are
shown (Table 6.1). Additional parameters are matrix = 64×64, FOV = 25×25mm.
Contrast enhanced MRI was performed as above (Section 6.2.3.2).
6.4.2 Results
For scanning, the DWASL sequence incorporated the interleaving modification in-
troduced in Section 5.3.2.3, with a range of b-values from b = 0 to 500 s/mm2.
These values were chosen based on the strength of the diffusion gradients, rather
than the b-value. DWASL data sets were obtained at all time points for five mice,
and partial data sets were acquired for the remaining three mice (Table 6.10). A
progressive drop in the signal over the whole brain was seen qualitatively as the
b-value increased by raising the gradient strength (Figure 6.8).
Day of Infection DWASL
Uninfected 3 3 3 3 3 3 3 3
7 3 3 3 3 3 3 3 3
9 × 3 × 3 3 3 3 3
11 × 3 3 3 3 3 3 3
14 × 3 3 3 3 3 3 ×
Table 6.10: Scans performed in Study 2
The number of data sets obtained in Study 2 using a single group of mice n = 8. Successful scans are denoted 3 and
unsuccessful scans (×). No usable CE-MRI data were obtained.
Due to the higher quality of the images obtained, smaller ROIs were able to be
used for analysis. ROIs were selected to include the full brain region as before and
the cerebral cortex (Figure 6.9).
For each data set, the mean signal was calculated for both ROIs and the data plot-
ted on a log-linear scale to examine the signal change for multiple b-values. The
data were fitted to the bi-exponential model (Equation 6.2). The coefficients A1
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Figure 6.8: DWASL images for one mouse in Study 2
For one mouse, all DM images are shown. The image colour scale is set from 0− 2x105 for all images. The b-values in units
s/mm2 are shown above each image. As the b-value increases, the signal intensity decreases.
Brain
Cortex
Figure 6.9: Regions of interest used for DWASL images
The regions of interest used for the study are shown in this image. The full brain region is shown in blue while the cortex
is outlined in pink.
and A2 represent the proportion of signal in the intravascular (IV) and extravascu-
lar (EV) compartments respectively. The mean ADC was calculated for the arterial
blood water (IV) and tissue water (EV) compartments. The DWASL signal plot for
one mouse, at the five MRI time points, is shown in Figure 6.10. Data were plotted
from b = 0 - 200 s/mm2 to examine any changes observed at low b-values. The
signal attenuation matched what had been seen previously in the development of
the DWASL sequence (Section 5.4.3). Similar results were seen across all mice and
all infection time points. To examine if there were significant differences between
the groups, the A1 coefficient was compared as an estimation of how much labelled
water has exchanged.
No changes were seen between the DWASL signal for an individual mouse. The
individual data also appeared noisy. To examine if any changes could be seen
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Figure 6.10: DWASL signal decay for Study 2 for a single mouse
DWASL data sets obtained at multiple time points from one mouse, were fitted to a bi-exponential model and plotted using
a log-linear scale. At each stage in the infection, the data shows a fast drop in signal at low b-values before a slow decay
at high b-values. This figure demonstrates the signal obtained from the IV compartment followed by the EV compartment.
in the group, the signal was averaged over each time point and the mean signal
examined. There were no statistical changes seen between the mean data at each
infection time point.
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Figure 6.11: Overall signal from Study 2 using DWASL
The mean signal over all mice at each time point was normalised and fitted to the bi-exponential model. The signals are
plotted on a log-linear scale. Error bars are the standard error. The mean signal from the control images of the non-infected
mice is plotted as a comparison. n = 6-8 dependent on the infection time point.
For the mean signal at each time point, the data were fitted to the bi-exponential
model and the values for the IV coefficient at each time point compared. The
value ADCtis value corresponds to values available in the literature (Ohene et al.
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2019). All values obtained from the bi-exponential fitting for each infection point
are displayed in Table 6.11. Between the groups, no significance was seen for the
IV compartment coefficient (A1) or the EV coefficient (A2) (p > 0.05). However,
comparison of ADCcap and ADCtis shows that the ADCtis is significant lower (p <
0.05) than the value for ADCcap. A comparison of the signal at each time point can
be seen in Figure 6.11, along with the mean signal from the brain tissue for the
uninfected group.
ADCcap ADCtis
Day of Infection A1 ×10−2 (mm2/s) A2 ×10−4 (mm2/s) n
Uninfected 0.163 6.82 0.84 12.9 8
7 0.18 5.57 0.82 11.3 8
9 0.15 12.1 0.85 13 6
11 0.12 9.3 0.87 12.3 7
14 0.19 5.78 0.806 11.27 6
Table 6.11: Fitting coefficients for DWASL in Study 2
Coefficients from fitting the mean normalised signal at each time point of infection to a bi-exponential model. No significant
differences (p>0.05) were seen between the values at the multiple time points. The number of scans used for each fitting
is represented by ‘n’. ADC values are measured in mm2/s.
To measure the value of pseudo-permeability for each mouse, a b-value of 0 and
74 s/mm2 was used. Pseudo-permeability maps (Figure 6.12) showed no changes
in permeability of the BBB as the infection progressed to day 14 post-infection.
When the data from each group were compared (using the GLM), no significant
differences were found between any of the groups (p> 0.05).
A
B
Day 0 Day 7 Day 9 Day 11 Day 14 1
0
Figure 6.12: Permeability maps for Study 2
Pseudo-permeability maps constructed following DWASL scans, produced using the ratio of signal b = 0 & 75s/mm2 at each
infection time point (uninfected, day 7, 9, 11, 14 post-infection). Two sets of maps are shown for the full experiment
(mouse A and mouse B). No overt changes in permeability were seen between the infection points.
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Figure 6.13: Comparison of DWASL permeability values for Study 2
The comparison of mean pseudo-permeability value for each infection time point showed no significant difference between
any of the values (p> 0.05). Comparison is made using a box plot with the mean, 25% and 75% quartiles, and maximum and
minimum values shown.
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6.4.3 Discussion
To determine whether changes in water permeability in the brain could be detected
using the DWASL sequence at later stages in the trypanosome infection, a second
study was designed to include a time point of day 18 post-infection along with
multiple earlier stage time points. Based on the literature, the breakdown of
the BBB occurs around day 14 post-infection and beyond. By including a time
point of day 18 post-infection, this would give DWASL data from the later stages
of infection when a change in BBB permeability could be detected with CE-MRI.
Rodgers et al. reported a significant change of 15.2% for day 14 post-infection
signal enhancement maps, compared to 7.1% for the uninfected mice. A significant
rise to 24% at day 21 post-infection further suggested that DWASL data should show
changes in the permeability of the BBB at day 18 post-infection. Enhancement was
seen in multiple brain regions, indicating that the use of a more specific ROI may
be appropriate. The cortex was therefore examined individually as well as looking
at overall brain changes. Unfortunately, data from the later time point could not
be collected due to not being able to access the scanner. This meant only data up
to day 14 post-infection was available for analysis.
Improvements to the DWASL sequence resulted in higher quality DWASL images with
the study designed to include images at multiple b-values. The study was designed
to look at how the signal changes with an increasing b-value, and values were cho-
sen based on an increasing gradient strength. This method has been shown by Wang
previously (Wang, Fernandez-Seara, et al. 2007), with changes in the plotted data
observed by changing the inversion time. The data obtained in Study 2 demon-
strated a fast drop in the signal from the low b-values. This indicated the signal
from the fast flowing labelled arterial blood in the intravascular compartment had
been attenuated. The signal decay then followed that of tissue, which was compa-
rable to the signal of the control image. DWASL has been applied by Tiwari et al.
(Tiwari et al. 2017) in rats, however only one b-value was used along with different
parameters make comparing coefficients unsuitable. Silva et al. has shown this
curve pre-clinically in rats (Silva et al. 1997) demonstrating a difference in fitting
coefficients for rats under normocapneic and hypercapneic conditions. Our results
compared favourable to the A1 fitting coefficient found by Silva. Furthermore, the
shape of decay in this research is the same as Silva and other clinical DWASL papers
(Wang, Fernandez-Seara, et al. 2007; Shao et al. 2019).
The trypanosome infection produces different levels of disease severity in mice.
This was observed in the varying parasitemia levels when animals were monitored
for infection. To further explore changes in barrier impairment, the mice in this
study were serially scanned to follow any changes. Looking at each individual
animal, results did not show any significant changes as hoped, in either the per-
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meability maps or the plot of different b-values. More variation was seen in the
individual results, showing DWASL was not sensitive enough to examine data from
a single animal.
No changes were seen in the plots between the infection time points compared
to the uninfected time point. This suggests that either there was no detectable
change in the BBB permeability or the sequence was not sensitive enough to iden-
tify changes. As the water content of the brain in HAT infected mice had not been
examined previously, it is difficult to compare the results to literature. It was clear
that a later stage time point was needed where significant barrier impairment had
previously been identified using CE-MRI to further explore the application of DWASL
to detect BBB impairment.
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6.5 Study 3: Examining BBB Changes Throughout the
Infection
6.5.1 Methods
Thirty-eight female CD-1 mice were used for the study. Experimental days were
set at days 7, 14, 21 and 28 post-infection plus an uninfected control group. Mice
were split into groups of n = 6 for the uninfected, day 7 and day 14 post-infection
groups and n = 8 for day 21 and day 28 post-infection. A DWASL sequence was
used to image mice at each time point with matrix = 96×96, FOV = 2.5×2.5cm.
Additional parameters are outline in Table 6.1. The b-values chosen were based
on values used in the literature (Wang, Fernandez-Seara, et al. 2007). Ten sets of
DWASL images were collected for each mouse. CE-MRI was performed as previously
described (Section 6.2.3.2) with n = 3 mice at each time point.
6.5.2 Results
The DWASL and CE-MRI data sets acquired at each time point are detailed in Ta-
ble 6.12. A set of CE-MRI scans (n = 3 at each time point) was collected. One
DWASL data set was not acquired at day 21 post-infection due to time constraints
associated with use of the MRI system.
Day of Infection DWASL CE-MRI
Uninfected 3 3 3 3 3 3 3 3 × × 3×
7 3 3 3 3 3 3 3 3 3 × × ×
14 3 3 3 3 3 3 × 3 3 × 3×
21 3 3 3 3 3 - 3 3 3 × × -
28 3 3 3 3 3 3 3 3 3 × × ×
Table 6.12: Data sets from Study 3 collected using DWASL and CE-MRI
Only three CE-MRI scans were performed at each time point with 3 indicating which animals were employed for CE-MRI
For each data set, ROIs were selected in the cerebral cortex and full brain re-
gions as used in the previous study (Figure 6.9). The mean signal from the cortex
region was plotted for all b-values (Figure 6.14a). Each data set was fitted to a bi-
exponential model and coefficients obtained (Table 6.13). The proportion of signal
in the intravascular (IV) and extravascular (EV) compartments were assessed to-
gether with the diffusion values for both compartments. Although the fitted data
displayed changes in the signal decay for the signal from the days 21 and 28 post-
infection compared to to the earlier time points, no significance was seen between
the groups for coefficients A1 and A2 (p > 0.05). For data at the uninfected time
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point and day 28 post-infection, p = 0.27 for A1 and p = 0.3 for A2 respectively. Sig-
nificance was seen for comparison of the mean values of ADCcap and ADCtis found
from fitting (p < 0.0001).
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Figure 6.14: Full comparison of the DWASL signal for all points of infection at multiple b-values
A comparison of DWASL signal at all dates of infection, with the signal from the control image (diffusion weighted image,
DW) plotted for further comparison. The ROI was taken from the cortex region and the signal from the control image of
an uninfected scan is shown as a comparison. The fast and slow separation of signal can be seen at all time points but no
significant difference (p > 0.05) was seen between the infection points. Figure a) shows all b-values where the comparison
of signal from the tissue can be easily seen. Figure b) shows the b-values from b = 0 - 200 s/mm2. There is overlap between
all the plots. A log-linear scale is used in both graphs with error bars representing the standard error.
The two b-values used for producing pseudo-permeability maps were b = 0 and 75
s/mm2. The permeability maps are shown along with the corresponding DWASL im-
age in Figure 6.15. The mean signal magnitude for the DWASL images has increased
for these images compared to the previous studies. The pseudo-permeability maps
do not show any qualitative changes between the different stages of infection. Per-
meability values are shown for the cortex region. A mean permeability of 0.73 was
observed for the uninfected group with a value of 0.71 for day 28 post-infection.
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ADCcap ADCtis
Day of Infection A1 ×10−2 (mm2/s) A2 ×10−4 (mm2/s)
Uninfected 0.101 3.5 0.9 7.9
7 0.12 3.8 0.88 7.1
14 0.13 2.4 0.88 7.2
21 0.16 3.0 0.83 7.0
28 0.18 2.3 0.82 6.8
Table 6.13: Fitting coefficients from Study 3
Coefficients from fitting the mean normalised signal at each time point of infection to a bi-exponential model. An change
in the ratio of IV to EV signal is seen as the disease progresses.
All values are in Table 6.14. No statistical difference (p > 0.05) were detected
between the values from each infection time point.
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Figure 6.15: DWASL images and pseduo-permeability maps from Study 3
DWASL images and pseudo-permeability maps produced using b = 0 and 75 s/mm2 for each infection time point. High quality
DWASL images are observed at each time point, but qualitatively no changes are detected between either the DWASL images
or the pseudo-permeability maps.
Day of Infection Pseudo-permeability
Uninfected 0.73 ± 0.03
7 0.72 ± 0.04
14 0.70 ± 0.05
21 0.69 ± 0.06
28 0.71 ± 0.08
Table 6.14: Pseudo-permeability values from Study 3
Values for mean pseudo-permeability at each infection time point for the full brain. No statistical difference (p>0.05) were
observed between values.
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6.5.2.1 CBF Results
Values for CBF were calculated using the method outlined in Chapter 4. The aver-
age CBF value for the full brain and cortex are displayed below (Table 6.15). The
mean CBF values at each infection point were within the values previously stated
in the literature (Baskerville et al. 2012; Duhamel et al. 2012). A significant dif-
ference (p< 0.05) was seen between Day 28 and Days 7, 14 and 21 (p = 0.008, p =
0.002 and p = 0.032 respectively) in the full brain ROI. The same significant differ-
ence was seen in the cortex region (p = 0.01, p = 0.002 and p = 0.019 respectively).
The average CBF value for the uninfected group was 144 ± 11 ml/100g/min. This
value was not significantly different to any other time point. The range of CBF
values was 75 to 328 ml/100g/min.
Day of Infection CBF (Full Brain) CBF (Cortex)
Uninfected 144 ± 11 160 ± 13
7 125 ± 2 143 ± 3
14 112 ± 12 126 ± 11
21 134 ± 18 145 ± 21
28 204 ± 24 227 ± 27
Table 6.15: CBF values for mice in Study 3
The CBF values found using the mbASL sequence. Significant (p < 0.05) differences were found between the values at day
28 and day 7, 14 and 21. There was no significant difference between the uninfected and day 28 values of CBF. CBF values
are displayed in the units ml/100g/min. The standard error is shown with the mean value.
6.5.2.2 CE-MRI Results
CE-MRI scans were collected at each time point (n = 3) to give n = 15 for the full
study. Percentage signal change (% SC) maps were produced for each image set
with the signal averaged over a full brain ROI. Figure 6.16 demonstrates maps for
each stage of infection. Signal enhancement can be seen for the later stage of
HAT, where higher levels of contrast agent were present. Day 21 (% SC = 25 ± 9
%) and 28 (% SC = 19 ± 7 %) post-infection show a significant (p < 0.05) change in
signal compared to the earlier time points. No significant change was seen in the
% SC for the uninfected group (% SC = 7 ± 3 %), day 7 (% SC = 7 ± 3 %) and day 14
(% SC = 12 ± 8 %) post-infection as shown in previous studies.
Figure 6.17 demonstrates the mean % SC seen at each time point with significance
(p<0.05), denoted by ∗. The highest percentage change was detected at day 21
post-infection.
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Uninfected Day 7 Day 14 Day 28 1
0
Day 21
Figure 6.16: Contrast enhanced MRI images for Study 3
CE-MRI images for each infection time point. Evidence of the contrast agent crossing the BBB is seen from day 14 on wards,
shown by an increase in signal enhancement. Images are scaled between 1 and 0 which represents the signal enhancement.
Figure 6.17: Box plot of contrast enhanced MRI
Using CE-MRI and a full brain ROI, the mean signal for n = 3 mice demonstrates a significant difference in % signal enhance-
ment for late stage HAT compared to early stage HAT and uninfected mice, with significant differences (p < 0.05) between
the groups denoted by ∗. The mean, 25% and 75% quartiles, and maximum and minimum values are shown.
6.5.2.3 Neuropathological Reaction
The inflammatory reaction of the infected brains at each time point was scored
using the neuropathological grading score (Table 6.3). The mean reaction score
for each time point is outlined in Table 6.16. Every group of infected animals
had a score significantly different to the uninfected group (p<0.05). Figure 6.18
displays H & E stains for a non-infected mouse (A and B), a mouse at day 14 post-
infection (C and D) and at day 28 post-infection (E and F). At day 14 post-infection,
the disease was progressing with a mild meningitis seen. A further significant
(p<0.001) increase in the severity of the neuroinflammatory reaction was seen
between day 14 and day 28 post-infection. At this late stage of the disease, there
was moderate inflammatory cell infiltration in the meninges with an increase in
the number of cells around the vessels (Figure 6.18F). Perivascular cuffing was seen
around the vessels in the hippocampus (Figure 6.18E).
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C D
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Figure 6.18: H & E staining of brain slices for Study 3
Histology slices of the hippocampus and cerebral cortex are shown for an uninfected mouse (A and B), a day 14 post-infection
mouse (C and D) and a day 28 post-infection (E and F). At day 14 post-infection a slight meningitis is seen with cell infiltration
in the cerebral cortex. At day 28 post-infection, a high cell infiltration is seen with perivascular cuffing around the vessels.
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6.5.3 Discussion
This study was used to examine changes in permeability of the BBB during the
early and late stages of the HAT infection. MRI scans were performed before in-
fection, early stage and late stage points of the infection. Significant changes in
the signal intensity of the contrast enhanced images were seen at days 21 and 28
post-infection, which was in the late stage classification of the disease. Changes
were observed in the coefficients from the bi-exponential model fitting at days 21
and 28 post-infection. Although no statistical significance was seen between the
groups at each stage, an increase in the value of the IV fitting coefficient suggested
a drop in the exchange of water across the BBB. This does not fit with the expected
hypothesis that the exchange rate of water across the BBB would increase with BBB
impairment. A suggestion as to why this was seen could be due to the Aquaporin-4
(AQP4) channels not functioning correctly as the disease progresses, resulting in a
change of water crossing the BBB.
Changes in AQP4 have been detailed in a recent study by Ohene (Ohene et al.
2019) where AQP4 knockout mice displayed a significant difference in the exchange
time of water compared to normal animals. A study using DWASL to image AQP4
knockout mice would be welcomed but time constraints restricted this study being
attempted in the limited research period of this thesis. There has been no research
into the AQP4 channels or in water exchange in HAT infected mice. With only minor
changes in the neuropathology of the infected brains, further investigation into any
changes in the AQP4 channels could give more information about how the brain has
been affected by the disease.
Pseudo-permeability maps were produced for all mice. No changes were seen
between the mean permeability of the brain using b = 0 and 75 s/mm2 for all
time points. These results indicate that any changes in water exchange across the
BBB are either too subtle to be detected by DWASL or there is no change in water
exchange even when the BBB is impaired in HAT.
Investigation of inflammation in the brain was undertaken for all mice using his-
tology. H & E staining showed that mild neuroinflammation was present for all
infected time points. The inflammation increased from the early stage of the in-
fected to the late stage, with a higher density of inflammatory cells in the meninges
and perivascular cuffing of the vessels. The highest score was at day 21 post-
infection with a grade of two. At this stage there is only a mild-moderate level of
meningitis and no encephalitis seen. Imaging of a different strain of the infection
producing a higher neuroinflammatory score could potentially see a difference in
the water exchange.
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Values for cerebral blood flow were calculated using the recently quantified mbASL
sequence (Chapter 4 and (Vallatos et al. 2018)). There is no previous literature on
CBF values in HAT, with no expectation on whether changes would be seen. There
was a significant increase in CBF at the end point of infection (day 28) compared
with day 7, 14 and 21 post-infection. There was no significant difference between
day 0 and day 28 post-infection, demonstrating a drop in mean CBF in the brain
during the early stage of the disease. However, this drop did not reach a significant
level. By the end point of the experiment, the CBF increased again and was sig-
nificant higher than the earlier infection time points. The mechanism behind this
is not currently known and further research into these changes are needed. Large
variation is seen in the values across all time points, but values agree with both the
literature and values found for CD-1 mice in Chapter 4. The relationship between
CBF and the IV fraction of signal needs to be further explored. A lower value of
CBF could result in a lower value of IV due to the labelled blood not reaching the
imaging plane during the inversion time. This could result in misleading changes
in BBB permeability. To explore this, an experiment could be designed to examine
the effect of CBF changes on the IV and EV fractions.
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6.6 Study 4: Measuring Changes in Water Content us-
ing the Wet-Dry Method
6.6.1 Methods
As a quantitative measure of the water content in the brain, a pilot study was
designed to compare uninfected and infected mice. A group of n = 8 mice were
separated into two groups of n = 3 control mice (uninfected) and n = 5 trypanosome
infected mice (as in Section 6.2.2.2). The infection progressed naturally until day
21 post-infection when the mice were treated with 40mg/kg diminazene aceturate.
Mice were culled 7 days following treatment using an overdose of anaesthetic. The
brains were excised, weighed, and then placed in an oven at 100°C to dehydrate.
Weights were taken at multiple time points until no further decrease in the weight
of the brain was detected. This final weight was considered as the dry weight.
The percentage water content was calculated using the following equation:
% water content = wet weight− dry weightwet weight × 100 (6.3)
6.6.2 Results
The mean wet weight, mean dry weight and percentage water content from the
infected and control groups taken at the beginning and end of the experiment are
shown in Table 6.17, with the standard error given. Five animals were used for the
infected group and three for the control group.
Day of Infection Wet brain (g) Dry brain (g) Water Content (%) n
Uninfected 0.46 ± 0.008 0.099 ± 0.0009 78.4 ± 0.3 3
28 0.5 ± 0.009 0.11 ± 0.002 77.3 ± 0.3 5
Table 6.17: Brain weights for the water content study
The mean values of wet weight, dry weight and water content for an uninfected and infected group of mice. The brains
were taken after scanning and weighed before being dried to obtain a dry weight.
A significant difference in wet weight between the control and infected brains (p =
0.045) was found, with the mean infected wet weight higher than the mean control
wet weight (Figure 6.19). Furthermore, the weight of the brains once dehydrated
was significantly different (p = 0.003), with the uninfected group mean weight
lower than the infected group mean weight. In contrast, the % water content
was found to be significantly lower (p = 0.044) between the infected group and
the control group, indicating an overall decrease in water content in the infected
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brains.
Figure 6.19: Comparison of wet weights for the water content study
The top plot is a comparison of the wet brain weight between the infected and uninfected group. The brain weight of the
infected group was significantly higher (p< 0.05) than the control group. The bottom plot depicts the water content of the
brain as a % between the wet and dry weight for the infected and control groups. The infected brains weighed significantly
lower than the control group brains (p< 0.05). The median, 25 % and 75 % quartile ranges and maximum and minimum
values are shown.
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6.6.3 Discussion
This study was designed to quantitatively examine the water content of the mouse
brain in non-infected and HAT infected mice. It was expected that the water
content in the HAT infected brains would be higher due to inflammation in the
brain and the impairment of the BBB, which has been shown in late stage HAT. By
using the wet-dry method to measure the percentage of water in the brain, the
late stage HAT group showed a significantly lower water content compared to the
control group. This was opposite to the expected increase in water content. This
compares positively with the DWASL data, which suggested a lower exchange rate
of water across the BBB. The drop in water in the brain could explain why there
was not an increase exchange as expected in the DWASL data. The decrease in
the percentage of water in the brain was only 1 % and this slight variation could
explain why changes in water content could not be measured using DWASL. The
DWASL sequence appears to be not sensitive enough to pick up changes of 1 % in
water exchange in the brain.
The water content in HAT infected mouse brain has not been explored previously.
Astrocyte activation in the CNS is a common feature during the late stage of HAT
(Rodgers, Bradley, et al. 2017; Kennedy and Rodgers 2019). AQP4 water channels
are present on astrocytes therefore an increase in water content of the brain could
be expected in conditions where astrocyte proliferation is present. However, the
opposite was seen in this study, with the water content decreasing. This stresses
the need for further investigation into the expression of AQP4 in the HAT infected
mouse brain. Although BBB impairment is present in this infection, and astrocytes
play a key role in the neuroinflammatory reaction (Section 6.5.2.2, (Rodgers, Mc-
Cabe, et al. 2011; Rodgers, Bradley, et al. 2017)) this is not accompanied by an
increase in water content in the brain. The results of this study indicate that the
BBB impairment may be more complex than initially expected and highlight the
need for further study in this area.
Hong et al. reported that AQP4 measure can be used as a measure of the integrity
of the endothelial cell-astrocyte relationship (Hong et al. 2016). Furthermore, they
showed that in a study on paediatric tumours, there was a disruption in this rela-
tionship along with reduced and disorganised staining of AQP4. In another study on
astrocytes in brain tumours, Nduom et al. demonstrated there was a breakdown in
the astrocyte-endothelial cell interaction where there was BBB disruption, which
was demonstrated by MRI. There was also a diffuse staining of APQ4 but there was
a lack of the normal pattern associated with a healthy and intact BBB (Nduom et al.
2013). Kaur et al. demonstrated an increase in AQP4 on astrocytes in rats after
being exposed to hypoxia (Kaur et al. 2006). An increase in vascular permeability
was shown with this study further confirming a link between AQP4 and BBB impair-
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ment. Overall, this research further suggests that exploration of AQP4 in HAT may
be beneficial to understanding the nature of the BBB impairment.
6.7 Conclusion
This chapter outlined the use of diffusion-weighted arterial spin labelling to mea-
sure the permeability of the blood brain barrier in the HAT infected mouse. Al-
though the pseudo-permeability of the brain had been examined at both early and
late stage of the trypanosome infection, no significant changes were seen between
the infection time-points. This work presents evidence that although a contrast
agent can cross the barrier demonstrating there is barrier impairment, the perme-
ability of the barrier to water may not have changed as was originally expected. It
also shows that the complexity of the trypanosome infection, with the impairment
of the barrier may not be as simple as was initially expected. More work is needed
to explain the lack of changes seen from the data in this chapter. Changes in the
AQP4 channels may explain the significant change in water content in the infected
brains and this merits further exploration.
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Chapter 7
Measuring Serial Changes in
Splenomegaly in the Trypanosome
Infected Mouse
7.1 Introduction
Splenomegaly is a common clinical sign associated with trypanosome infection in
both man and animals. This study is the first to image splenomegaly serially in a
mouse model of trypanosome infection. Two hypothesis were made:
• MRI can be used to follow the development of splenomegaly as the trypanosome
infection progresses.
• Haematological changes will develop alongside the splenomegaly.
Studies were performed to examine both hypothesis. For the first hypothesis,
groups of infected and uninfected mice were serially scanned to assess the spleen
volume at five MR scan points. For the second hypothesis, blood samples were
taken after each scanning session for both groups, along with histology at the end
point of both studies.
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7.2 Methodology
7.2.1 Animals, Infection and Sampling
A group of n = 6 female CD-1 mice, weight = 35 ± 3g were infected as outline in
Section 6.2.3.2. Each mouse was scanned pre-infection and at day 7, 14, 21 and
28 post-infection. A second group of n = 5 CD-1 mice with weight = 34 ± 4g were
used as a control. These mice were not infected but were scanned at the same
time points as the infected mice.
A 100µL blood sample was taken from each mouse at each scan day to assess haema-
tological parameters. The blood was obtained by puncturing the tail vein and the
sample collected in a hepranised microvette collection vial and immediately taken
to the University of Glasgow Veterinary Diagnostic Service Histopathology Labora-
tory for haematological analysis detailed below. Due to clotting some samples
were unsuitable for analysis (Table 7.1).
Following the final scan the mice were sacrificed, exsanguinated by cardiac punc-
ture and the spleens removed. The spleens were weighed and fixed in neutral
buffered formalin to allow histopathological assessment (previously described in
Section 6.2.5). H & E stains were prepared to assess the histopathology, in addi-
tion to special stains.
Day of Infection Infected Uninfected
Uninfected 3 3 3 3 3 3 3 3 3 3 3
7 ×××××× 3 3 3 3 3
14 ×××××× ×××××
21 ×××××× 3 3 3 3 3
28 3 3 3 3 3 3 3 3 3 3 3
Table 7.1: Blood samples obtained from mice in the study
Although blood was successfully obtained from all animals, some samples clotted which resulted in those samples not being
suitable for processing. Successful blood counts are indicated by 3, whilst clotted samples are indicated as ×.
Following haematological analysis, one mouse from the infected group was re-
moved from the study results due to the presence of anaemia before infection had
taken place.
7.2.2 MRI and Animal Setup
A custom built cradle was designed for full body imaging of the mouse using a 4-
channel Bruker rat head coil (Figure 7.1). The coil was placed upside down and
secured in the cradle with a movable section above to lay the mouse in. The mouse
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was positioned so that the spleen would be above one of the four receiver coils for
maximum signal. The cradle was designed so that anaesthetic and a water jacket
could be used as described previously (Section 4.5.1).
Coil Water Jacket
Anaesthetic
Coil
Figure 7.1: Cradle used in splenomegaly study
A custom made cradle was designed for full body mouse imaging. The cradle housed a 4-channel Bruker rat head coil in
which the mouse could be positioned above the desired coil. The cradle was designed so that the animal could be moved
for adjustment of positioning to allow optimal scanning.
For each animal, a T1 and T2 weighted whole body scan was performed, with the
use of respiratory gating. T1 FLASH parameters were as follows: TE = 2.534ms, TR
= 600ms, NA = 4, flip angle = 30°, hermite pulse length 0.9ms. T2 RARE parame-
ters were as follows: TE = 13.75ms, effective TE = 55ms, RARE Factor = 8, TR =
8000ms, NA = 1. For both T1 and T2: FOV = 5×5cm. Matrix size = 200×200 with
a resolution of 250 µm/pixel. Slice thickness = 1mm with 30 slices taken covering
the whole abdomen. Scan time was approximately 8 minutes for the T1 scan and
approximately 4 minutes for the T2 scan. Total scan time was less than 20 minutes
including a preliminary scan to ensure optimal positioning of the mouse.
7.2.3 Image Analysis
In-house MATLAB (Mathworks, Inc.) code was written to analyse the MR images.
Scans were imported into MATLAB in a DICOM format. For each T1 and T2 image set,
all images were examined and if determined to include the spleen, an ROI was hand
drawn and saved. The number of voxels in each spleen ROI were summed together
giving a total number of voxels for the full spleen. The total voxel number was
multiplied by the volume of one slice (0.25×0.25×1mm) to give the total volume
of the spleen from MRI in mm3.
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7.2.3.1 Statistics
MRI data and haematology results were statistically analysed using Minitab 17
(Minitab Inc.). The general linear model and ANOVA were used to compare the
groups while Tukey’s multiple range comparison test was employed to identify dif-
ferences between the groups. P-values of <5% were considered as statistically
significant. Means, standard errors (SE) and 95% confidence intervals (CI) are pro-
vided as summary statistics.
7.3 Results
7.3.1 MRI
7.3.1.1 Serial MRI of Splenomegaly
The set of images produced for each mouse showed the spleen in its entirety, along
with the kidneys, stomach, bladder and other organs, depending on the position
of the mouse in the cradle. The spleen cross-section in each 1mm slice appeared
triangular in shape in the scans taken before infection. Once the animals were
infected, the increase in the size of the spleen was clearly visible in the MR images
from day 7 post-infection onward. The spleen size, shape and position appeared
different for each mouse. Figure 7.2 demonstrates one slice of the body from each
T1 data set for a single mouse. As the spleen increased in size, it changed shape
and displacement of other organs was seen. On clinical examination, the enlarged
spleen could be observed from day 14 post-infection around the abdomen area
of the mouse. In Appendix C, a full set of images from a mouse at day 21 post-
infection is shown.
A B C D E
Figure 7.2: Spleen in one infected animal
One 1mm slice from each MR data set is shown for an infected mouse which had been serially scanned at uninfected (A),
day 7 (B), day 14 (C), day 21 (D) and day 28 (E) post-infection. The spleen enlarged from as early as day 7 post-infection,
increasing in size throughout the infection. The spleen is highlighted in pink. The kidney was used to estimate the same
spatial position in the body for each image used for this demonstration.
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For each mouse, the spleen volume from the MR scans from each session was cal-
culated from the T1 and T2 scans. The total volume from each scan type was
compared, with no statistical significance seen between the data sets (p >0.05) of
the infected animals. Following this, the T1 scan data sets were used for statistical
analysis.
The mean volume of the spleen from the T1 image set was compared between
each scan point (Table 7.2). There was a significant difference in the mean spleen
volume between the first scan point (uninfected) and all infected scan points (p <
0.005). The mean volume was plotted to compare the difference at each scan point
(Figure 7.3). A sharp increase in spleen volume was seen between the uninfected
(82 ± 12 mm3) and day 7 post-infection (627 ± 14 mm3 p = 0.005 CI = [144, 946])
time point. This increase continued until day 21 post-infection (1783 ± 108 mm3),
when the disease had entered the late stage. There was no significant difference
between the mean volume at day 28 post-infection (1483 ± 121 mm3) compared
to day 14 (1339 ± 135 mm3) and day 21 post-infection (p> 0.05).
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Figure 7.3: Volume of spleen at each infection point
The mean volume of the spleen from each scanning session is plotted in mm3. Significance is denoted by groups not sharing
a letter. There was a large increase in the mean spleen volume from the first scan point. There was no significant difference
between day 21 and 28 post-infection or day 14 and 28 post-infection. Error bars are denoted as the standard error and n
= 5 mice were used.
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7.3.1.2 Serial MRI Imaging of Uninfected Mice
Examination of the MR images at all scan points for the uninfected mice showed
the expected triangular cross-section spleen shape. No qualitative changes were
seen in the MR images throughout the repeated scanning sessions. For a single
mouse, one image is shown from the T2 data set (Figure 7.4). The shape and size
of the spleen was maintained across the five scan points. In Appendix C, a full set
of images of the spleen for an uninfected mouse are shown.
A B C D E
Figure 7.4: Spleen images for one mouse in the uninfected group
The spleen in the uninfected group was examined by MR scanning at five scan points corresponding to those in the infected
group; uninfected (A), day 7 (B), day 14 (C), day 21 (D) and day 28 (E). The spleen size and shape was maintained throughout
the study. One mouse is shown from the T2 data set with the spleen highlighted in pink.
The mean volume of the spleen calculated from the T1 and T2 images showed no
significant difference from each other (p>0.05). Comparison of the mean volume
of the spleen, calculated from the T1 images, for the uninfected mice showed no
significant difference (p>0.05) between any of the scan points (Table 7.3). The
range of mean spleen volumes from the uninfected mice was 133 ± 6 mm3 at day
0 to 137 ± 6 mm3 at day 28. The mean volume was plotted (Figure 7.5) with only
a small variation in the mean spleen volume seen across all scan points.
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Figure 7.5: The volume of the spleen for the uninfected mice at each scan point
Only a small variation in the mean volume of the spleen calculated from each scanning session. The average volume in mm3
was 133 ± 6, 137 ± 7, 126 ± 8, 133 ± 12 and 137 ± 6 for the scan points 0, 7, 14, 21 and 28. There was no significant
difference between any of the groups. This is denoted by each group sharing the same letter. n = 5 mice are used and error
bars denote the standard error.
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7.3.2 Haematology
For haematology analysis, the following parameters were examined: red blood cell
(RBC) count, haemoglobin (Hb), haematocrit (HCT %), white blood cells (WBC),
neutrophils, lymphocytes and monocytes. Table 7.4 displays the mean cell counts
for each scan point in infected or uninfected mice, where blood analysis was possi-
ble. The normal range of values seen in the literature is also displayed (O’Connell
et al. 2015; Weiss et al. 2010).
7.3.2.1 Infected mice
A comparison was made between the haematological parameters measured at the
first scan point (before infection) and day 28 post-infection. There was a significant
difference (p<0.05) for the following counts: RBC, Hb and HCT % with reduced
levels seen at the later time point. In contrast, there was a significant increase
in the number of neutrophils (1.65 ± 0.04 ×103/µL) and monocytes (0.61 ± 0.2
×103/µL) compared to the cell count at day 0 (p = 0.024 [2.1 ×103, 2.2 ×104];
p = 0.049 [1.2, 1.1 ×103]). There was no change in the white blood cell count
between the two points, with values of (5.4 ± 1 ×103/µL) and (5.6 ± 1 ×103/µL)
at day 0 and day 28 respectively. In comparison to the normal ranges shown in
the literature, the red blood cell count, haemaglobin and haematocrit at day 28
post-infection were lower than the expected values.
7.3.2.2 Uninfected Mice
For the uninfected mice, the only blood samples that clotted were for the day
14 scan point. For the RBC count, there was a significant difference (p < 0.05)
between the day 0 (8.2 ± 0.7 ×106/µL) and day 7 (10.5 ± 0.4 ×106/µL) scan
point, and the day 0 and day 21 (10.1 ± 0.2 ×106/µL) scan point. All the values
were, however, within the normal ranges. A similar pattern was seen for the value
of haemoglobin, with a significant increase between the day 0 (13.4 ± 1.1 g/dl)
and day 7 (16 ± 0.2 g/dl) scan point, but all values were within the normal range.
For HCT, a significant increase (p < 0.05) was found at day 7 (38.8 ± 3 %) and day
21 (48.5 ± 2 %) compared to the first scan point. At day 28 the value of HCT (38
± 1 %) had decreased back to a similar value at day 0.
At the day 28 scan point, the WBC count (2.0 ± 0.4 ×103/µL) had significantly
decreased (p < 0.05) compared to all the other scan points. There was no change
in the number of neutrophils, although the lymphocyte count did show a significant
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difference between day 7 (9.1 ± 2 ×103/µL) and day 28 (1.7 ± 0.4 ×103/µL), and
also between day 21 (9.1 ± 2 ×103/µL) and day 28.
7.3.2.3 Comparison Between Infected and Uninfected Cohorts
The cell counts for the day 0 pre-infection group were similar to those seen in
the uninfected cohort (p > 0.05). For the last scan point (day 28 post-infection),
there was a significant difference between all the cell counts (p < 0.05) apart from
lymphocytes. For the infected mice, a significant decrease in the RBC, Hb and HCT
levels were seen, whereas there was a significant increase in the WBC count and
neutrophils. There was no change in lymphocytes. The WBC count was still within
the normal range for a mouse, with the RBC, Hb and HCT values below the normal
range observed in the literature.
7.3.3 Spleen: Gross Anatomy and Histology
7.3.3.1 Gross Findings
The spleens were removed at the end of the study for the infected group (Figure
7.6). The average spleen weight was 1.51 ± 0.04g making the spleen 4.1% of the
mean body weight (37 ± 5g). The mean spleen volume calculated from the MR
images was 1.48 ± 0.3 mm3. This was very close to the actual weight and no
significant difference was found between the volume from the MR images or the
weight of the spleens (p> 0.05). The average spleen weight of the uninfected mice
was 0.094 ± 0.007g and constituted 0.27% of the body weight (35 ± 2g) at the end
of the experiment (Figure 7.6). The mean volume from the MR images was 0.13
± 0.01 mm3 and this was significantly higher than the actual weight (p = 0.002).
This may be a factor of the much smaller range of spleen size found in this group
in both actual weight and extrapolated volume.
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Uninfected Infected
Figure 7.6: Excised spleens for the infected and uninfected mice
Spleens taken from mice in both the infected and uninfected group were photographed using the same parameters to
examine changes between the two groups. The infected spleens are clearly larger than the uninfected spleens, being on
average double the length.
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7.3.3.2 Histopathology
Histopathological analysis was carried out on the spleens excised after the last
scan point (day 28), for both infected and uninfected groups of mice.
In the uninfected animals, the H & E staining (Figure 7.7A) demonstrated the nor-
mal architecture of the spleen, with a clear distinction seen between the white
pulp and the red pulp. Numerous T cells were found within the PALS surrounding
the central arteries with smaller numbers extending into the marginal zone and
the red pulp. Large numbers of B cells were present in the follicles, the marginal
zone and spreading into the surrounding red pulp.
In the infected mice, H & E staining showed many pathological changes in the
spleen (Figure 7.7D) with an obvious breakdown in the distinction between the red
pulp and the white pulp. The central arteries were still visible, but the follicles had
become indistinct with more diffuse margins. Although numerous T cells could still
be found surrounding the central arteries, they also appeared to be more diffusely
spread throughout the tissue (Figure 7.7E) compared to the pattern seen in the
uninfected mice. The effect of trypanosome infection on the presence of B cells
in the spleen was much more overt (Figure 7.7F) with only small numbers of B cells
detected in the follicle and the marginal zone and an almost complete absence of
any B cells in the red pulp.
156
AB
C
D
E
F
Uninfected Infected
H
&
E
PA
X
5 
(B
 c
el
ls
)
C
D
3 
(T
 c
el
ls
)
Figure 7.7: Histology of the spleen
Three stains; H & E, CD3 (T cell marker) and Pax5 (B cell marker) are shown for an uninfected mouse (left) and an infected
mouse (right). There was a clear breakdown in the architecture of the spleen in the infected animal, with the T cells
becoming more diffuse and a distinct lack of B cells. Images are shown at a ×40 magnification.
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7.4 Discussion
Splenomegaly is a known symptom of trypanosome infection in humans and an-
imals, therefore the aim of this study was to explore the development of the
splenomegaly in a murine model of HAT over the course of infection. Splenomegaly
has been explored in rodents previously, but this has been achieved by examining
the spleen invasively through histology. This study for the first time, uses a non-
invasive imaging approach to explore splenomegaly development through the early
and late stages of HAT in the same group of mice.
7.4.1 Infected mice
7.4.1.1 MRI
The infected mice were scanned at weekly intervals from day 0, before infection,
until day 28 post-infection. The splenomegaly was obvious in both the T1 and
T2 images from the MRI beginning at day 7 post-infection. At this early stage
of infection the splenomegaly could not be detected on clinical examination of
the mouse but the MRI indicated that spleen enlargement was already present.
Two different measurements were made of the spleen using a T1 and T2 weighted
sequence with the spleen volume calculated from both image sets. As expected,
comparison of the average spleen volume was very similar from both sequences,
therefore further analysis was performed using only the T1 data set. All infected
animals showed splenomegaly in the MR images. Although the rate at which the
spleen size increased varied, the same trend was seen for all mice.
The spleen volume was significantly lower when comparing the first scan point
day 0 (before infection), with day 7, 14, 21 and 28 post-infection in the infected
animals. Compared to the volume at day 0, an average increase of ∼ 2200% was
observed by day 21 post-infection, when the infection had entered the late stage.
There was no significant difference between day 14 and day 28 post-infection and
day 21 and day 28 post-infection, however the spleen continued to enlarge be-
tween day 14 and day 21 post-infection. This provides new insights into the chang-
ing of the spleen throughout the whole infection, which has not been measured
serially before and shows that spleen enlargement occurs quickly after infection.
This however is not apparent on clinical examination. Amole et al. reported that
splenomegaly occurred 8 days after infection with T. brucei, with a splenic weight
of 0.8g, and a weight of 0.85g after 30 days of infection. This increase is smaller
than seen in this study, which may be due to a difference in infections. Overall,
this reflects the change in spleen volume that was seen in this study, with a large
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increase in weight at an early infection point.
At the end of the study, the volume of the spleen from the MR images (1.48 ± 0.3
mm3) was not significantly different to the actual weight of the spleens (1.51 ±
0.04g). Overall, this demonstrates that repeated MR scanning is a viable technique
for accurately measuring changes in the volume of the spleen.
7.4.1.2 Haematology and Histology
A small volume of blood was taken after each scanning session. For serial bleeding
only 10% of the total blood volume of the mouse could be taken at each scan point,
with 100 µL being taken for each mouse. Unfortunately some blood samples clot-
ting prior to analysis. Although haematological analysis was successful at the first
and last scan point of the study (before infection and day 28 post-infection), all re-
sults between these scan points clotted. This prevented any correlation between
changes in spleen size and haematological parameters from being compared fur-
ther. In the infected group there was a significant reduction in the red blood cell
count, haemoglobin and haematocrit counts for day 28 post-infection, compared
to the uninfected point. This drop indicated that the mice were suffering from
anaemia, which has been noted in other studies in trypanosome infection (Anosa
et al. 1984). Amole et al. also noted anaemia in both the acute and chronic stages
of their mice infected with T. brucei (Amole et al. 1982). In the present study,
all values of RBC count, Hb and HCT were considered outside of the normal range
of cell counts seen in mice. There was a significant increase in the number of
neutrophils and monocytes, however, the total white blood cell count was not sig-
nificantly different at the end scan point. Although no changes were detected in
the total number of lymphocytes, further analysis, where the number of T cells and
B cells are examined would potentially show a difference between the uninfected
and infected data, since an almost complete lack of B-cells and a change in the
distribution of T cells was detected in the spleen on histological examination.
The spleens were removed at the end of the study to compare to the MR im-
ages (Figure 7.6). The infected spleens appeared grossly enlarged confirming the
splenomegaly seen in the MRI. Histology showed that the distinction between the
red pulp and white had pulp had become indistinct in the infected mice. A de-
creased level of T cells was apparent with the cells more diffusely spread through-
out the tissue and fewer were located around the central arteries. However, the
most overt change was seen in the pattern of B cell staining, with an almost com-
plete loss of this cell type in the spleen. When B cells come into contact with
an antigen they transform into plasma cells and this may explain the reduced B
cell staining in the infected group. Although plasma cells were apparent in the H
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& E stained spleen, special stains to enhance their detection were unsuccessful.
Other trypanosome studies have found similar results. Morrison et al. reported a
drop in lymphocytes in the spleen, along with cells mixing between the red and
white pulp following the infection of mice with Trypanosoma congolense (Morrison
et al. 1981). Murray et al. (Murray et al. 1974b) reported similar findings in mice
infected with T. brucei an increase in mature plasma cells in the white pulp of
infected spleens with the white pulp extending into the red pulp.
7.4.2 Uninfected Mice
7.4.2.1 MRI
The average volume at all the scan points for the uninfected mice remained similar
throughout the study. There was a minimal change of approximately one percent
between the volumes, in contrast to the 2200% increase seen in the infected an-
imals. There was no obvious change in the visual size or shape of the spleen on
the images. These findings confirm that the procedures associated with serial MRI
and blood sampling do not precipitate changes in the volume of the spleen and
indicate that the splenomegaly noted in the infected group is attributable to the
trypanosome infection.
7.4.2.2 Haematology and Histology
All cell counts for the uninfected mice at the first scan point were within the normal
range. Blood samples were successfully analysed for four of the five scan points in
the uninfected mice. Only the blood collected at day 14 could not be analysed due
to clotting. Changes in cell counts can be expected between the scan points from
natural fluctuations. In the RBC count, Hb concentration and HCT, changes were
detected between the various time points, but all values fell within the normal
ranges, again confirming serial blood sampling had a minimal impact on the health
of the mice.
The histology images compared favourably with the literature for non-infected
mice. A clear distinction was seen between the red pulp and white pulp, with T
cells and B cells seen in the relevant staining. Estimation of the volume of the
spleen was over-estimated using MR for the uninfected mice. This is believed to
be due to the small size of the uninfected spleens on the MR images with the edges
of the spleen over estimated when the ROI was selected.
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7.4.3 Comparison of Infected and Uninfected Mice
The two studies can not be compared directly as the two groups of mice had a
significantly different spleen volume at the beginning of each study. However, as
there was no significant difference between any of the volumes measured at the
various time points in the uninfected group, any changes in the volume of the
spleen seen in the infected animals are attributed to the trypanosome infection,
and not from the MR scanning or sampling.
Comparison of the haematology results between the infected and uninfected groups
at day 28 post-infection saw the same changes as seen between the first (unin-
fected) and last scan points in the infected mice, with a significant reduction in
the RBC count, Hb and HCT% and a significant increase in neutrophils and mono-
cytes in the day 28 post-infection mice. This demonstrated that changes that
occurred in the infected mice at the end point of the study, were not a result of
serial bleeding or repeated anaesthetics.
Comparison between the weight of the spleen showed the infected spleens to be an
average of 16 times bigger compared to the spleens from the uninfected animals.
Similar results have been reported in the literature, where Anosa et al. measured
a 25 fold increase in spleen weight, with a rise from 0.026g to 0.673g, in deer
mice (Anosa et al. 1984). An increase in spleen size of up to 30 times was noted by
Murray et al. who attributed the change to a marked rise in plasma cell hyperplasia
(Murray et al. 1974a). Furthermore, an increase of greater than 20 times in spleen
weight was measured by Morrison et al. who measured the weight between 4 and
24 days post-infection (Morrison et al. 1981). They also found that the spleen
weight remained constant after this point. This suggests that if the infected group
had continued, there may not have been any further significant changes in the
weight of the spleen since no significant changes in volume were detected between
day 21 and day 28 post-infection. An increase from 0.23g to 0.85g in mean spleen
weight was reported by Amole et al. in mice infected with T. brucei, where the
percentage size of the spleen compared to the body weight had changed from 0.8%
to 2.4% (Amole et al. 1982). This was smaller than the change seen in this study,
which saw an increase from 0.27 % to 4.1 %.
7.5 Conclusion
This study has been able to show successfully for the first time, the progression of
splenomegaly in trypanosome infected mice by using a combination of MRI, haema-
tology and histology. A significant increase in the spleen size was shown from MR
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images until day 21 post-infection. The spleen did not continue to increase in size
past day 21 post-infection, demonstrating new information about splenomegaly
in trypanosome infections. This suggests that expansion of the spleen tissue is
finite in this infection model. Analysis of haematology results revealed the in-
fected animals developed anaemia at the end point of the study with a marked
increase in neutrophils and monocytes. Histology sections of the spleen from in-
fected and uninfected mice showed a clear loss of architecture of the white and
red pulp in the infected mice and with a marked reduction in T cells and B cells.
The MR findings were confirmed by the weight of the infected spleen comparing
favourably with the MR images. This study provides new insights into the devel-
opment of splenomegaly in HAT and indicates that further research is required
to understand why the enlargement of the spleen appears to plateau at day 21
post-infection. Possible further studies would include an in depth haematological
analysis and more infection points for comparison. Following this, serial MRI could
be used to image the effects of trypanosomal drug treatment in the spleen, and
monitor changes in the spleen. This technique could also potentially be used to
image microhaemorrhages or congestion in the spleen using serial MRI.
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Chapter 8
Conclusion
This thesis was focused on the development of a non-invasive MR sequence, dif-
fusion weighted ASL, that would be sensitive to changes in water permeability in
the rodent brain. By the quantification of a new high SNR ASL sequence, multiple
boli ASL, and multiple developmental experiments, DWASL was shown to be sensi-
tive to changes in water exchange in the mouse brain. The DWASL sequence was
applied to a biological model where blood brain barrier impairment had been iden-
tified previously. This approach investigated whether changes in water exchange
could be detected prior to the onset of the BBB damage that was known to occur
in the infection timeline. When DWASL was applied, no changes in water exchange
were seen during the late stage of the infection, while impairment can be seen
using a contemporary contrast agent approach. Although these findings were in
contrast with the expected outcome, the research provided a new insight into BBB
impairment in HAT.
The development of a quantitative model for mbASL means the sequence can be
used to quantify cerebral blood flow. As ASL sequences are inherently low in SNR,
the increase in SNR compared to FAIR makes the sequence a viable alternative in
pre-clinical imaging. This research highlights the importance of using an appro-
priate value for the number of pulses and labelling slab thickness, not just for
different rodent species, but for different strains. This was clearly seen in C57
and CD-1 mice for example, where the CD-1 mice needed more labelling pulses to
reach a signal plateau compared to the C57 mice, as they were larger. The com-
parison of various labelling thicknesses demonstrates that there is a limited range
that can be used for optimal scanning, but also shows the versatility of sequence
to adapt, for example, to the size of the animal being scanned.
The modification of the Buxton kinetic model for ASL to incorporate the multi-
ple pulses, labelling slab thickness and varying distance between the imaging and
labelling slab means the model does not need to make large assumptions or simpli-
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fications, which have been seen in the literature previously when calculating CBF.
Although some assumptions still remain, for example a constant blood velocity and
an infinitely long tube for a capillary, the model predicts value of CBF which agree
with the current literature. A quantitative comparison of mbASL to PASL and pCASL
sequences on the same group of rodents, along with implementation at other pre-
clinical MR sites would be a logical extension to the investigations completed in
the current study. The mbASL sequence was shown in Chapter 6, to be sensitive
to changes in CBF during the HAT infection. This suggests that the application of
mbASL to other neurological diseases such as cancer or stroke, where changes in
CBF are known to be important in the disease pathology, may be favourable.
At the present moment, the mbASL sequence is designed primarily for pre-clinical
imaging, and has currently only been developed using rodents. The adaption of
mbASL to be used in a clinical setting is desirable for a number of reasons. mbASL
is non-invasive, as with other ASL sequences, making ASL safer for the patient than
other invasive techniques, such as DCE-MRI. Although comparison with pCASL is still
needed for mbASL, it has a higher SNR and signal than FAIR, which is important in
both clinical and pre-clinical imaging, due the inherently low SNR associated with
ASL. Furthermore, by altering the thickness of the labelling slab and the number
of pulses used, it may be possible to adapt the sequence to suit the needs of each
patient, due to the SAR levels associated with multiple adiabatic inversion pulses.
More research is needed into the feasibility of transferring this sequence to the
clinical setting. However, this may not be an issue with the large labelling slabs
in humans, hence mbASL could be a a robust sequence in the future in both pre-
clinical and clinical perfusion imaging.
The combination of mbASL and diffusion weighted ASL has resulted in the first
successful research to demonstrate changes in water exchange in the mouse brain
using DWASL. Previous work in this area has only been performed in humans and
rats. Although the DWASL sequence has been applied in models of sleep apnea and
ischaemic stroke, the sequence is inherently low in signal. The current project
used mbASL to provide a higher SNR than would be seen using FAIR. Multiple de-
velopment experiments were performed to make the sequence user friendly and
facilitate longer scanning sessions, where physiological effects would previously
lead to anomalies.
The DWASL sequence was shown to be sensitive to changes in water exchange in the
mouse brain, providing a proof of concept of the sequence, comparable to results
seen previously in human and rat studies. To try and improve the signal seen at
low b-values, the DWASL sequence was altered to incorporate a bipolar gradient
pair. Although this research did not show any improvement of the DWASL signal
using this new sequence, it does warrant further research using a larger study of
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smaller b-values.
This validation of DWASL in mice is extremely important for pre-clinical imaging,
as having such a MR sequence available opens research opportunities into disease
models that are used primarily in mice but not rats. It also provides a non-invasive
method to examine changes in BBB permeability, where using the current invasive
gold-standard contrast agent may not be suitable. Furthermore, the sequence is
more sensitive than a contrast agent, providing opportunities to examine diseases
such as cancer and stroke in earlier stages.
The application of DWASL to human African trypanosomiasis is the first research
to examine the permeability of the BBB throughout this infection without using
a contrast agent. With BBB impairment already shown in both clinical and pre-
clinical cases using CE-MRI, this research has demonstrated that the impairment of
the BBB is more complex than first expected. Multiple experiments were under-
taken to examine the permeability of the BBB during the early and late stage of
the HAT infection. These experiments confirmed that BBB impairment can be seen
in the late stage of infection, but demonstrated there were no significant changes
in water exchange at any point in the infection timeline. This result highlights the
complexity of the mechanisms behind BBB impairment in infectious diseases and
warrants further research in this area.
Astrocyte activation has been demonstrated in trypanosome infections. Hence,
increased water exchange was expected due to the assumed increase in expres-
sion of AQP4 proteins on the astrocyte end-feet, which is known to facilitate water
exchange into the tissue. However, this research found no significant difference
in the pseudo-permeability of the BBB throughout the early and late stage of in-
fection and provides an opportunity for further research into AQP4 during the HAT
infection. As the method of transport across the BBB for trypanosomes is currently
unclear, this research demonstrates that more exploration of the role of astro-
cytes and the mechanisms resulting in impairment of the BBB would be useful in
this model. A final study on the BBB in HAT using the wet-dry method saw a sig-
nificant decrease in the water content in the infected mouse brains compared to
non-infection mice. This further provides evidence that BBB impairment can not
be easily understood in HAT. Overall this research has opened up more questions
about the process of BBB impairment in HAT and warrants further research, using
both MRI and histological approaches.
The limited research and application of MR imaging in HAT was a motivating factor
in the exploration of the spleen in HAT infected mice in Chapter 7. This study is
the first to apply MR techniques to examine the spleen over the course of infection
in individual animals using a serial study. Although splenomegaly was a recognised
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symptom of HAT, there was no research looking at how the enlargement develops
over the course of infection individually, or any research into splenomegaly in the
GVR35 strain. Overall, it was shown that there is a significant increase in the
spleen size during the early stage of infection before external signs of splenomegaly
occur. The spleen continued to increase in size up to day 21 post-infection, but
then decreased, with no significant difference in size between day 14 and 28 post-
infection. Hence, this provides new insights into how the spleen responds to the
HAT infection. Most studies into splenomegaly in HAT compare limited time points,
making this study extremely useful in tracking the changes occurring in the spleen.
This study is also the first to look at splenomegaly in the GVR35 strain, providing
more information about this strain of trypanosome which may provide researchers
with further insight into the pathology of this infection in the future.
Furthermore, this research provides HAT researchers with a non-invasive serial
method to explore not just splenomegaly but other organs such as the kidneys,
liver and heart. Further research into this area would be beneficial, especially
when looking at drug treatments. It also provides evidence of early splenomegaly
before other symptoms, which could help in a clinical setting, where symptoms for
HAT are non-specific.
Overall, this project has developed and adapted novel methodologies that pro-
vide valuable new tools to facilitate further research in the investigation of the
pathogenesis of trypanosomiasis. In addition, many of the sequences developed
could be applied to investigate other conditions of novel therapeutic approaches
in a pre-clinical setting. Furthermore, it is possible that the approaches could be
translated to a clinical setting allowing improved, safer and non-invasive disease
investigation.
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Appendix A
Classical Derivation of the Larmor
Equation
If a magnetic moment µ is placed in a magnetic field, it will experience a torque
τ equal to:
t = m× B (A.1)
And will precess around the axis of the magnetic field, where the change in angular
momentum is equal to:
DL = Lsin(θ)wDt (A.2)
for a small time Dt with w the angular velocity, and Lsinθ the radius from the
magnetic field axis. The rate of change of angular momentum (which is equivalent
to torque) can be written as:
dL
dt = Lsin(θ)w (A.3)
By combining A.2 and A.3, the following relationship occurs
(where m = µsinθ):
µB sin(θ) = wLsin(θ) (A.4)
Where the Larmor equation is:
w0 =
µ
LB = γB0 (A.5)
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Appendix B
Recipe for solutions in HAT Infection
Phosphate buffered saline (PBS)
Di-sodium hydrogen phosphate (anhydrous) 1.48g
Potassium di-hydrogen pohsphate (anhydrous) 0.43g
Sodium chloride 7.2g
Add the above to 800ml of distilled water with the solution stirred constantly.
Adjust to pH to a value of 7.4 and then add distilled water untill the volume is one
litre.
Phosphate glucose buffer saline (PGBS)
Stock buffer (containing no glucose
Di-sodium hydrogen phosphate (anhydrous) 13.48g
Potassium di-hydrogen pohsphate (anhydrous) 0.622g
Sodium chloride 4.25g
Dissolve the above in one litre of distilled water and adjust the pH to 8.0.
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Working solution (containing glucose)
Dilute the stock buffer in a ratio of 6:4 distilled water and add 15g/l of glucose
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Appendix C
MR Images of the Spleen
Figure C.1: T2 images of the spleen for one healthy animal
For one healthy mouse, all slices containing the spleen are shown from a T2 weighted scan. The typical triangular cross
section is seen.
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Figure C.2: T1 images of the spleen for one infected animal
For one infected mouse, all slices containing the spleen are shown from a T1 weighted scan. The splenomegaly is clear
throughout all the images, with an elongated shape and displacement of other organs seen throughout.
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